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ABSTRACT 
In the context of the limited availability of antiretroviral drugs for young children and 
the emergence of drug resistance, excellent adherence is required to achieve an undetectable 
viral load (VL) and an elevated CD4 count. However, characteristics of the caregiver, child, 
regimen, clinic and social context affect clinic attendance and medication-taking, both of 
which constitute adherent behaviour. In this thesis, through the lens of Bronfenbrenner’s 
Ecological Systems Theory (EST), I explored the barriers to and facilitators of ART 
administration to children younger than five years in a rural area of South Africa with a high 
prevalence of HIV.  
The research was conducted in two phases. Phase 1 included nine interviews and three 
focus groups to determine how doctors, nurses, counsellors, traditional healers and caregivers 
understood the barriers and facilitators to ART adherence among children residing in rural 
South Africa. The data were transcribed, translated into English from isiZulu where 
necessary, and coded using ATLAS.ti version 7. At the level of the microsystem, the 
unpalatability of medication and large volumes of medication were problematic for young 
children. The characteristics of the caregivers that contribute to poor adherence were absent 
mothers, grandmothers as caregivers and denial of HIV amongst fathers. At the level of the 
mesosystem, language barriers and inconsistent attendance of caregivers to monthly clinic 
visits were factors affecting adherence. At the level of the exosystem, the nature of adherence 
counselling and training of counsellors were the most problematic features influencing 
adherence. At the level of the macrosystem, the effects of food insecurity and the controversy 
surrounding the use of traditional medicines were most salient. I concluded Phase 1 of the 
thesis by recommending increased supervision and regular training amongst lay adherence 
counsellors, as well as regular monitoring of the persons attending the clinic on the child’s 
behalf. 
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In Phase 2, I purposively recruited 33 caregiver-child dyads from the Hlabisa HIV 
Treatment and Care Programme database. Children were divided into three groups based on 
their VL at the time of recruitment. Children with a VL ≥ 400cps/ml were grouped as 
unsuppressed (n=11); children with a VL ≤400 cps/ml were grouped as suppressed (n=12); 
and children with no VL data were grouped as newly-initiated (n=10). I observed caregiver-
child dyads at their monthly adherence counselling visit to document information they 
received from adherence counsellors. I then visited caregiver-child dyads at their households 
to document, by means of video-recording, how treatment was administered to the child. 
Observational notes and video-recordings were entered into ATLAS.ti v 7 and analysed 
thematically.  
On average counselling sessions lasted 8.1 minutes (range 2 - 18). Little behaviour 
change counselling was conducted, even in instances where children were doing poorly on 
treatment. Thematic video analysis indicated five key areas of caregiver practices that may 
contribute to poor outcomes. These were context-related, medication-related, caregiver-
related, and child-related factors and interactions between caregiver and child. Although the 
majority of children in this sample took their medicine successfully, the way in which 
medications were prepared and administered by their caregivers was problematic. I concluded 
Phase 2 of the thesis by recommending that with emerging drug resistance, efforts are needed 
to carefully monitor caregiver knowledge of treatment administration by counsellors during 
monthly clinic visits.  
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OPSOMMING 
Binne die konteks van die beperkte beskikbaarheid van antiretrovirale behandeling vir 
jong kinders en die verskynsel van weerstand teen middele is uitstekende navolging nodig om 
by ’n onwaarneembare virale lading (VL) en ’n verhoogde CD4-telling uit te kom. Die 
kenmerke van die versorger, kind, regimen, kliniek en die sosiale konteks affekteer egter 
kliniekbywoning en die neem van medikasie, wat albei navolgingsmaatstawwe is. Ek het in 
hierdie studie die struikelblokke en fasiliteerders tot ARV-behandeling van kinders jonger as 
vyf jaar in die landelike streke van Suid-Afrika verken aan die hand van Bronfenbrenner se 
Ekologiese Stelselteorie (EST).  
Die navorsing is in twee fases gedoen. Fase 1 het nege onderhoude en drie 
fokusgroepbesprekings ingesluit ten einde vas te stel hoe dokters, verpleegsters, beraders, 
tradisionele genesers en versorgers die struikelblokke en fasiliteerders tot ARV-navolging 
sien. Die data is getranskribeer en in isiZulu vertaal waar nodig, en gekodeer met behulp van 
ATLAS.ti weergawe 7. Op die vlak van die mikrosisteem was die onsmaaklikheid van 
medikasie en die groot hoeveelhede medikasie vir jong kinders problematies. Die kenmerke 
van versorgers wat bydra tot swak navolging is afwesige moeders, oumas as versorgers en 
ontkenning van MIV onder vaders. Op die vlak van die mesosisteem is taalhindernisse en 
ongereelde kliniekbywoning geidentifiseer as faktore wat navolging beïnvloed. Op die vlak 
van die eksosisteem is die aard van navolgingsberading en die opleiding van beraders uitgelig 
as die mees problematiese faktore wat navolging beïnvloed. Op die vlak van die 
makrosisteem is die gevolge van voedselonsekerheid en die kontroversie rondom die gebruik 
van tradisionele behandelings geopenbaar as die mees opvallend. Fase 1 van die tesis sluit af 
met ’n aanbeveling dat daar meer toesig en gereelde opleiding vir die leke 
navolgingsberaders moet wees, sowel as gereelde monitering van die persone wat die kliniek 
bywoon namens die kind. 
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Gedurende Fase 2 het ek 33 versorger-kind-pare doelgerig gewerf uit die Hlabisa MIV 
Behandelings- en Sorgprogram se databasis. Kinders is verdeel in drie groepe gebaseer op 
hulle VL ten tyde van werwing. Kinders met ’n VL ≥ 400kps/ml is gegroepeer as nie-
onderdruk (n=11); kinders met ’n VL ≤400kps/ml is gegroepeer as onderdruk (n=12); en 
kinders met geen VL data is gegroepeer as nuut-geinisieer (n=10). Ek het die versorger-kind-
pare waargeneem tydens hulle maandelikse navolgingsberadingsbesoek om te dokumenteer 
watter inligting hulle van navolgingsberaders ontvang. Ek het daarna die versorger-kind-pare 
in hulle huishoudings besoek om met behulp van video-opname te dokumenteer hoe 
behandeling toegedien is. Waarnemingsnotas en video-opnames is in ATLAS.ti v 7 ingevoer 
en tematies geanaliseer.  
Beradingsessies het gemiddeld 8.1 minute (range 2 - 18) geduur. Min berading oor 
gedragsverandering het plaasgevind, selfs in gevalle waar kinders sleg gevaar het op die 
behandeling. Die tematiese video-analise toon vyf sleutelareas binne versorgerpraktyke wat 
moontlik bydra tot swak uitkomste. Hierdie areas is die konteksverwante-, 
medikasieverwante-, versorgerverwante- en kindverwante faktore en die interaksies tussen 
versorger en kind. Alhoewel die meerderheid van kinders in hierdie monster hulle medikasie 
suksesvol geneem het, was die manier waarop medikasies deur versorgers voorberei en 
toegedien is problematies. Fase 2 sluit af met die aanbeveling dat beraders in die lig van 
stygende medikasieweerstand moeite moet doen om versorgers se kennis van die toediening 
van behandeling te monitor. 
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GLOSSARY 
Adherence counsellors Lay health personnel that provide (inter alia) voluntary 
counselling and testing, pre-ART initiation education training, 
psychosocial support and adherence counselling services to ART 
users in the public healthcare system. 
Adolescent Aged 10 to 19 years old. 
Adult Aged 19 years and older. 
ART A combination of three or more antiretroviral drugs to achieve 
viral suppression in HIV-infected persons. 
ARV The medications to treat HIV infection. 
Caregiver The individual responsible for administering ART to the child 
AND/OR attending clinic visits on behalf of the child. 
Child Aged 10 years and younger. 
Clinic adherence Attending monthly clinic visits to collect prescribed medications. 
Infant Child younger than one year of age. 
Medication adherence The extent to which a person’s behaviour – taking medication, 
following a diet, and/or executing lifestyle changes, corresponds 
with agreed recommendations from a healthcare provider. 
Newly initiated Not yet had a viral load test since initiation on ART. 
Older child Aged 3 to 5 years old. 
Pre-ART education Three compulsory HIV education sessions undertaken by HIV 
infected individuals prior to initiation on ART. 
Primary caregiver The individual responsible for administering ART to the child 
AND attending clinic visits on behalf of the child. 
Suppressed (viral 
suppression) 
Number of copies of HIV present in the blood is below the 
detectable level (<400cps/ml). 
Treatment event The time period in which the caregiver was seen measuring and 
administering ART to the child at the household. 
Unsuppressed 
(treatment failure) 
Two consecutive occasions where the number of copies of HIV 
present has been detectable in the blood (>400cps/ml). 
Young child Aged 2 to 3 years old. 
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CHAPTER 1  
Introduction 
This thesis aims to examine the barriers and facilitators of adherence to antiretroviral 
therapy (ART) among children younger than five years on ART in rural South Africa. The 
research uses Bronfenbrenner’s Ecological Systems Theory (EST) (Bronfenbrenner, 1979) 
and multiple qualitative approaches to explore the factors influencing adherence to ART 
among children in this age group.  
HIV/AIDS in infants and young children 
Since the first documented cases of paediatric Human Immunodeficiency Virus (HIV) 
in 1982 (Centers for Disease Control, 1982; Sepkowitz, 2001), countries throughout the 
world have responded to this major public health concern. Now, more than 30 years later, 
despite considerable advances in the field and the availability of life-saving treatments, 
children continue to become infected with HIV and die of HIV-related causes. 
Of the estimated 3.2 million children under the age of 15 years living with HIV at the 
end of 2013, 240 000 were new HIV infections (Joint United Nations Programme on 
HIV/AIDS [UNAIDS], 2014). Sub-Saharan Africa (SSA) bears more than 90% of the global 
burden of HIV, with an estimated 2.9 million children infected by end of 2012 (UNAIDS, 
2013). More than 80% (210 000) of new infections occurred in this region. In South Africa an 
estimated 360 000 children aged 0 -14 years were living with HIV in 2013, representing close 
to 7% (16 000) of new infections globally among children in that age range during that year 
(UNAIDS, 2014).  
Prevention of mother-to-child transmission (PMTCT)  
New infections in children occur mainly as a result of transmission of HIV during 
pregnancy (Taha et al., 2011), birth (Dunn et al., 1994) or breast feeding (Newell, 1998). The 
most important public health intervention to date to eliminate new infections in HIV-exposed 
Stellenbosch University  https://scholar.sun.ac.za
  
2 
 
children has been the prevention of mother-to-child transmission (PMTCT) programme. 
Following international and local guidelines for PMTCT, all pregnant women who are HIV 
positive are required to receive ART as soon as possible, regardless of CD4 count or clinical 
staging (Department of Health South Africa, 2014; World Health Organization [WHO], 
2013).  
Scale-up of the PMTCT programme has virtually eliminated mother-to-child 
transmission (MTCT) of HIV in most high income countries and in some low income 
countries (UNAIDS, 2014). For example, MTCT in Cuba has now been completely 
eliminated, making Cuba the first country in the world to do so (WHO, 2015).  
In South Africa, the available evidence shows that MTCT rates have decreased from 
3.5% in 2010 to 2.7% in 2011(Goga, Dinh, & Jackson, 2012). The success of PMTCT in 
South Africa may be seen in the reduced number of infant, younger than five years and 
maternal mortality rates. In 2011, infant mortality rates decreased from 40 to 30 deaths per 
1000 live births; younger than five years mortality rates decreased from 56/1000 live births in 
2009 to 42/1000 live births (a 25% reduction); maternal mortality decreased from 188.9/100 
000 in 2009 to 156.5/100 000 (a 17% reduction) (Pillay et al., 2014).  
In other resource-limited settings in SSA such as Ghana, HIV transmission from 
mother to child has decreased from 31% in 2009, to 9% in 2012 (UNAIDS, 2013). These 
results indicate major successes in implementing large scale preventative interventions 
amongst persons living with HIV in these settings.  
Paediatric ART  
Since the approval of the first drug, Zidovudine (also known as, Azidothymidine 
[AZT]), to treat HIV in 1987 and the availability of highly active antiretroviral therapy 
(HAART) in the 1990’s (Sepkowitz, 2001), ART has averted close to 8 million early deaths 
globally, with 5 million deaths averted in SSA alone (UNAIDS, 2014). Evidently, the 
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introduction and availability of ART has transformed a once fatal illness into a chronic and 
manageable illness (Mofenson & Cotton, 2013; Nischal, Khopkar, & Saple, 2005). ART has 
shown to slow down and delay the progression to AIDS (Jordan, Gold, Cummins, & Hyde, 
2002), and increase life expectancy (Mills et al., 2011). In addition to improving the lifespan 
and overall health of people living with HIV (PLWH), ART has also markedly reduced the 
rates of HIV transmission to uninfected individuals (Cohen, 2011; Tanser, Bärnighausen, 
Grapsa, Zaidi, & Newell, 2013). 
Following protracted delays for political reasons, the national roll-out of ART in 
South Africa occurred at the end of 2003 (Rohleder, Swartz, Kalichman, & Simbayi, 2009). 
Since then, ART provision has continued to expand and by mid-2014 the Department of 
Health was providing ART to more than 2.6 million PLWH (Department of Health South 
Africa, 2014). 
Compared to adults (37% global ART coverage), ART coverage among children still 
remains unacceptably low (UNAIDS, 2014). Worldwide, an estimated 630 000 children aged 
15 years and younger were receiving ART in 2012, of which an estimated 544 000 (86%) 
were residing in SSA, suggesting a meagre 23% global coverage (UNAIDS, 2014). In 2013, 
an estimated 44% (156 706) of children eligible for treatment (0-14 years) living with HIV in 
South Africa were receiving ART (UNAIDS, 2014).  
Low coverage of ART amongst children persists due to poor awareness of the disease 
and socio-economic barriers (Meyers et al., 2007; Yeap et al., 2010). In the absence of timely 
initiation on ART, evidence suggests that at least a third of children will die before they are 1 
year old, and more than half will die before the age of 2 years (Newell et al., 2004). In the 
context of rapid disease progression, higher levels of co-morbidity with equally life 
threatening illnesses (such as tuberculosis (TB), malaria and malnutrition), and high mortality 
rates among untreated children younger than five years, current global and national 
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guidelines recommend immediate ART initiation for infected children younger than five years 
(Department of Health South Africa, 2014; WHO, 2014).  
Paediatric adherence to ART 
Near perfect levels of adherence (≥95%) to ART are necessary to ensure favourable 
treatment outcomes such as a suppressed viral load (VL), a CD4 count >500 cells/mm3, 
slower disease progression, fewer opportunistic infections and decreased mortality rates 
(Bangsberg, Hecht, & Charlebois, 2000; Bangsberg et al., 2003). While perfect adherence to 
the regimen remains a priority, lower levels of adherence (<80%) have been associated with 
viral suppression among children on ART (Nyogea et al., 2015). Despite initial concerns that 
paediatric ART was not feasible for children living in resource-limited settings given their 
poorer access to healthcare (Dijk, Sutcliffe, & Munsanje, 2011), evidence shows that 
estimates of adherence rates in low- and middle-income (LMIC) countries (Vreeman, Wiehe, 
Pearce, & Nyandiko, 2008) are comparable and often higher than those in high-income 
countries (Simoni et al., 2007). However, in the absence of a gold standard to measure 
adherence, these estimates of adherence vary widely (Haberer et al., 2012).  
Despite increasing reports of high adherence rates among children in SSA (Haberer et 
al., 2011; Nyogea et al., 2015; Olds, Kiwanuka, & Ware, 2015), these reports do not 
consistently predict viral suppression. Consequently, children can remain on failing regimens 
(i.e. regimens that no longer suppress viral replication in the blood) for prolonged periods of 
time, and this eventually causes drug resistance (Pillay et al., 2014). Drug resistance to 
treatment occurs when plasma concentrations of the ARV agents are no longer sufficient to 
inhibit the replication of the virus (Steele & Grauer, 2003; WHO, 2010).  
In the context of limited ARV drug options available for adults and children in South 
Africa (Davies et al., 2011), adherence to first-line regimen is key to ensure optimal and 
prolonged benefits of treatment. Second-line regimens, although available, remains costly 
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and often difficult to access (Davies et al., 2011). Particular concern has been raised 
regarding developing resistance to second-line regimens in resource-limited settings, 
especially as monitoring of patient VLs is either sub-standard or absent (Davies et al., 2011; 
Fox, Ive, Long, Maskew, & Sanne, 2010; Lessells et al., 2014).   
For young children, especially those younger than five years who rely on parental or 
non-parental caregivers to administer their medication to them daily, adherence becomes an 
even greater task to manage. Developmentally, a child’s first five years of life are critical for 
acquiring fundamental cognitive, physical, emotional, and social capacity (Richter, 2004). 
For children the world over, these fundamental needs require careful attention and 
considerable commitment from a caregiver, as without these their development is likely to 
suffer. For children living with HIV (CLWH), the majority of whom reside in SSA in areas 
that are predominantly poverty stricken and under-resourced, meeting their very basic needs 
is a daily struggle and requires overwhelming commitment (Rochat, Mitchell, & Richter, 
2008).  
In addition to having to provide for children’s most basic needs, caregivers of children 
younger than five years on ART have to integrate and manage complicated regimens into 
their daily lives. For example, in the absence of fixed dose combinations available to children 
younger than five years, caregivers of children in this age group are required to carefully and 
accurately measure and administer volumes of liquid drug formulations to children on ART 
twice a day (WHO, 2013). As children grow older and gain weight, the doses have to be 
adjusted and can change up to three times in the first year of ART (Department of Health 
South Africa, 2014). Moreover, some of the medications have special storage requirements 
and some are highly unpleasant and require creative strategies to mask their taste in order to 
aid administration (Department of Health South Africa, 2014).  
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The above-mentioned factors highlight several characteristics of paediatric ART that 
complicates adherence. In addition to regimen-related factors, factors related to the child-, 
caregiver-, healthcare system and cultural context influence paediatric adherence to ART and 
may be inhibitory (i.e. act as barriers) or facilitative (Biadgilign, Deribew, Amberbir, & 
Deribe, 2009; Fetzer et al., 2011; Olds et al., 2015). For example, child-related factors 
influencing adherence to ART include biological characteristics such as a lack of tolerance of 
the side effects of medication (Bikaako-Kajura et al., 2006; Van Dyke et al., 2002), regimen 
characteristics such as the poor palatability of certain drug formulations (Byrne, Honig, 
Jurgrau, Heffernan, & Donahue, 2002; Mukhtar-Yola, Adeleke, Gwarzo, & Ladan, 2006; 
Pontali, 2005), and psychosocial characteristics such as the influence of knowledge of HIV 
status on adherence to ART (Biadgilign et al., 2009; Bikaako-Kajura et al., 2006; Vreeman, 
Gramelspacher, Gisore, Scanlon, & Nyandiko, 2013). Similarly, caregivers may face 
psychosocial factors that affect adherence, such as depression and substance abuse (Jaspan, 
Mueller, Myer, Bekker, & Orrell, 2011). Caregiver forgetfulness (Chesney, 2003; Fetzer et 
al., 2011) and difficulty adjusting the regimen to their lifestyle routines (Hammami et al., 
2004; Mills et al., 2006; Santer, Ring, Yardley, Geraghty, & Wyke, 2014) have also 
influenced ART adherence in children. 
Healthcare system factors that negatively impact on adherence to ART include long 
waiting times at clinics and hospitals that may not be child-friendly (Coetzee, Kagee, & 
Vermeulen, 2011) and staff that are inadequately trained to treat HIV-infected children 
(Rochat et al., 2008). These factors, often referred to as structural barriers to adherence to 
ART, are the socio-economic, institutional, political, and cultural domains (Shriver, Everett, 
& Morin, 2000) that may influence the extent to which caregivers are able to follow a 
treatment regimen. Facilitative factors include health literacy among the caregivers (Ciampa 
et al., 2012; Howard et al., 2014; Yin et al., 2008), positive relationships with clinic 
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personnel, on-going counselling to caregivers on adherence (Biadgilign et al., 2009; Mills et 
al., 2006) and social support (Katz et al., 2013; Olds, Kiwanuka, Ware, et al., 2015).  
Other structural barriers to adherence to ART are socio-economic problems in the 
household, such as a lack of money for food and transport (Coetzee et al., 2011; Hardon et 
al., 2007; Tuller et al., 2010), and a fear of stigma and discrimination following disclosure of 
the child’s HIV status to others (Bhattacharya & Dubey, 2011; Biadgilign, Deribew, & 
Amberbir, 2011; Biadgilign et al., 2009; Fetzer et al., 2011). Unlike other chronic illnesses, 
HIV is uniquely challenged by the perceived stigma associated with the illness. Cultural 
factors include the influence of cultural norms (Wachira, Middlestadt, Vreeman, & Braitstein, 
2012), religion (Park & Nachman, 2010) and traditional medicines on adherence to ART 
(Haberer & Mellins, 2009; Wasti, Simkhada, Randall, Freeman, & van Teijlingen, 2012).  
Most of our knowledge regarding the barriers to and facilitators of paediatric 
adherence to ART has been obtained through quantitative studies (Haberer & Mellins, 2009; 
Simoni et al., 2007; Vreeman et al., 2008), the majority of which have been conducted in 
high-income countries (Simoni et al., 2007). Quantitative studies, however, have not been 
able to adequately explain the associations between various determinants of adherence. In 
addition, the associations are rarely found consistently across different settings and studies 
often include children across a wide age range.  
A growing body of qualitative literature is beginning to contribute considerable and 
much-needed depth to the understanding of these factors that influence adherence in various 
contexts (Coetzee, Kagee, & Bland, 2015; Nyogea et al., 2015; Olds, Kiwanuka, Ware, et al., 
2015; Santer et al., 2014). A good example of the problematic nature of identifying factors 
affecting adherence to ART in children via quantitative means alone was recently 
demonstrated in a mixed-method study among children (aged 2 – 19 years) on ART living in 
rural Tanzania (Nyogea et al., 2015). Based on data showing a strong positive association 
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between education level and non-adherence, Nyogea et al.(2015) have argued that secondary 
school-aged children (≥12 years) who only had primary level education or were still in 
primary school were more likely to be non-adherent to ART compared to those of secondary 
school-age (Nyogea et al., 2015). Given that half of these children lived with non-parental 
caregivers, Nyogea et al. (2015) have argued that a possible explanation for the finding was 
that non-parental caregivers were possibly providing less support to the children than parental 
caregivers. In contrast, qualitative findings showed that children attending school sometimes 
skipped morning doses when they were in a rush to leave for school, or when food was not 
prepared beforehand (Nyogea et al., 2015). The findings thus present different interpretations 
of the data, with qualitative data representing actual experiences.  
A large proportion of the available qualitative data largely adopts interview and focus 
group methodologies to explore key stakeholder perspectives. While these methods may not 
be useful or appropriate with children younger than five years, observational methods have 
been useful among children in this age group (Rochat et al., 2008). Given the dynamic and 
changing contexts that many children infected and affected by HIV live in, a better 
understanding of treatment adherence within a child’s particular context is necessary. 
Understanding the factors that affect adherence to ART will go a long way to designing 
interventions aimed at improving adherence. To my knowledge, at the time of writing, no 
study has observed and documented the barriers and facilitators associated with treatment 
administration of ART to children younger than five years by their caregivers in their homes 
during medication times in the morning and evening.  
Problem statement and rationale 
Paediatric adherence to ART may be conceptualized at two levels, namely adherence 
to the medication, and adherence to clinic appointments (Coetzee & Kagee, 2013). Thus, the 
success of ART for the treatment of HIV relies predominantly on optimal adherence to 
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treatment, which may be defined as daily medication taken as prescribed at the correct times 
with appropriate nutrition (Schönnesson, Diamond, Ross, Williams, & Bratt, 2006), as well as 
monthly clinic attendance to collect prescribed medication. For children younger than five 
years, caregivers are responsible for the measurement and administration of medication doses 
to children and attendance of monthly clinic visits to collect prescribed medication. Failure to 
adhere to the regimen as prescribed may lead to high VLs, immune suppression and 
ultimately drug resistance (Pillay et al., 2014). Acquired drug resistance to ART is prevalent 
amongst children in South Africa (Davies et al., 2011; Pillay et al., 2014), and poor adherence 
to the dosing regimen by caregivers is associated with this problem.  
Study aim and objectives 
The aim of this study was to explore the barriers to and facilitators of adherence to 
ART among young children (younger than five years) who rely on caregiver administration of 
ART in rural KwaZulu-Natal. The study triangulated interview and focus group data from the 
perspectives of doctors, nurses, adherence counsellors, caregivers and traditional healers with 
observational data of treatment administration practices by caregivers to children on ART. 
The objectives of the study were: 
1. to explore caregivers', doctors', nurses', HIV counsellors', and traditional healers' 
perspectives on the barriers and facilitators to the administration of medication to 
children younger than five years by their caregivers (Phase 1: Interviews and focus 
groups); 
2. to observe and document what information caregivers received during their routine 
adherence counselling sessions at their monthly clinic visits (Phase 2: Direct 
observation);  
3. to directly observe and document the administration of medication to children younger 
than five years by their caregivers (Phase 2: Direct observation). 
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General positioning in the Social Sciences 
This dissertation is located within the interpretivist paradigm (Creswell, 2013). The 
research sought to understand the underlying phenomenon in context, with the researcher 
adopting an empathic manner that prioritizes the subjective experiences of those involved 
(Blanche, Durrheim, & Painter, 2006). Such information is adequately captured through 
qualitative research, which is flexible in nature and concerned with understanding a particular 
phenomenon from multiple interpretations and meanings (Creswell, 2013). An interpretivist 
paradigm will allow an in-depth understanding of the context in which paediatric adherence 
to ART occurs through various interpretations of the behaviours and circumstances that 
influence it.  
Theoretical framework 
Ecological theories of health  
This study was conceptualized, interpreted and understood through the lens of EST as 
laid out by Urie Bronfenbrenner in 1979. Ecological theories of health, like EST, consider 
individual as well as environmental (contextual) factors when trying to understand or when 
examining a target behaviour. Several ecological theories of health have been put forward by 
various authors. Some of these theories (e.g. Ecological Psychology (Lewin, 1951), Social 
Ecology (Moos, 1979) and EST (Bronfenbrenner, 1979)) were specifically designed to 
explain health behaviours (Glanz, Rimer, & Viswanath, 2008), while others, for example the 
Operant Learning Theory (Skinner, 1953), Social Ecology Model for Health Promotion 
(Stokols, 1992), and the Ecological Model of Health Behaviour (McLeroy, Bibeau, Steckler, 
& Glanz, 1988) were specifically designed to guide behavioural interventions (Glanz et al., 
2008). Thus, unlike individual theories (described below), ecological theories consider 
multiple levels of influence on individual health behaviour (Glanz et al., 2008; Grzywacz & 
Fuqua, 2000; Vreeman et al., 2009). By giving explicit consideration to multiple levels of 
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influence, ecological models help guide more comprehensive interventions (Glanz et al., 
2008). 
Bronfenbrenner’s Ecological Systems Theory (EST) 
Bronfenbrenner (1979) put forward the EST in his work titled ‘The Ecology of 
Human Development’ in 1979 and theorized that the socio-ecological environment played an 
important role in the psychological and social aspects of human development.  
The ecological environment is made up of four levels of interrelated systems, 
represented as concentric circles in his model, where all of the systems interact with one 
another. Bronfenbrenner describes levels of context in his model, which situates a child at the 
centre of the model nested inside each of the other levels (Figure 1.1). He refers to each of 
these levels as the micro-, meso-, exo- and macrosystems.  
 
Figure 1.1. The four systems of Bronfenbrenner’s EST  
The microsystem is at the centre of all the levels and is also the level where the child 
is embedded. The microsystem demonstrates the environment in which a child lives and 
moves, like for instance the interactions children have with their immediate surroundings. 
Occupying the microsystem alongside the child are immediate family members, and 
depending on the age of the child, also school teachers and peers. A very young child will 
Macrosystem
Exosystem
Mesosystem
Microsystem
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have a smaller number of microsystems (Bronfenbrenner, 1979). The microsystem thus 
represents the most important setting in which a child develops, as this is where the child is 
likely to spend most of his/her time. In the context of this research study and a child younger 
than five years, the microsystems include the caregiver(s) and any other person(s) responsible 
for direct care and treatment of the child.  
The microsystem is nested within the mesosystem level. The mesosystem refers to the 
interactions that occur between the members of the microsystem, so the child is not directly 
involved in this level. Interactions may therefore occur between parents and childcare 
providers or between neighbours (Bronfenbrenner, 1979).   
The mesosystem is nested within the exosystem. The exosystem demonstrates the 
broader context or community in which a child lives. These contexts include extended family 
and family networks, media, workplaces, family friends, and community health services, 
legal and social welfare. Although the child has no direct contact with any of the exosystems, 
these systems may affect the development and socialization of the child.   
The outermost level, the macrosystem, contains the attitudes, ideologies, values, laws 
and customs of a particular culture or subculture. Bronfenbrenner’s theory is a suitable lens 
through which to both design and interpret this research as we consider adherence to ART 
behaviours of a child younger than five years as nested within a complex environment 
predominantly overseen by a primary caregiver.  
Bronfenbrenner’s EST (1979) has been used as a framework for understanding factors 
influencing adherence to ART in both the adult (Coetzee et al., 2011; Kagee, Nothling, & 
Coetzee, 2012) and paediatric HIV literature (Coetzee et al., 2015; Naar-King et al., 2006; 
Vreeman et al., 2009). For example in the literature on adults, EST has been used to 
understand and contextualize structural barriers to adherence to ART among adults in South 
Africa (Coetzee et al., 2011). In their study, Coetzee et al. (2011) have sought to identify the 
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structural barriers to adherence to adult ART users attending a peri-urban primary healthcare 
facility in South Africa from the perspectives of patients’ healthcare providers (doctors and 
nurses). Using EST, the authors have argued that at an individual level, disclosure to 
members within patients’ microsystem facilitated adherence through the social support gains 
that disclosure offered. However, fear of stigma and discrimination prohibited many ART 
users from disclosing. Lack of disclosure to members within their microsystem impeded 
patients’ ability to access healthcare, thereby disrupting their interactions with healthcare 
providers (mesosystem). Coetzee et al. (2011) have also argued that disruptions in the 
microsystem are likely to have a cascading effect throughout the meso-, exo- and 
macrosystem. 
In a seminal qualitative study by Vreeman et al. (2009) the authors have provided a 
conceptual model for understanding childcare amongst HIV-infected children in Western 
Kenya (Vreeman et al., 2009). The researchers drew on Bronfenbrenner’s EST (1979), as 
well as further interpretations of Bronfenbrenner’s model by Grzywacz and Fuqua (2000) and 
Moos (1979, 2003). Vreeman et al. (2009) have stated that, “Pediatric adherence could not be 
conceptualized as primarily an individual behavior, or even a child–caregiver behavior, but 
was best understood as a set of behaviors crucially influenced by the many integrated factors 
that defined the context in which adherence-related behaviors occurred” (Vreeman et al., 
2009 p. 1724).  
As with Bronfenbrenner’s model, Vreeman et al. (2009) have placed the child at the 
centre of the nested arrangement, with parents/caregivers and household factors situated at 
the next level, followed by community factors at the level after that, ethnic group factors at 
the next level and healthcare system related factors at the outmost level. Vreeman et al. 
(2009) have found that optimal adherence relied on the successful integration of the various 
domains by means of ongoing information-sharing between key role players. Conversely, a 
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failure to maintain the dynamic process of information-sharing was likely to disrupt the care 
domains and limit access to a supportive culture and context necessary for optimal adherence.  
The authors have argued that other theories (such as the Health Belief Model (HBM) 
and the Children’s Health Belief Model (CHBM)), “did not adequately conceptualize the 
importance of cohesively integrating multiple cultural factors, the dynamic process of 
information sharing and response, and the developmental continuum central to pediatrics that 
emerged from the shared experiences of our interview participants” (Vreeman et al., 2009 p 
1724-1725).  
Criticisms. Ecological health models, like EST, have largely been criticized for 
lacking specificity about those influences hypothesized to be most central to a specific 
behaviour. In addition, even those ecological models that are behaviour-specific have been 
criticized for not adequately addressing how the broader environmental levels operate, 
interact and influence factors across the different levels. Individuals level theories thus 
become useful for identifying and specifying salient factors at each level and how they 
influence behaviour (Glanz et al., 2008). 
Individual level theories  
The theories listed and described in the table below (Table 1.1) are known as 
individual level theories of adherence (Munro, Lewin, Swart, & Volmink, 2007). Although all 
of them are supported empirically across various populations, the most important criticism of 
each of these theories is that the focus is predominantly on the individual with little 
consideration of the environmental, social and contextual factors that influence adherence 
behaviour. These theories have been somewhat useful in paediatric intervention designs 
aimed at improving adherence (Mbuagbaw et al., 2015).  
Since I did not measure adherence as an outcome and rather explored the complex 
interacting factors that contribute to poor adherence, the theories were of limited applicability 
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in this study. However, I used concepts associated with the Information-Motivation-
Behavioural Skills Model (IMB) by Fisher, Fisher, Amico, and Harman (2006) to discuss and 
explain specific observed behaviours in Phase 2 of this study (Fisher, Fisher, Amico, & 
Harman, 2006). The table is based on information obtained from Rapoff (2010) and Munro et 
al. (2007). Rapoff (2010) has provided a description, critical appraisal, and a discussion of the 
clinical implications of the adherence theories in the paediatric chronic disease literature 
(Rapoff, 2010). Munro et al. (2007) have provided a review article on health behaviours and 
have determined their usefulness for developing interventions specific to long term 
medication adherence for the treatment of TB and HIV/AIDS. The table is not exhaustive of 
all the theories and models that are currently used to describe and predict behaviour change in 
adherence research, but it presents the main theories. Among the theories presented, only the 
CHBM has been tailored to some extent to consider multiple key role players as would be 
needed in the case of paediatric adherence. Amongst children residing in LMIC, where 
multiple female caregivers is usually the norm, consideration of multiple levels of influence 
is needed to accurately depict factors influencing adherence behaviours.  
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Table 1.1 
Individual level adherence theories 
Theory Author(s) Description Key elements of the theory 
HBM/CHBM (Bush & 
Iannotti, 1990; 
Janz & Becker, 
1984) 
The model posits that the extent to 
which a person perceives a disease 
as a threat is determined by the 
perceived susceptibility to or 
seriousness of the disease. Internal 
and external cues (triggers) and 
perceived barriers influence the 
degree to which the threat is 
perceived. CHBM is similar to 
HBM, but includes the caregivers' 
beliefs of the benefits of treatment 
adherence. 
The theory identifies six elements to explain and predict adherence: 
1) Perceived susceptibility: refers to the beliefs held by an 
individual about the prospect of being susceptible to an illness. 2) 
Perceived severity: refers to a person’s assessment of the 
consequences of contracting an illness, or of not taking or receiving 
treatment. Perceived susceptibility and perceived severity are 
collectively known as perceived threat. 3) Perceived benefits: the 
beliefs held by the person that taking the recommended treatment 
or health action will be beneficial. 4) Perceived barriers: the 
perceived factors that may influence the extent to which the person 
is able to adhere to recommended treatments or health actions. The 
barriers and facilitators of taking treatment or taking a particular 
health action are usually weighed up against one another. 5) Cues 
to action: refers to triggers such as the onset of symptoms or 
encouragement by others to seek treatment. 6) Self-efficacy: The 
HBM also incorporates concepts such as self-efficacy to describe 
the extent to which the persons believe that they are able to adhere 
to the recommended treatment or health action. 
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Table 1.1 (continued) 
Theory Author(s) Description Key elements of the theory 
Social cognitive 
theory (SCT) 
(Bandura, 
1989) 
Also referred to as self-efficacy 
theory. It emphasizes the social 
nature of learning and knowledge 
acquisition through observation. 
The SCT model considers 
behavioural, interpersonal and 
environmental factors as key 
determinants of human agency, of 
which perceived self-efficacy, 
especially in the context of 
medication adherence, is 
considered a key aspect. The theory 
thus posits that behaviour change 
will occur when the individual 
believes they have control over the 
outcome, experience few barriers 
and have a strong belief in their 
ability to perform the desired 
behaviour. 
Key organizing principle: reciprocal determinism – continuous 
dynamic interaction between the person and the environment.  
Perceived self-efficacy: belief in your own ability to accomplish a 
task or behaviour through enactive mastery, vicarious experience, 
verbal persuasion, physical and emotional states. Outcome 
expectancies: judgements of the possible consequences on one's 
actions. 
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Table 1.1 (continued) 
Theory Author(s) Description Key elements of the theory 
Theory of 
reasoned 
action/planned 
behaviour 
(TRA/TPB) 
(Fishbein & 
Ajzen, 1975) 
TRA/TPB developed to understand 
why attitudinal measures 
inaccurately predicted behaviour. 
The TRA was also used to 
determine ways to improve the 
predictive ability of the measures. 
The theory posits that in order for 
an individual to engage in a certain 
action or behaviour there has to be 
sufficient intention to perform the 
behaviour. The intention is 
influenced by the individual’s 
attitude towards the behaviour, 
subjective norms, the individual’s 
perceived behavioural control.  
The theory identifies four elements needed to improve the ability of 
attitudinal measures to predict behavioural outcomes using 
attitudinal measures: 1. The measure should contain the action or 
behaviour that has to be executed. 2. The measure should contain 
the target at which the behaviour is directed. 3. The measure should 
contain the context or situation. 4. The measure should contain the 
time frame. Behavioural intention refers to the perceived likelihood 
that the individual will perform the desired behaviour. Attitude 
toward behaviour refers to the behavioural beliefs and evaluation of 
behavioural outcomes (opinions about the behaviour and 
consequences of performing the behaviour). Subjective norms 
include normative beliefs and motivation to comply (whether 
important members in their lives approve or disapprove of the 
behaviour - whether motivated to meet their expectations). 
Perceived behavioural control refers to control beliefs, perceived 
power (belief in performing the behaviour and the outcome of 
performing the behaviour).  
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Table 1.1 (continued) 
Theory Author(s) Description Key elements of the theory 
Transtheoretical 
model (TTM) 
(Prochaska, 
1979) 
Focuses on intentional change. The 
theory posits that individuals go 
through various stages and 
processes in order to bring about 
behavioural change.  
The theory states that two dimensions are necessary for intentional 
change: 1) progression through stages of change and 2) processes 
of change (i.e. strategies undertaken by individuals to make the 
behavioural change. 
1) Stages of change: There are 5 stages through which an 
individual progresses when changing a particular health behaviour. 
1. Precontemplation stage: no immediate intention to change. 2. 
Contemplation stage: intention to change. 3. Preparation stage: 
immediate intention to change. 4. Action stage: visible lifestyle 
changes made. 5. Maintenance stage: strategies undertaken to avoid 
relapse.  
2) Processes of change: 1. Decisional balance: weighing-up of pro's 
and con's. 2. Self-efficacy: confidence to cope with and prevent the 
intensity of urges to relapse. 
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Table 1.1 (continued) 
Theory Author(s) Description Key elements of the theory 
Information–
Motivation–
Behavioural 
Skills Model 
(IMB) 
(Fisher et al., 
2006) 
The theory posits that behaviour 
change is dependent on 
information, motivation and 
behaviour skills. The model 
specifies causal relationships 
between determinants of adherence. 
Thus, adherence to medication is 
reliant on sufficient information 
about adherence, motivation to 
adhere and behavioural skills to 
perform the necessary tasks. 
Positive health outcomes reinforce 
the individual’s motivation and acts 
as a positive feedback loop. 
Moderating factors (psychological 
ill health, unstable living condition, 
poor access to medical services 
etc.) affect adherence behaviour 
and health outcomes.  
The theory identifies three components that result in behaviour 
change: 1. Information: basic knowledge about HIV and adherence 
that is accurate and facilitates adherence - necessary for consistent 
and correct use of ART. 2. Motivation: motivation to adhere is 
based on personal (own attitude towards ART, and beliefs about 
outcome) and social motivation (social support from significant 
others) to adhere.3. Behaviour skills: objective abilities and 
perceived self-efficacy to perform adherence-related tasks. 
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Chapter conclusion 
Infants and young children receiving ART in resource-limited settings such as South 
Africa are uniquely challenged by the complex array of factors that influence their adherence 
to treatment. This research sought to gather information-rich data from children and key 
members in their microsystems (caregivers, doctors, nurses, counsellors and traditional 
healers) in order to conceptualize and understand how these factors contribute to poor 
adherence. Following this chapter is the literature review, which provides a lens through 
which the findings could be understood and interpreted.   
Thesis layout 
Chapter 2 presents the literature review. The review summarizes and synthesizes the 
literature related to the barriers and facilitators associated with adherence to paediatric ART.  
Chapter 3 describes the research context and provides information on the study 
location and the HIV programme. The chapter also gives a methodological overview of the 
research.   
Chapter 4 describes the methods and data analysis approach used during Phase 1 of 
this research.  
Chapter 5 offers the results of Phase 1. The results reflect several themes emanating 
from the thematic analytic approach employed during the analysis.  
Chapter 6 presents a discussion of the results presented in Chapter 5. The chapter also 
contains the strengths and limitations of this research. 
Chapter 7 describes the methods used during Phase 2 of this research.  
Chapter 8 presents the results of Phase 2. The results provide data on the participant 
and household characteristics, counselling and household observations. The chapter 
concludes with an overview of the main findings.  
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Chapter 9 offers a discussion of the results presented in Chapter 8. The chapter also 
contains the strengths and limitations of this research. 
Chapter 10 presents the research conclusions. The chapter describes the implications 
of this research and makes recommendations for the future research. 
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CHAPTER 2 
Literature review 
Introduction 
The literature review aims to summarize and synthesize the literature related to the 
barriers and facilitators associated with adherence to paediatric ART. The review process 
drew on an ecological approach (Bronfenbrenner, 1979), situating the child at the centre of a 
complex and dynamic set of systems that influence adherence to ART. First, I provide an 
overview of the search strategy. Second, I provide definitions of adherence and highlight 
various components that are necessary for optimal adherence. Third, I provide the current 
estimates of the rates of paediatric adherence across settings and emphasize their variability 
in the absence of a gold standard. Fourth, I provide a review of the factors influencing 
paediatric adherence to ART. Fifth, I provide evidence on interventions that have aimed to 
improve adherence to ART. Last, I identify the gaps in knowledge.   
Literature search strategy 
The title of this thesis, research question and sub-questions formed the key 
terminology and search strings that I used to gather and review the evidence and theory for 
this thesis. I searched Scopus, Academic Search Premier (Ebscohost), Web of Science, 
PubMed, Google Scholar, PsycInfo and Medline. Further, I searched the Cochrane Library 
for systematic reviews and meta-analyses involving paediatric adherence rates to ART. I also 
searched grey literature, including unpublished masters and doctoral dissertations using 
World Cat. I used a combination of separate search strings (Search 1 to Search 4 as seen 
below) to locate the literature on this topic. In addition, I surveyed and obtained references 
from the reference lists of articles considered of particular importance to the literature review.  
Search 1: (paediatric OR pediatric) AND (adherence OR compliance) AND 
(medication) AND (chronic) 
Stellenbosch University  https://scholar.sun.ac.za
  
24 
 
Search 2: (barrier*) AND (adherence) AND (antiretroviral*) AND (HIV OR AIDS) 
AND (paediatric OR pediatric) AND (high-income) AND (low-income) 
Search 3: (facilitator*) AND (adherence) AND (antiretroviral*) AND (HIV OR AIDS) 
AND (paediatric OR pediatric) AND (high-income) AND (low-income) 
Search 4: (paediatric OR pediatric) AND (adherence OR compliance) AND 
(medication) AND (chronic) AND (caregiver*) 
I organized the review of the literature thematically (Mouton, 2001) and in keeping 
with the overarching theoretical framework. The literature review subsequently considers 
paediatric adherence on a micro-, meso-, exo- and macrolevel.  
Definitions of adherence  
The most widely used and quoted definition of adherence to medication in the 
literature states that adherence is, “. . . the extent to which a person’s behaviour (in terms of 
taking medications, following diets, or executing lifestyle changes) coincides with medical or 
health advice” (Haynes, 1979, pp. 1–2).  
Rapoff (2010) has provided three reasons why this definition is preferred over others. 
Firstly, the definition is preferred to others as it specifies the behaviours necessary to satisfy 
regimen requirements. Secondly, the word “extent” conveys that there are various factors that 
contribute to non-adherence and that it is not a unidimensional phenomenon. Lastly, the 
definition also brings into focus the degree to which patient behaviour coincides with the 
recommendations from the clinician, in other words whether patients are taking the 
medication in the way it has been prescribed to them (Rapoff, 2010).  
The World Health Organization (WHO) has offered a similar definition of adherence 
and defines it as, “the extent to which a person’s behaviour – taking medication, following a 
diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a 
healthcare provider” (WHO, 2003, pp. 3–4). Rapoff (2010) has stated that this definition 
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captures all the elements of the Haynes definition, but has added “agreed recommendations”, 
which suggests that patients consent to, and agree with, the regimen as prescribed. Similarly, 
Nunes et al., (2009) have defined adherence as, “the extent to which the patients behaviour 
matches agreed recommendations from the prescriber” (Nunes et al., 2009, pp 367).  
Patients are therefore expected to adhere to dose, schedule and dietary aspects of 
adherence (Nilsson Schönnesson et al., 2006), as agreed to in consultation with their 
prescriber. Nilsson Schönnesson et al. (2006) have proposed definitions of dose, schedule and 
dietary adherence. Dose adherence refers to the quantity of a drug or medicine that is taken as 
recommended or prescribed (by a clinician) at a particular time daily (Nilsson Schönnesson et 
al., 2006). In the context of HIV and ART, dose adherence refers to taking the correct number 
of ARV pills (or liquid formulations), as recommended or prescribed, at a single time. In the 
context of adherence to ART, schedule adherence refers to taking the correct number of pills 
at the correct time every day. According to the South African Department of Health (2004), 
ARVs are meant to be taken at strict twelve-hour intervals (e.g. at 7am in the morning and at 
7pm in the evening) (Department of Health South Africa, 2004). For adults, dose and 
schedule adherence usually requires taking a single dose of medication, or a combination of 
pills, once daily. However, dose and schedule adherence in infants and young children is 
more complicated as they ordinarily receive a combination of three liquid antiretroviral 
preparations, each requiring specific measurements and accuracy (Department of Health 
South Africa, 2004). For example, for a young child in South Africa weighing between 5kg 
and 7kg and on triple combination regimen consisting of Abacavir (ABC), Lamuvidine (3TC) 
and Lopinavir/ritonavir (LPV/r), a typical prescription would be: 3ml of ABC + 3ml 3TC + 
1.5ml LPV/r (Department of Health South Africa, 2013b). Each of these medications should 
be accurately measured by a caregiver and administered to the child. A description of the 
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ART available for infants and young children in South Africa is provided in Chapter 3 
(section: ART for infants and young children). 
Dietary adherence describes doses taken correctly with food (if food is required) 
(Nilsson Schönnesson et al., 2006). Although several of the medications can be taken with or 
without food, some of the liquid formulations administered to young children have to be 
administered on an empty stomach (e.g. for children older than three years, Didanosine must 
be taken alone, on an empty stomach, at least half an hour before (or 2 hours after) a meal), 
(Department of Health South Africa, 2004). Other formulation requirements include 
refrigeration. It is recommended that LPV/r and d4T (in oral solution) be kept in a fridge or 
stored at room temperature (25°C) for a maximum of 6 weeks (Department of Health South 
Africa, 2013b).  
The definitions above emphasize a patient-provider, as well as family-centred 
approach to adherence. These aspects of adherence (dose-, schedule- and dietary adherence) 
are especially important for adherence in children, where regimen requirements may be 
shared amongst several people that may be involved in the treatment and care of the child 
(Haberer & Mellins, 2009).  
To achieve optimal results from ART, all of these aspects of adherence have to be 
satisfied (Nilsson Schönnesson et al., 2006). In the case of paediatric adherence, dose, 
schedule, and dietary adherence are chiefly the responsibility of the primary caregiver. In 
most cases, caregivers are directly responsible for the administration of medication doses and 
reporting of doses to clinicians at monthly clinic visits. Moreover, as explained by De Civita 
and Dobkin (2004), adherence to paediatric ART involves a ‘triadic partnership’ (De Civita & 
Dobkin, 2004, p.571), which involves constant and meaningful engagement between the 
caregiver, the healthcare team, and the child. In the context of a triadic partnership, non-
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adherence is then likely to occur when either party in the partnership is unable to fulfil the 
requirements necessary to adhere to the regimen, whether intentionally or unintentionally.  
Bauman (2000) has distinguished between volitional and inadvertent nonadherence. 
Volitional nonadherence refers to the consistent decision made by the patient (or in this case 
caregiver) to not administer medication to the child, despite a clear understanding of the 
regimen as prescribed to them by their health provider (Bauman, 2000). The decision is likely 
due to conflicting ideas of the goals of therapy, the intrusion of therapy on daily life, or the 
differences between patient and provider in health beliefs. Inadvertent nonadherence refers to 
patients (or in this instance caregivers) that make the decision to administer the medication, 
as they are accepting of their providers’ instructions and are convinced that they are doing so 
satisfactorily, but are not in fact sufficiently adherent. According to Bauman (2000), 
inadvertent nonadherence is likely due to caregivers’ poor understanding of the regimen, an 
inability to overcome the number of barriers they face with the regimen despite being highly 
motivated to adhere optimally, and caregivers who miss doses but still feel that they are 
sufficiently adherent to the regimen (Bauman, 2000).  
Estimating paediatric adherence rates in the absence of a gold standard 
Much like the estimates of adherence amongst adult ART users globally (Mills et al., 
2006, 2011), estimates of adherence from literature on paediatric patients (Simoni et al., 
2007; Vreeman, Wiehe, Ayaya, Musick, & Nyandiko, 2008) suggest that it is sub-optimal. 
Simoni et al. (2007) have reviewed 50 research articles on paediatric adherence to ART, of 
which the majority were purely descriptive in nature. Thirty-two of the articles provided 
adherence estimates, with a large proportion of the studies (69%) providing adherence rates 
from research conducted in the United States. Estimating adherence across these studies was 
challenging due to wide ranges in sample size (ranging from 10 to 262 participants), patient 
age (ranging from three months to 24 years old), various methods of adherence assessment 
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(pill counts, self-reports, pharmacy refill etc.), and differences in assessment intervals (ranged 
from one day to one year) (Simoni et al., 2007).   
Based on the small number of studies included in the review and the aforementioned 
factors, Simoni et al. (2007) have been unable to provide a global estimate of adherence. The 
adherence rates provided were grouped according to method of assessment, with the most 
widely used method of assessment being self- and caregiver report. Estimates of adherence 
ranged widely across, as well as within, similar methods of assessment. For example, self-
reported data on adherence showed that 20% to 58% of respondents reported 100% 
adherence. Similarly, data from caregiver reports of adherence showed that 34% to 100% of 
caregivers reported 100% adherence. Studies that used more than one method of assessment 
allowed for a better suited comparison as multiple methods controlled for the effects of 
sample size (Simoni et al., 2007).  
Vreeman et al. (2008) have also provided a systematic review of paediatric adherence 
to ART and showed that estimated adherence rates among children in developing countries 
ranged between 45% and 100 %, with estimates averaging at around 75%. Both reviews on 
paediatric adherence to ART have been unable to provide pooled estimates of adherence due 
to the variable definitions, in other words whether patients needed to take their medications 
as prescribed more than 85%, or 90%, or 95% or 100% of the time. Furthermore, pooled 
estimates of adherence were limited by broad ranges in recall periods for estimating 
adherence using self-report measures, in other words whether patients had taken their drugs 
(based on the percentage level required) in the past three days, in the past week, or within the 
past year (Simoni et al., 2006, 2007; Vreeman, Wiehe, Pearce, et al., 2008).  
With no available gold standard for ART adherence (Haberer et al., 2012; Vreeman, 
Nyandiko, & Liu, 2015), several subjective and objective measures exist to measure 
medication adherence amongst adults and children on chronic and acute medication regimens 
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(Rapoff, 2010). Adherence measures may be categorized into either direct methods or indirect 
methods (Osterberg & Blaschke, 2005; Reda & Biadgilign, 2012). Table 2.1 summarizes the 
available direct and indirect methods to measure adherence to ART. In the section following 
the table, a description of each of the methods is given. 
Table 2.1 
Direct and Indirect Measures of Paediatric Adherence to ART 
Method Measure 
Direct methods  
 
Biological markers 
Body fluid assays 
 
  
Indirect methods  
Primary outcome measures  
 Caregiver self-report 
 Pill counts/ volume measure 
 Pharmacy re-fill records 
 Clinic attendance records 
 Electronic drug monitoring (EDM) 
Secondary outcome 
measures 
 
 Clinical response assessment (VL, CD4 lymphocyte count) 
 
Physiological markers (Drug monitoring in hair, Resistance 
testing) 
    
 
Direct methods. Biological markers and body fluid assays. Direct methods make use 
of laboratory tests to measure the amount of drug metabolite present in urine or blood using 
biological assays, and are also able to measure the amount of drug available in the blood by 
detecting biological markers associated with the different formulations (Osterberg & 
Blaschke, 2005). Laboratory tests such as these are expensive and require sophisticated 
laboratory infrastructure, but are also highly prone to confounding when patients take their 
medications shortly before a scheduled clinic visit (Osterberg & Blaschke, 2005). 
Furthermore, given the uncertainty of paediatric ARV pharmacokinetics, direct methods such 
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as plasma drug levels have seldom been used as a measure of adherence in children globally 
(Bain-Brickley, Butler, Kennedy, & Rutherford, 2011).  
In a recent study by Vreeman et al. (2014), the authors used EDM (in the form of the 
Medication Events Monitoring System (MEMS)), caregiver reports and blood drug 
concentration levels of Nevirapine (NVP) and Efavirenz (EFV) to assess adherence rates 
among 191 children with a mean age of 8.2 years at baseline. Plasma drug concentrations of 
NVP and EFV were dichotomized as ‘adherent’ when therapeutic (NVP 3.0–7.6 
micrograms/millilitre [µg/mL] or EFV 1.0–4.0 µg/mL) and supra-therapeutic (NVP >7.6 
µg/mL or EFV >4.0 µg/mL) drug levels were observed, and as ‘non-adherent’ when sub-
therapeutic (NVP <3.0 µg/mL or EFV <1.0 µg/mL) levels were observed. MEMS adherence 
was estimated using the percentage of doses (NVP/EFV) returned and dichotomized as 
‘adherent’ if more than 90% doses were taken, and ‘non-adherent’ if fewer than 90% of doses 
were taken over a one-month period. Using Kappa statistics to compare adherence estimates 
across the adherence measures, plasma drug concentrations of NVP and EFV showed poor 
agreement (Kappa statistics 0.04–0.37) with MEMS data (Vreeman et al., 2014).  
One of the explanations for this finding was that the MEMS data represented a 
calculation of adherence across a one-month period, whereas drug concentrations only 
reflected adherence within the past hours or days of the medication being taken. The authors 
have stated that drug correlations were likely to have a higher correlation with MEMS data if 
MEMS calculations were restricted to doses taken within the past 2 to 3 days (Vreeman et al., 
2014).  
Indirect methods. Indirect measures include caregiver self-report questionnaires, 
clinical response assessments (VL monitoring, CD4 lymphocyte count monitoring), 
physiological markers (drug monitoring in hair, resistance testing), pill counts, pharmacy 
refill records, clinic attendance and EDM.  
Stellenbosch University  https://scholar.sun.ac.za
  
31 
 
Caregiver self-report. Among the paediatric population, caregiver self-report is the 
predominant measure used to estimate adherence (Arage, Tessema, & Kassa, 2014; Bain-
Brickley et al., 2011; Buchanan & Montepiedra, 2012; Müller et al., 2011; Teasdale et al., 
2013; Usitalo et al., 2014). Caregiver self-report measures usually require caregivers to recall 
the number of doses administered in a specified time bracket (e.g. in the past week). In a 
recent study by Arage et al. (2014), adherence rates were estimated via caregiver self-report 
of children (mean age 9.4 years) attending hospitals in North-East Ethiopia. The authors 
collected data from 440 caregivers using face-to-face structured interviews. Caregivers 
reported adherence rates of 78.6% in the month prior to the structured interview (Arage et al., 
2014). These adherence rates are comparable to other LMIC countries in Africa (Azmeraw & 
Wasie, 2012) and Vietnam (Do, Dunne, Kato, Pham, & Nguyen, 2013).  
Despite the cost-effectiveness and reporting ease associated with self-report measures, 
estimates of adherence using caregiver self-report compared to other adherence indicators 
such as VL and CD4 count are inconsistent in the literature, with self-reports erring on 
overestimating adherence as a consequence of over-reporting, recall problems, as well as 
social desirability bias, in high, as well as LMIC. Consequently, researchers have tried to 
statistically validate self-report questionnaires against other indirect methods considered to be 
more objective measures (such as EDM) (Allison et al., 2010; Berg & Arnsten, 2006; Chalker 
et al., 2010; Davies, Boulle, Fakir, Nuttall, & Eley, 2008; Mellins, Brackis-Cott, Dolezal, & 
Abrams, 2004; Naar-King, Frey, Harris, & Arfken, 2005; Vreeman et al., 2015; Wagner & 
Miller, 2004). 
Vreeman et al. (2015) are amongst the first authors to evaluate caregiver self-report 
against EDM in a resource-limited setting in a paediatric population. These authors 
developed a 48-item adherence questionnaire that includes items assessing missed doses by 
recall in the past 3, 7 and 30 days, as well as by visual analogue scale (VAS). The 
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questionnaire also includes items pertaining to barriers to adherence and household 
characteristics. MEMS adherence was dichotomized as either >90% or <90%. Children (aged 
new-born to 14 years) and caregivers were followed over a period of 6 months and caregivers 
completed the self-report measure every month. One hundred and ninety one caregivers 
completed the adherence measure (seven times each). Using a novel method for variable 
selection (the Least Absolute Shrinkage and Selection Operator (LASSO) (Meier et al., 
2008)), the authors identified nine items that best predicted adherence and corresponded with 
MEMS adherence data (>90%) (Vreeman et al., 2015). The adherence questionnaire items are 
shown in Table 2.2 below. 
Table 2.2 
Nine item adherence questionnaire developed by Vreeman et al. (2015) 
1 Ever have problems keeping time with the medicines  
2 Currently enrolled in AMPATH nutrition programme  
3 Ever have problems getting child to take medicines 
4 How many doses of medicine has child missed in last month  
5 Child-level factors make it difﬁcult to give medicines  
6 Caregiver-level factors make it difﬁcult to give medicines 
7 Number of days missed at least one dose in past week 
8 Number of days dose given more than one hour late in past week 
9 Number of extra doses in past week 
 
Clinical response assessments (VL monitoring, CD4 lymphocyte count monitoring). 
Clinical response assessments consist of VL monitoring and CD4 counts. In the research 
literature, these assessments are usually secondary outcome measures of adherence and are 
used alongside other indirect methods, such as caregiver self-report to estimate adherence 
rates (Simoni et al., 2007). In the context of resource-limited settings, VL monitoring 
alongside patient self-report is considered the best predictor of long-term adherence 
(Nieuwkerk & Oort, 2005; Vreeman et al., 2015). However, VL testing is not available 
everywhere, and thus many resource-limited countries still rely on indirect methods, 
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especially self-report measures (Haberer et al., 2012; Vreeman, Wiehe, Pearce, et al., 2008; 
Vreeman et al., 2014). In the absence of VL testing, self-report and pill counts have shown to 
correlate well with objective measures such as EDM (Haberer et al., 2012; Van Dyke et al., 
2002).  
Physiological markers (drug monitoring in hair). Although not commonly used to 
assess adherence to ART in paediatric populations, assessing ARV drug levels using hair is 
considered a promising new approach to measuring adherence (Olds, Kiwanuka, Nansera, et 
al., 2015; Prasitsuebsai et al., 2015). The method reflects adherence levels over longer 
periods of time (weeks to months), is easy to collect and store, and correlates with drug levels 
in plasma and VL suppression (Gandhi et al., 2013; Olds, Kiwanuka, Nansera, et al., 2015; 
Prasitsuebsai et al., 2015). Given the cultural significance of hair among certain cultural 
groups, more evidence is needed to inform its use as a drug level testing application across 
different cultural contexts (Coetzee, Kagee, Tomlinson, Warnich, & Ikediobi, 2012).   
Pill counts/liquid formulation weights. Pill counts offer an estimation of adherence 
based on counting the number of pills or measuring/weighing the amount of liquid returned at 
each clinical follow-up visit compared to the amount previously prescribed (Chalker et al., 
2010; Haberer et al., 2012; Ross-Degnan et al., 2010). Studies estimating paediatric 
adherence rates using pill counts have shown high rates (>80%) of adherence to ART 
(Bagenda et al., 2011; Eticha & Berhane, 2014; Haberer et al., 2011). However, pill counts 
may be confounded by patients who deliberately remove pills from their bottles (Haberer et 
al., 2011). Haberer et al. (2012) have estimated ART adherence using multiple subjective 
(Visual Analogues Scale (VAS), three-day recall, pill counts/liquid formulation weights) and 
objective (MEMS data, and six-monthly HIV/ ribonucleic acid [RNA] levels) measures of 
adherence among 121 children aged 2 to 10 years in Uganda. Although pill counts/liquid 
formulation weights were significantly correlated with MEMS data, they did not significantly 
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correlate with HIV RNA levels. The authors have argued that unannounced pill counts/liquid 
formulation weights were resource intensive and possibly failed to significantly correlate 
with HIV RNA levels due to the inability to accurately measure the amount of liquid 
dispensed at refill visits (Haberer et al., 2012).  
Pharmacy refill records. Similar to estimates based on caregiver self-report, studies 
that estimate adherence using pharmacy refill are inconsistent with regard to the specific 
period over which adherence is estimated (whether over three months or the past year) 
(Bagenda et al., 2011; Burack, Gaur, Marone, & Petrova, 2010; Farley, Hines, Musk, Ferrus, 
& Tepper, 2003; Marhefka, Tepper, Brown, & Farley, 2006; Müller et al., 2011). Furthermore, 
complicating the usefulness of pharmacy refill data are the broad cut-off percentages used to 
estimate adherence, with studies estimating adherence based on more than 75% of 
medications refilled to more than 95% of medications refilled (Simoni et al., 2007).  
Clinic attendance. In the context of paediatric HIV, caregiver attendance at the clinic 
to collect medication has been used to monitor adherence (Yoder et al., 2012). However, as 
with several other measures, adherence rates varied widely. Studies that have reported on 
adherence as assessed by clinic attendance suggest that adherence to clinic attendance 
decreases when estimated over longer periods of time (Simoni et al., 2007).  
Electronic drug monitoring (EDM). EDM in the form of devices like MEMS-cap 
and Wisepill (www.wisepill.com) have been considered among the most reliable methods of 
adherence monitoring (Haberer et al., 2012; Olds, Kiwanuka, Nansera, et al., 2015). The 
devices electronically capture the number of times the lid of the medication bottle, or the bag 
containing liquid formulations, has been opened and wirelessly communicates this 
information to the receiver (clinician or researcher) (Olds, Kiwanuka, Nansera, et al., 2015). 
The device, however, is not able to capture whether pills were removed and subsequently 
ingested, or only removed. EDM is considered the most favourable of the indirect methods as 
Stellenbosch University  https://scholar.sun.ac.za
  
35 
 
it is less prone to respondent bias, and has been shown to correlate highly with secondary 
outcome measures like VL (Farley et al., 2003; Müller, Bode, Myer, Roux, & von 
Steinbüchel, 2008). However, the financial and logistical needs of this electronic device have 
made it unfeasible in resource-limited settings (Müller et al., 2011).  
Despite the variability in adherence measures and adherence assessment criteria, the 
literature shows that adherence rates in SSA are comparable and in several instances higher 
than those in high-income countries. However, the higher rates are still not suggestive of 
optimal rates of adherence, and research suggests that adherence rates may worsen over time 
(Byakika-Tusiime et al., 2009; Gill, Hamer, Simon, Thea, & Sabin, 2005).  
Consequences of poor adherence to ART 
In order to achieve the optimal outcomes of HIV treatment (suppressed VL and an 
increased CD4 count), excellent adherence to ART is required. Excellent adherence requires 
taking ≥ 95% of the prescribed dose (Bangsberg, 2001). However, research amongst adults 
has shown that viral suppression can be achieved at lower rates of adherence (>70%) with 
different regimen types, for example nucleoside reverse transcriptase inhibitor (NNRTI) 
versus protease inhibitor (PI)-based regimens, with ART users on PI regimens achieving viral 
suppression at lower rates of adherence (Parienti et al., 2010). A similar finding was made 
amongst a small number of South African children (n=66), where children on boosted PI 
regimens achieved viral suppression with lower rates of adherence (<80%) (Muller et al., 
2009). Nevertheless, the percentage adherence required to achieve viral suppression remains 
unclear among infants and children on ART (Teasdale et al., 2013). For example, amongst 
children in Zambia, more than 80% adherence was necessary to achieve viral suppression 
(Haberer et al., 2011), whereas amongst children in a South African cohort more than 90% 
adherence to ART was necessary to achieve viral suppression (Davies et al., 2008). Similar 
rates (>90%) of adherence were needed amongst children in the United States (Farley et al., 
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2008). In a study by Teasdale et al. (2013) amongst 269 children on ART, more than 85% 
adherence to ART was required for viral suppression. Non-adherence, especially to LPV/r, 
increased the likelihood of not achieving viral suppression (Teasdale et al., 2013).  
Poor adherence is associated with minimalizing the effects of antiretrovirals (ARVs) 
(due to lower blood levels of ARVs), eventually resulting in virological resistance leading to 
opportunistic infection and ultimately to sustained drug failure (Davies et al., 2011; Genberg 
et al., 2012; Maggiolo et al., 2007; Pillay et al., 2014; Shekelle et al., 2007). Recent evidence 
from KwaZulu-Natal in South Africa shows that increasing numbers of children left on 
failing regimens are developing drug resistant mutations in their DNA, which if left 
uncontrolled have serious implications for future treatment options (Pillay et al., 2014). 
In a study by Davies et al. (2011), data from more than 6000 children belonging to 
seven paediatric programmes in South Africa (International epidemiologic Databases to 
Evaluate AIDS (IeDEA) Southern Africa) was used to estimate the probability of virologic 
failure and a switch to a second-line regimen. The findings showed that the probability of 
virologic failure at three years was close to 20% (19.3%, 95% confidence interval (CI), 17.6 
– 21.1). Two hundred and fifty-two children were followed up one year after failure, of which 
38% were switched to a second-line regimen. These data suggest that children experienced 
virologic failure and increased access to second-line ART is needed (Davies et al., 2011). 
Viral resistance is problematic, especially in South Africa where access to second-line 
regimens is poor and no third-line options are available (Pillay et al., 2014). Untreated, 
resistant strains may be transmitted, especially amongst children maturing into adolescence 
and engaging in sexual relationships (Haberer & Mellins, 2009).  
Factors affecting adherence to ART 
Factors affecting paediatric adherence to ART have been identified via both 
quantitative and qualitative methods, with the majority of factors identified via quantitative 
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means. Several systematic reviews of paediatric adherence to ART have been conducted 
(Haberer & Mellins, 2009; Pontali, 2005; Reda & Biadgilign, 2012; Santer et al., 2014; 
Simoni et al., 2007; Steele & Grauer, 2003; Vreeman, Wiehe, Pearce, et al., 2008), some of 
which have drawn on literature reporting on factors influencing adherence in order to provide 
a framework for and conceptualization of adherence (Haberer & Mellins, 2009); while others 
have specifically aimed to provide estimates on adherence rates across developing and 
developed settings, with an additional focus on predictors and correlates of adherence 
(Simoni et al., 2007; Vreeman, Wiehe, Pearce, et al., 2008).  
In an attempt to provide a conceptual framework for understanding paediatric 
adherence to ART, Haberer et al. (2009) have suggested four dimensions for organising the 
factors, namely (1) child-related factors (e.g. the influence on adherence of physical and 
neurological development, as well as the role of health, nutrition and psychosocial function); 
(2) caregiver-related factors (e.g. the influence of caregivers’ physical and mental health, 
knowledge and beliefs about ART); (3) regimen-related factors (e.g. difficulties involved with 
drug formulation, and changes in regimen); and (4) social- and cultural-related factors (e.g. 
the influence of traditional or other non-Western medicine on adherence) (Haberer & Mellins, 
2009). An additional dimension includes health system-related factors (e.g. the influence of 
drug stock-outs, drug costs, healthcare facility accessibility, relationship with healthcare 
provider (s) and counselling services) on adherence to ART (Pontali, 2005; Reda & 
Biadgilign, 2012). 
The above-mentioned factors are in keeping with constructs related to EST 
(Bronfenbrenner, 1979). Child-related factors, and factors specific to the key role players 
(such as caregivers, family members and health providers) may be conceptualized as 
operating in the child’s microsystem. Factors affecting the relationships between members of 
the microsystem that either directly or indirectly influence adherence may be conceptualized 
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as operating within the mesosystem. Health systems-related factors may be conceptualized as 
operating within the exosystem, and social and cultural factors in the macrosystem (Naar-
King et al., 2006; Vreeman et al., 2009). Table 2.3 summarizes factors influencing adherence 
as identified in the systematic reviews mentioned above.  
Table 2.3 
Factors Affecting Paediatric Adherence to ART  
Level  Factors 
Child-related factors Developmental stage and age 
 Health and nutrition  
 Treatment fatigue 
 Knowledge of HIV status 
 Psychosocial function 
 
Orphan status 
Palatability 
 Refusal of treatment 
 Pill burden  
 Lack of benefits associated with taking medications  
 Forgetfulness  
 Attitude and beliefs about ART 
Caregiver and family-
related factors  
 Nature of caregiver and caregiver permanence  
 
Caregiver knowledge and beliefs about ART  
Caregiver education and comprehension of ART administration  
 Caregiver psychosocial function  
 Disclosure of HIV status to child and others 
 Caregiver-child relationship  
 Poverty and food insecurity  
 Caregiver ill health  
 Substance abuse 
 Family disruptions/extended caregiving 
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Table 2.3 (continued)  
Level  Factors 
Regimen-related factors  
 Changing regimen 
 Drug formulation 
 Taste and palatability 
 Size of tablets and capsules 
 Storage requirements 
 Regimen complexity 
 Toxicity and side effects 
Health system-related 
factors  
 Drug stock-outs 
 Drug costs 
 Healthcare facility accessibility 
 Relationship with healthcare provider 
 Adherence counselling 
Social and cultural- 
related factors  
 Traditional medicines and distrust in western medicine 
  Cultural norms 
 
Child related factors. Developmental stage and age. As children get older, the 
literature suggests that adherence becomes progressively worse (Marhefka et al., 2008; 
Mellins et al., 2004; Williams et al., 2006), as the need to be independent from the caregiver 
and to establish an identity amongst peers begins to outweigh the importance of adherence to 
medications (Azzopardi et al., 2014; Haberer & Mellins, 2009). However, the influence of 
age on adherence remains undecided as some studies have found no age relation with non-
adherence (Marhefka et al., 2008). Marhefka et al. (2008) have argued that the lack of support 
for a definitive association may be due to mediating factors such as regimen responsibility. In 
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a qualitative study by Fetzer et al. (2011) children (aged 8 to 17 years) from the Democratic 
Republic of the Congo stated that they felt constrained by the regimen in that they had to take 
medication daily, and they were markedly aware that their peers did not have to deal with 
such issues. The frustration experienced with the treatment was especially salient amongst 
those who were unaware of their status, and those children who were older (Fetzer et al., 
2011). In a quantitative study amongst 269 South African children (aged 6 to 104 weeks), the 
most commonly reported barrier to adherence as reported by their caregiver was the child 
being uncooperative when medication was administered (Teasdale et al., 2013).  
Health and nutrition. Children with chronic illnesses often have several health-
related complications that influence adherence. The relationship between adherence and 
health status, however, remains obscure. For example, Nabukeera-Barungi et al. (2007), have 
found that CLWH in Kampala, Uganda, who were hospitalized one or more times before 
commencing treatment were significantly more likely (OR 0.44, 95% CI 0.20-0.92) to have 
optimal rates of adherence, defined as taking more than 95% of the prescribed medication 
(Nabukeera-Barungi, Kalyesubula, Kekitiinwa, Byakika-Tusiime, & Musoke, 2007). The 
higher reported rates of adherence may have been a sign of motivation to get better (Haberer 
& Mellins, 2009).  
Furthermore, children on ART predominantly reside in resource-limited settings 
where access to nutritional foods to aid growth and development are often lacking (Young, 
Wheeler, McCoy, & Weiser, 2014). In the absence of nutritional foods, children often 
experience side effects (e.g. nausea) associated with taking medication on an empty stomach. 
Children have reportedly experienced side effects such as a burning sensation when ART was 
taken on an empty stomach, dizziness or light-headedness when they did not take their 
medications with food (Fetzer et al., 2011). In the study by Fetzer et al. (2011), food was not 
always available and some of the children stated that they refused to take medication without 
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food (Fetzer et al., 2011). In the absence of food some caregivers forgo ART administration, 
which affects adherence to ART (Coetzee et al., 2015). 
Treatment fatigue. Although there appears to be no clear definition of treatment 
fatigue in the literature (Claborn, Meier, Miller, & Leffingwell, 2015), factors contributing to 
treatment fatigue in infants and young children include high pill burden and side effects 
(Marhefka et al., 2006), while increased autonomy of medication management among 
adolescents has been associated with lower levels of adherence (Mellins et al., 2004).  
Knowledge of HIV status. As children age, it becomes increasingly important to 
communicate to them the nature of their health problems. Evidence from disclosure studies 
(discussed again further on) suggest that children’s knowledge about the nature of their 
illness facilitates on-going participation in a treatment regimen, and also allows the child to 
adjust better to living with a chronic illness (Vreeman et al., 2013). A lack of open 
communication with a parent or caregiver may result in the child being unable to address 
difficulties surrounding the illness (Havens & Mellins, 2008). Effective communication 
between the child and the caregiver may be said to exist when the caregiver (provided he/she 
has been adequately advised on the treatment regimen) has communicated the importance of 
taking medication and the child understanding this, and thereby participating in the necessary 
activities. In a study by Fetzer et al. (2011), children living in Kinshasa in the Democratic 
Republic of the Congo who had not been disclosed to struggled to understand the rationale of 
continued medication taking while healthy (Fetzer et al., 2011).  
Psychosocial function. Children living with chronic illnesses, particularly highly 
stigmatized illnesses such as HIV, experience psychological distress in the form of depression 
and anxiety, which has negative outcomes on adherence (Mellins et al., 2004; Reisner et al., 
2009). In a study by Mellins et al. (2004), children reporting more stressful life events were 
more likely to be non-adherent than those not reporting stressful life events. CLWH 
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experience emotional pain and complicated feelings related to being alone following the 
death of one or more family members. CLWH also experienced guilt and anger, as well as 
confusion, depression and fear (Battles & Wiener, 2002; Brown, Lourie, & Pao, 2000). The 
loss of a parent is psychologically traumatic, especially when no support is received during 
the period of bereavement (Battles & Wiener, 2002; Rao, Kekwaletswe, Hosek, Martinez, & 
Rodriguez, 2007).  
Orphan status. Children orphaned by HIV face several difficulties associated with 
treatment initiation, family care and stability and adherence (Mokgatle & Madiba, 2015). 
Evidence from SSA show a high prevalence of orphanhood among undiagnosed children 
(Mokgatle & Madiba, 2015). For example, a recent cross-sectional survey from South Africa 
of primary caregivers’ (n=406) reasons for seeking HIV testing among children aged 5-18 
years showed that 45.1% were maternal orphans, 31.5% were paternal orphans and 39.9% 
were double orphans1. Thus, many CLWH in SSA are shown to present late for treatment 
initiation following several months or years of poor health (Mokgatle & Madiba, 2015). 
Several studies have shown that children initiating ART at an advanced disease stage are at a 
heightened risk for morbidity and mortality (Davies, Egger, Keiser, & Boulle, 2009; Davies, 
2015; Fenner et al., 2010).  
In many African settings, including South Africa, family members (usually 
grandparents) take responsibility for an orphaned child’s care (Mokgatle & Madiba, 2015; 
Wacharasin & Homchampa, 2008). In many ways the disruption in family structure 
contributes to poor adherence. In a study by Bhattacharya and Dubey (2011) in India, orphan 
status was significantly associated (OR=3.57, 95% CI 1.13 -9.25) with poorer adherence. The 
authors have argued that this relationship may reflect the inability of extended families to 
                                                 
1 The percentage for orphan status exceeds 100% as double orphans were calculated from maternal and 
paternal orphans (Mokgatle et al., 2015).  
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care for orphaned children (Bhattacharya & Dubey, 2011). In addition to poorer access to 
healthcare and family disruption among orphaned children, the loss of a parent is traumatic 
and psychologically burdensome. Consequently, the trauma of losing a parent coupled with 
the psychosocial stressors related to living in poverty may contribute to depression and 
anxiety in some children (Rochat et al., 2008), often with long-lasting effects (Bowlby, 1969; 
Richter, 2004). 
Palatability and refusal of treatment. Infants and young children (especially those 
younger than five years) struggle with palatability issues, especially with bitter tasting 
medications like LPV/r (Davies et al., 2008; Horace & Akbarian-Tefagh, 2013; Lowenthal et 
al., 2011), which often leads to vomiting, spitting out of medications or a refusal to take their 
medications (Biadgilign et al., 2009; Coetzee et al., 2015). Even for most adults, engaging in 
behaviour with noxious side effects for future health benefits is effortful (Havens & Mellins, 
2008). For children, poor palatability of the medications is coupled with consistent refusal to 
take the medications, and instances of repeated vomiting where a caregiver may then be 
reluctant to re-administer the dose (Elise et al., 2005). In a recent study by Arage et al. 
(2014), child refusal of the medication (among 19% of the sample) constituted one of the 
major reasons for non-adherence, and is supported by several other studies (Arage et al., 
2014; Biressaw, Abegaz, Abebe, Taye, & Belay, 2013; Wasti et al., 2012).  
Although the literature suggests that young children struggle with medication 
palatability and often refuse treatment on this basis, there is evidence to point to the contrary. 
For example, amongst 48 children (younger than five years of age) enrolled in a qualitative 
study in South Africa, most children acknowledged taking medicine and liking it as well. A 
more important concern for children in this study was receiving an injection. Furthermore, 
none of the children reacted negatively when they were presented with treatment cues 
(medicine spoon and syringe). In fact, children demonstrated (using a toy doll) that they were 
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able to take ownership of the medication by showing the research staff how to administer 
medication (Rochat et al., 2008).  
Pill burden. Young children usually take several ARV medications at the same time as 
other medications to treat opportunistic infections, including TB medications. Consequently, 
high pill burden has been associated with poor adherence in children on ART (Bhattacharya 
& Dubey, 2011; Biadgilign et al., 2009).  
Forgetfulness. Among older children who have taken increased responsibility for 
their treatment, factors such as forgetfulness influence adherence (Buchanan & Montepiedra, 
2012; Elise et al., 2005; Fetzer et al., 2011; Marhefka et al., 2008). Integration of the 
treatment into children and caregivers’ daily routine has been shown to facilitate adherence 
and reduce forgetfulness (Hammami et al., 2004).  
Caregiver and family-related factors. Nature of caregiver and caregiver 
permanence. The role of a caregiver or family member in the lives of young CLWH is vital 
(Richter, 2004; Rochat et al., 2008). Caregivers’ behaviours and responses to the environment 
are studied, scrutinized and eventually modelled by the child (Bandura, 1989; Rochat et al., 
2008). The influence of caregivers’ biological relationship to the child on adherence is 
inconsistent throughout the literature. A study by Jaspan et al. (2011) among caregivers and 
children (median age of 4 years) in South Africa has shown an improvement in adherence 
when a mother was in charge of, and responsible for the treatment and care of the child. 
However, the authors never ascertained whether these mothers were the biological mothers of 
these children, as culturally (in isiXhosa, a language spoken in South African) the word 
“mother (mama)” is used to describe any female taking care of a child. Furthermore, the 
authors never assessed whether these children were living with their biological fathers 
(Jaspan et al., 2011). However, in a study in the United States among children with a mean 
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age of 11 years, biological mothers were associated with poorer adherence (Williams et al., 
2006).  
Paediatric adherence may be disrupted by a change in caregivers due to reasons such 
as the death of caregiver, daily commitments to other activities, extended periods of work, 
migration to new areas for schooling purposes (Hosegood, Preston-Whyte, Busza, Moitse, & 
Timaeus, 2007), attending holy places or other places of residence for periods of time 
(Biadgilign et al., 2009), lack of disclosure and limited adherence counselling and education 
with a new caregiver (Haberer & Mellins, 2009). Some studies have found that younger 
children receiving ART from non-parental caregivers (e.g. foster parents) achieved superior 
levels of adherence than those receiving ART from their biological parents (Giacomet et al., 
2003), whereas others have found worse levels of adherence (Cupsa, Gheonea, Bulucea, & 
Dinescu, 2000). Similarly, the influence of multiple caregivers (i.e. more than one person 
administering medication) on adherence to ART remains inconclusive (Fassinou et al., 2004; 
Haberer et al., 2011).  
Caregiver knowledge and beliefs about ART. Caregiver education levels have been 
associated with adherence. For example, some studies have reported poorer rates of 
adherence amongst caregivers with low levels of education (Bhattacharya & Dubey, 2011), 
while others report that higher caregiver education levels are associated with poorer rates of 
adherence (Arage et al., 2014). Other studies have found that caregivers who are on ART 
themselves may draw from their own treatment experiences in order to optimize adherence 
for the child (Haberer & Mellins, 2009). In the study by Arage et al. (2014) Ethiopian 
caregivers who had education beyond primary level were less likely to adhere to the regimen 
than illiterate caregivers (Arage et al., 2014). Arage et al. (2014) have argued that caregivers 
with higher levels of education were more likely to be employed and spend less time with 
children to administer medications or to forget to do so on busy days (Arage et al., 2014).  
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While the influence of caregivers’ education levels on adherence is inconsistent within 
the literature, studies have shown that children whose caregivers are knowledgeable about 
ART are more likely to be adherent than those with no knowledge about ART (Arage et al., 
2014; Olds, Kiwanuka, Ware, et al., 2015; Wachira et al., 2012). For example, in the study by 
Arage et al. (2014), caregivers who were knowledgeable of the regimen were 2.7 times more 
likely to be adherent to the regimen compared to those with no knowledge. Caregivers with 
no knowledge of the benefits of ART may thus be poorly motivated to adhere to the treatment 
regimen (Arage et al., 2014).  
Some caregivers find motivation to adhere to the regimen through the visible 
improvement of the child’s overall health on ART. In the qualitative study by Olds et al. 
(2015), the authors have noted the impact of the ‘Lazarus effect’ on motivation to adhere to 
ART amongst caregivers to children on ART (median age of 7 years) in rural Uganda. Thus, 
the visible improvement in the child’s overall health motivated caregivers to consistently 
provide the child’s medication (Olds, Kiwanuka, Ware, et al., 2015). However, the benefits 
are often weighed against the costs of regular clinic attendance (Wachira et al., 2012). 
Administration of medication, especially liquids, to children is challenging as they spill easily 
during administration. Using a syringe and taking accurate measurements has also proved a 
difficult task, especially for elderly caregivers. Some studies have shown that caregivers’ 
perceived difficulty with ART administration (i.e. their perceptions that they are not able to 
administer treatment to those in their care adequately) is negatively associated with adherence 
(Polisset, Ametonou, Arrivé, Aho, & Perez, 2009; Reddington et al., 2000). 
Caregiver psychosocial function. Caregivers’ ability to care for the various needs of 
children is severely compromised in the presence of mental health issues (Rochat et al., 
2008), and psychosocial stress (Marhefka et al., 2006). Depression has consistently been 
linked with poor adherence in adults and adolescents on ART (Amberbir, Woldemichael, 
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Getachew, Girma, & Deribe, 2008; Byakika-Tusiime et al., 2009). The influence of caregiver 
depression on children’s adherence to ART is not well described in the literature, and is 
almost absent in research from Africa (Jaspan et al., 2011). However, studies on maternal 
depression amongst HIV positive women have shown that symptoms of depression 
negatively impact caregiving ability, as depressed caregivers are less likely to interact 
meaningfully with their children (Murray, Fearon, & Cooper, 2015; Naar-King et al., 2006; 
Parsons, Young, Rochat, Kringelbach, & Stein, 2012). Gonzalez, Batchelder, Psaros and 
Safren (2011) have emphasized that interventions aimed at reducing depression should be a 
priority in behavioural research (Gonzalez, Batchelder, Psaros, & Safren, 2011). Ongoing 
adherence counselling and psychosocial support improve caregiving ability and have been 
associated with higher rates of adherence among children who rely on caregivers (Biadgilign 
et al., 2009). Caregivers who lack an adequate support structure have difficulty with 
consistently and accurately providing treatment to children on ART (Mellins et al., 2004; 
Polisset et al., 2009).   
Disclosure of HIV status to child and others. For caregivers of children living with 
ART, disclosure of a child’s HIV status to the child remains a controversial topic. A 
systematic review by Vreeman et al. (2013) of disclosure to children in resource-limited 
settings have shown that disclosure rates are low (ranging from 0% -62%, among samples 
aged between 0 and 21 years) (Vreeman et al., 2013). For example, Feinstein et al. (2010) 
have reported that among 492 children between the ages of four and 18 years in Soweto, 
South Africa – 3% of four- to six-year-olds knew their status, 17% of seven- to 10-year-olds 
knew their status and 77% of children older than 11 knew their status (Feinstein, Moultrie, 
Myers, & Rie, 2010).  
The review identified seven studies (six qualitative (Demmer, 2011; Kouyoumdjian, 
Meyers, & Mtshizana, 2005; Moodley, Myer, Michaels, & Cotton, 2006; Myer, Moodley, 
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Hendricks, & Cotton, 2006; Petersen et al., 2010; Yeap et al., 2010) and one quantitative 
(Feinstein et al., 2010)) on disclosure to children in South Africa. Only three of the studies 
provided proportions of disclosure among their samples (Feinstein et al., 2010; Moodley et 
al., 2006; Petersen et al., 2010), while all provided factors influencing disclosure. Salient 
factors contributing to non-disclosure (across the studies included in the review) were 1) 
child was too young, 2) fear that the child would disclose to others and invite stigma, 3) 
concerns that the child’s emotional and physical health would worsen, 4) feeling unprepared 
to disclose to the child and 5) and fear of resentment from the child.  
Caregivers to children in high-income countries share many of these fears and 
concerns (Hammami et al., 2004). For example, in a qualitative study by Hamammi et al 
(2004), caregivers in Belgium stated that children who were not physically ill had difficulty 
understanding why they needed to take their medicines. Caregivers stated that they felt their 
children were too young to be disclosed to and they commonly told children that taking the 
medication was necessary for them not to feel sick again (Hammami et al., 2004).  
Studies reporting on the impact of disclosure on adherence to ART remain 
inconclusive, although Vreeman et al. (2013) have argued that based on available evidence 
(mostly from qualitative studies), disclosure plays an important role in adherence (Bikaako-
Kajura et al., 2006; Corneli et al., 2009; Fetzer et al., 2011; Hejoaka, 2009). In a recent cross-
sectional study among 440 children on ART in Ethiopia (aged 0 – 14 years, mean = 9.4 
years), at least half knew their status. Children who knew their HIV status were nearly four 
times (Adjusted Odds Ratio [AOR] = 3.47(95% CI: 2.10, 6.81) more likely to be adherent 
than those without knowledge of their status (Arage et al., 2014).  
Disclosure provides children with the opportunity to become involved and take 
increased responsibility for their own treatment (Fetzer et al., 2011; Hammami et al., 2004). 
Growing evidence supports a gradual process of disclosure where children receive age-
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appropriate information about their illness until they are older and considered emotionally 
and cognitively equipped to deal with the knowledge of their illness (Atwiine, Kiwanuka, & 
Musinguzi, 2015; Vreeman et al., 2013). Despite available guidelines for disclosure (e.g. 
World Health Organization, 2011), more evidence is needed to include context specific and 
culturally informed recommendations (Vreeman et al., 2013). 
Equally burdensome to many caregivers is the disclosure of their own status to the 
child, and disclosure of their own status and the child’s status to others (Vreeman et al., 
2013). In a study conducted by Wachira et al. (2012) in Kenya, disclosure of the caregivers’ 
HIV status to the child as well as to family and other community members presented various 
challenges to the caregivers interviewed. Disclosure to close family members was done as a 
means to access both emotional and financial support. Non-disclosure was largely attributed 
to a fear of being stigmatized by others and losing financial support from a male partner. The 
inability to disclose meant that caregivers had difficulty in getting time off from work to 
attend clinic visits and were unable to access valuable sources of support (Wachira et al., 
2012). Supportive relationships with adult family members, healthcare providers and teachers 
have also shown to improve adherence to ART (Bikaako-Kajura et al., 2006).  
Busza, Dauya, Bandason, Mujuru, and Ferrand (2014) have found that a lack of 
disclosure to others limited ways in which Zimbabwean caregivers were able to administer 
medications to the child while in the company of others and often led to skipping doses 
(Busza, Dauya, Bandason, Mujuru, & Ferrand, 2014). Similarly, in a qualitative study by 
Biadgilign et al. (2009), both caregivers and healthcare providers reported that children 
seldom knew their HIV status and that this impacted on the available space to administer 
treatment to the child when others were visiting (Biadgilign et al., 2009). Non-disclosure may 
also force caregivers to become secretive about the treatment and hide medications. When 
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medications are hidden away caregivers may miss dosing times, which may negatively 
impact on the child’s health (Calabrese et al., 2012).  
Caregiver-child relationship. Among infants and young children, caregivers are 
responsible for every aspect of a child’s needs (Richter, 2004). Strong and supportive 
caregiver-child relationships are fundamental to child development, especially in the first 
three years of life. However, the quality of the care a child receives from their carer is based 
on how sensitive the caregiver is to the child’s needs (sensitivity) and whether the caregiver 
responds appropriately (responsiveness) to any distress the child may be experiencing 
(Richter, 2004).  
In the context of triple combination therapy treatment for children on ART and 
distasteful medications, medication events are likely to be stressful for young children. 
Caregivers should be able to respond appropriately to stressful cues (such as crying) in a 
child, as failure to do so might contribute to poor health outcomes in the child (Richter, 
2004). There is evidence to suggest that poor relationships between caregivers and children 
contribute to poor adherence. In a study amongst caregivers and children in New York, 
Mellins et al. (2004) have shown that poor parent-child communication, as assessed by the 
Parent-Child Relationship Inventory (Gerard, 1994), was significantly associated (t =2.45, 
P=0.017) with non-adherence (Mellins et al., 2004). A strong caregiver-child relationship has 
also been shown to foster a sense of motivation and obligation amongst caregivers to keep the 
child healthy and nourished (Olds, Kiwanuka, Ware et al., 2015).  
Poverty and food insecurity. Poverty is one of the most debilitating barriers to 
adherence to ART and fuels many other barriers associated with non-adherence, such as 
financial and food insecurity. Structural barriers as a result of poverty include the lack of 
money for transport to adhere to monthly clinic appointments and the inability to take time 
off from work to attend appointments in the context of unemployment (Coetzee et al., 2011; 
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Hardon et al., 2007; Olds, Kiwanuka, Ware, et al., 2015). The prohibitive costs of transport 
and inability to attend clinic appointments are well documented in the literature (Hardon et 
al., 2007; Kagee et al., 2011; Tuller et al., 2010).  
Children with HIV living in resource-limited settings are at risk of increased food 
insecurity and malnutrition, which may interrupt treatment administration and also result in 
treatment discontinuation (Weiser et al., 2010; Young et al., 2014). Children on ART are 
known to experience a large increase in appetite even after a short period on ART (Nagata et 
al., 2012; Walakira, Ddumba-Nyanzi, & Kaawa-Mafigiri, 2014) and they require food to 
mitigate medication-related side effects (Nagata et al., 2012).  
However, in the context of poor households where the majority of children on ART in 
SSA reside, poor adherence to ART has been described as a consequence of the poor 
availability of food (Biadgilign et al., 2009; Coetzee et al., 2015; Fetzer et al., 2011; Skovdal, 
Campbell, Madanhire, Nyamukapa, & Gregson, 2011; Vreeman et al., 2009). In qualitative 
interviews with key stakeholders in the treatment and care of children younger than five years 
on ART in South Africa, Coetzee et al. (2015) have demonstrated that caregivers were 
reluctant to administer ART in the absence of food (Coetzee et al., 2015). Biadgilign et al. 
(2009) and Fetzer et al. (2011) have reported similar reasons for refusal to provide ART in 
Ethiopia and Congo respectively (Biadgilign et al., 2009; Fetzer et al., 2011). In Zimbabwe, 
elderly caregivers faced additional challenges in procuring food as their immobility and 
inability to work limited the extent to which they could provide food and care for the child 
(Skovdal et al., 2011). In a study by Kundu et al. (2012), food supplementation for children 
on ART in Eastern India resulted in regular clinic attendance, improved CD4 counts, and 
contributed to fewer deaths (Kundu, Samanta, Sarkar, Bhattacharyya, & Chatterjee, 2012). In 
one study, caregivers felt obliged to go without food themselves if food was scarce in the 
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household in order to make sure that the children were able to take their medications with 
food (Olds, Kiwanuka, Ware, et al., 2015).  
According to the WHO (2009), children on ART need to consume at least 10% more 
calories than HIV-uninfected children following enrolment on ART (WHO, 2009). 
Consequently, poor nutrition influences the progression to HIV morbidity and mortality 
(Walakira et al., 2014).   
Caregiver ill health. Caregiver ill health negatively impacts on adherence to ART in 
children (Azzopardi et al., 2014; Mellins, Kang, Leu, Havens, & Chesney, 2003) as 
caregivers often have to cope with the competing demands of their own health needs and that 
of the children in their care. Caregiver ill health influences the quality of care that the 
caregiver is able to provide to the child. For example, caregiver ill health may result in poor 
treatment supervision and forgetfulness, both of which have been associated poor adherence 
(Azzopardi et al., 2014).   
Substance abuse. In a study by Arage et al. (2014) caregiver use of substances such 
as alcohol, chat (‘Khat’ a naturally occurring stimulant in Ethiopia), and nicotine was 
associated with poorer adherence in children on ART. Caregivers who reported no substance 
abuse were twice as likely to be adherent to the regimen than those reporting substance use 
(Arage et al., 2014). A study in Vietnam (Do et al., 2013), and Nepal (Wasti et al., 2012) 
showed similar findings. In South Africa, available evidence suggests that alcohol abuse 
among caregivers of children on ART is rare and therefore limited data exist to assess the 
association of alcohol use on paediatric adherence to ART (Jaspan et al., 2011). Jaspan et al. 
(2011) have conducted a cross-sectional study assessing the effects of caregivers’ depression 
and alcohol use on paediatric adherence to ART. Jaspan et al. (2011) have recruited 56 
children (median age = 4 years) on ART and their caregivers (median age = 31 years) 
attending a public healthcare clinic in Cape Town, South Africa. Depression was assessed 
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using the Beck Depression Inventory (BDI1) (Beck, Ward, Mendelson, Mock, & Erbaugh, 
1961) and substance abuse was assessed the Alcohol Use Disorders Identification Test 
(AUDIT) scale (Saunders, Aasland, Babor, de la Fuente, & Grant, 1993). While depression 
rates were high (33%) among caregivers in their study, alcohol abuse was rare. Only one 
caregiver scored above 8 on the AUDIT, which is indicative of alcohol abuse and problems 
with drinking. However, Jaspan et al. (2011) have cautioned that the small sample size might 
not be representative of the population (Jaspan et al., 2011).  
Family disruptions/extended caregiving. In many instances the biological parents of 
CLWH are either too ill to look after their children, have died of HIV or migrated to other 
areas to find employment (Hosegood et al., 2007; Kuo & Operario, 2010). Some studies have 
indicated that older caregivers (in most instances grandparents to the children) often become 
the caregiver to the child when the biological mother has died or moved away for work 
(Mokgatle & Madiba, 2015; Sikstrom, 2014; Skovdal et al., 2011; Ssengonzi, 2007). In the 
event that grandparents become responsible for the child, studies have also suggested that 
grandparents have difficulty understanding the regimen requirements due to low levels of 
education and not seeing the overall benefits associated with ART (Coetzee et al., 2015).  
In several instances, caregiving responsibilities become shared amongst available, 
often female, members of the households (Okomo, Togun, Oko, Peterson, & Jaye, 2012; Yeap 
et al., 2010). Disorganized family structures have shown to impact negatively on adherence to 
ART (Bhattacharya & Dubey, 2011; Cupsa et al., 2000). Shared responsibility among 
household members contributes to poor adherence when caregivers become occupied with 
other daily household requirements, and also when information sharing among those involved 
in the treatment and care of the child is poor or lacking (Coetzee et al., 2015; Vreeman et al., 
2009).  
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Regimen-related factors. Changing regimen and regimen complexity. Compared to 
adults, children on ART have fewer treatment options available to them in South Africa and 
most resource-limited settings. Children on ART experience regular dose changes as they 
grow older and their weight increases (Department of Health South Africa, 2014). 
Furthermore, children who experience more than one raised VL on a particular regimen may 
be switched to other medications that may require different methods of preparation and 
administration. In the context of caregiver inconsistency, changes to the regimen may not be 
communicated effectively to the various individuals responsible for the medication of the 
child (Coetzee et al., 2015). Furthermore, in the context of poorly educated caregivers, 
regimen instructions may be difficult to follow and further disrupted with regular changes. 
Changing regimens may also be required when primary healthcare facilities experience drug 
stock-outs (Haberer et al., 2009). Despite the perceived complexity associated with the ART 
regimen, studies have also indicated no significant associations between regimen complexity 
and non-adherence (Mellins et al., 2004).  
Formulation (liquid, tablet, capsule). Children younger than five years of age on 
ART receive either a combination of liquid formulations or a regimen consisting of both 
liquids and either pills or capsules. In the context of fixed-dose combinations (FDC) 
becoming readily available to children on ART, emerging evidence shows that caregivers and 
children prefer tablets over formulations (Bagenda et al., 2011). Despite the preference for 
tablets and capsules, large tablets are difficult to crush and many children experience 
difficulty in swallowing tablets whole. Liquid formulations spill easily and require accurate 
administration, which may be problematic when there is poor communication about dosing 
size amongst multiple caregivers, or caregivers who struggle to understand the dosing 
requirements (Coetzee et al., 2015; Nahirya-Ntege et al., 2012). Older caregivers may find it 
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difficult to read measurements on the syringe or on a medication measurement cup (Haberer 
& Mellins, 2009; Nahirya-Ntege et al., 2012).  
Storage requirements. Liquid formulations such as LPV/r and d4T require 
refrigeration or to be kept in a cool place (<25 °C) (Department of Health South Africa, 
2014). CLWH typically reside in poor communities where access to refrigeration and 
electricity may be scarce.   
Toxicity and side effects. Life-long use of ART exposes children to long-term 
toxicities, metabolic complications (Barlow-Mosha, Eckard, McComsey, & Musoke, 2013) 
and kidney disease (Bhimma, Purswani, & Kala, 2013). For example, Stavudine (d4T), which 
used to be a recommended first-line nucleoside reverse transcriptase inhibitor (NRTI) 
medication for children, led to lipoatrophy and lactic acidosis (Palmer et al., 2013). Current 
recommendations have replaced d4T with ABC (Department of Health South Africa, 2014).  
Health system-related factors. Drug stock-outs and costs. Drug stock-outs and 
delays in dispensing patient prescriptions have been associated with non-adherence. Delays in 
dispensing prescriptions make it necessary for patients to attend healthcare facilities more 
often than is necessary to collect their medication supplies, which in turn interferes with 
family responsibilities and adds financial strain(Busza et al., 2014; Mukherjee, Ivers, 
Leandre, Farmer, & Behforouz, 2006). Although ART is available freely in many resource-
limited settings, added costs such as clinic enrolment fees and costs associated with treating 
opportunistic infections have contributed to difficulties with accessing treatment (Kimani-
Murage, Manderson, Norris, & Kahn, 2013).  
Healthcare facility accessibility. In a study by Arage (2014), distance from the clinic 
was significantly associated with poorer adherence. Children who lived more than 10km 
away were less likely to be adherent than those who lived closer. Studies from Ethiopia 
(Biadgilign et al., 2009) and Nepal (Wasti et al., 2012) also reported distance from the clinic 
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as a barrier to adherence. Child-friendly healthcare facilities that include play equipment for 
children have been suggested as facilitators to adherence (Biadgilign et al., 2009). In a 
qualitative study, it was found that Ethiopian children liked attending the hospital as they 
were able to engage with children their own age and partake in child-orientated activities 
such as picture drawing and painting (Biadgilign et al., 2009).  
Relationship with healthcare provider (s). The healthcare environment in resource-
limited settings is largely overburdened and characterized by inadequate infrastructure and 
staff resources, which often leads to frustration and burnout among healthcare staff (Coetzee 
et al., 2011; Murray et al., 2009; Smit, 2005). The influence of these structural barriers places 
significant strain on the relationship between ART users and healthcare workers. 
Unsatisfactory work conditions may cause healthcare staff to behave in an unsympathetic 
way towards caregivers or ART users (Coetzee et al., 2011). In a study by Wachira et al. 
(2012), Kenyan caregivers to children on ART viewed clinic and healthcare staff as impolite 
and unprofessional. They also viewed the staff as lacking valuable empathetic skills and 
feared verbal abuse or being treated differently from others, resulting in caregivers 
postponing clinic appointments. Among caregivers in Mpumalanga, South Africa, many had 
disclosed the child’s status to close family members, especially fathers (Kimani-Murage et 
al., 2013). However, almost half wished they could keep it a secret from healthcare workers. 
Caregivers were particularly concerned that some of the healthcare staff would compromise 
their confidentiality. This perceived threat of identification prevented caregivers from 
attending healthcare facilities in the first place. Caregivers believed disclosure resulted in 
increased stigmatization and discrimination, subsequently affecting their child’s development. 
Caregivers reported that healthcare staff treated them badly and they did not feel comfortable 
with the way they had been addressed.  
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The nature of communication between patient and provider is important for overall 
treatment success with ART and establishing meaningful healthcare partnerships (De Civita 
& Dobkin, 2004; Schwartz & Axelrad, 2015). A failure to communicate effectively exposes 
ART users and caregivers of children to possible misunderstandings of treatment 
requirements (De Civita & Dobkin, 2004). In several resource-limited settings ART nurses 
and adherence counsellors are predominantly responsible for educating ART users and 
caregivers on ART via pre-ART adherence counselling sessions (Remien et al., 2013), while 
doctors often communicate to caregivers through an interpreter (Bland, Ndirangu, & Newell, 
2013; Coetzee et al., 2015). Doctors frequenting primary health facilities in resource-limited 
settings often work on a rotational basis that may disrupt the opportunity for effective rapport 
building, which is necessary in addressing adherence difficulties with the treatment regimen. 
Regular and in-depth engagement between caregivers and healthcare providers has shown to 
influence adherence to ART (Biadgilign et al., 2009). 
Adherence counselling. Inadequate psychosocial support to ART users and their 
caregivers by skilled healthcare workers is characteristic of many resource-limited settings. In 
the context of an expanding ART programme in South Africa and the prevailing concerns of 
poor patient adherence to ART, lay healthcare personnel (adherence counsellors) have been 
tasked with providing psychosocial support to ART users (Dewing et al., 2012, 2015). Yet, 
adherence counsellors are known to receive short periods of unstandardized training with 
little to no follow-up in the form of supervision, monitoring and debriefing (Kagee, 2013; 
Petersen, Fairall, Egbe, & Bhana, 2014; Remien et al., 2013, Gibson, Swartz, & 
Sandenbergh, 2009). Furthermore, the brief training periods usually equip counsellors with 
knowledge of HIV and ART and not with the counselling skills necessary to promote 
behaviour change (Dewing et al., 2012; Kagee, 2013).  
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Despite the caveats in training, some evidence shows that the counselling skills of 
adherence counsellors may be improved with training programmes (Igumbor, Scheepers, 
Ebrahim, Jason, & Grimwood, 2011; Kagee, 2013). However, the effects of the training on 
adherence to ART is not well described. In the context of an overburdened healthcare system, 
adherence counsellors often have limited counselling space as well as little privacy for 
consultations (Bland, Ndirangu, & Newell, 2013). Further, long waiting times at the clinic 
have repeatedly been reported as a disincentive to clinic attendance (Coetzee et al., 2011; 
Hardon et al., 2007; Roura et al., 2009).  
Social and cultural-related factors. Traditional healing and medicines. The 
influence of traditional healers and traditional medicines in the fight against HIV has been 
somewhat controversial in the literature. For example, in a qualitative study among 31 
caregivers in Mpumalanga, South Africa, Kimani-Murage et al. (2013) reported that some 
caregivers sought traditional healing for HIV-infected children in instances where healthcare 
providers had told them that children were too young for ART. Caregivers who sought 
traditional healing reported that traditional healers referred to their children as being 
bewitched and provided them with several herbal remedies believed to cure the child of HIV 
(Kimani-Murage et al., 2013). In contrast, other studies from South Africa (specifically from 
KwaZulu-Natal) have shown that traditional healers acknowledge HIV and are accepting of 
ART as treatment and its use in conjunction with traditional medicines (Appelbaum Belisle et 
al., 2015). Several studies have examined the negative impacts of traditional medicines on 
adherence to ART (Dahab et al., 2008; Peltzer et al., 2011). In the case of children, the uses 
of traditional medicines such as herbal enemas have resulted in numerous child deaths 
(Bland et al., 2004).  
Cultural norms. In the context of child-rearing and caregiving, women traditionally 
assume the responsibility to look after children’s needs. Women-headed households are still 
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the norm in many African settings today, and women often have to take care of several 
children (Wachira et al., 2012). Traditionally women provide physical and emotional care to 
children, while men provide financial support and are consulted on important household 
decisions (Makusha & Richter, 2014).  
Interventions to improve paediatric adherence to ART 
Globally, very few interventions, especially randomized control trials (RCTs), have 
been conducted to improve medication adherence in CLWH. Moreover, those that have been 
conducted have demonstrated little improvement in adherence (Bain-Brickley et al., 2011).  
In 2011, Bain-Brickley et al. (2011) published a global review on interventions aimed 
to improve adherence to ART in children with HIV. Their review focused specifically on 
adherence interventions that included a control group, measured adherence to ART as an 
outcome and included children younger than 18 years. Four studies met their inclusion 
criteria. Two of the studies were RCTs, of which one was conducted in the United States 
(Berrien, Salazar, Reynolds, & Mckay, 2004) and the other in Kenya (Wamalwa et al., 2009). 
The other two studies were non-randomized trials of which one was conducted in France 
(Funck-Brentano et al., 2005) and the other in South Africa (Müller, Myer, & Jaspan, 2009).  
Berrien et al. (2004) have conducted a home-based nursing intervention with 37 
patients (aged 1.5 years – 20 years, mean age = 10 years) and their parents to improve HIV 
and ART knowledge and adherence. The intervention group received eight structured home 
visits from the same nurse over a three-month period. The home visits were structured to 
improve participants’ understanding of HIV and to overcome barriers to medication 
adherence. The control group received the standard training on HIV and ART, which includes 
one home visit and reminder aids such as pill box organizers and beepers. Self-report 
measures and pharmacy refill data were used to assess adherence. While self-report measures 
showed an improvement in adherence immediately after the intervention the difference 
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compared to the control group was not significant (p=0.07). However, using pharmacy refill 
data there was a significant improvement in adherence in the intervention group compared to 
the control group (p=0.02). Despite improved adherence, neither of the groups showed 
changes in VL as measured three to eight months after the intervention (Berrien et al., 2004).  
Wamalwa et al. (2009) have conducted an intervention in Kenya with the caregivers 
of 99 children (aged 15 months – 12 years, median = 4.7 years) to improve adherence to ART 
in children. The intervention group received medication diaries and counselling, while the 
control group only received counselling. Caregivers kept the medication diaries for nine 
months, and were checked by staff at each clinic/hospital visit. Although caregivers in the 
intervention group reported higher adherence (as measured by caregiver self-report), 
compared to the control group, this was not statistically significant (p = 0.08). There was no 
difference between groups regarding VL. However, mean CD4 counts at six months was 
higher in the control group compared to the intervention group (although not significantly 
different) (Wamalwa et al., 2009).   
Funck-Brentano et al. (2005) have conducted a three-arm non-randomized trial using 
a peer support group among HIV-infected adolescents (aged 12 – 17 years) attending an 
outpatient clinic in France. Thirty adolescents formed the study population and were grouped 
according to those who could attend support groups, those who declined the support group 
and those who lived too far to attend the session. The intervention group received 90 minute 
therapy sessions every six weeks from trained therapists over 26 months. After two years, 
there was no statistical difference in adherence across the three groups using patient self-
report. There was also no statistical difference in VL and CD4 count (Funck-Brentano et al., 
2005).  
Muller et al. (2009) have conducted a three-arm non-randomized trial comparing the 
effects of three different ART regimens on adherence and VL outcome among 66 children 
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(mean age = 51 months) in South Africa. Adherence was assessed using MEMS data every 
month for three months, and VL data was collected every six months. There was no statistical 
difference in adherence between the groups. However, children receiving a boosted and 
unboosted PI -based regimen had significantly lower VLs compared to those on non-
nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens (p = 0.002) (Müller et al., 
2009). 
In 2014, Nieuwlaat et al. (2014) updated the comprehensive review on ‘Interventions 
for enhancing medication adherence’ across the spectrum of chronic illnesses on which RCTs 
have been conducted. The review includes evidence from 182 randomized controlled trials 
(RCT’s) that met their inclusion criteria. Thus, the RCT’s included had data on medication 
adherence as well as clinical outcomes. Comparability across these reviews is challenged by a 
broad range of adherence measures. Despite studies reporting similar conclusions, the small 
samples sizes and inadequate methods often prevented definitive and convincing conclusions. 
Furthermore, many studies lacked any theoretical underpinning to their findings. Moreover, 
Nieuwlaat et al. (2014) have stated that despite the large number of RCTs added to the review 
since their last publication in 2008, their conclusions are only slightly altered - adherence 
interventions to date remain complex and mostly ineffective (Nieuwlaat et al., 2014).  
Of these interventions included, 36 were identified as interventions to improve 
medication adherence among ART users. Only two interventions were with individuals 
younger than 16 years of age (Abrahams et al., 2010; Berrien et al., 2004), of which one was 
conducted in South Africa (Abrahams et al., 2010), and the other in the United States. Both 
have been described above (Berrien et al., 2004).  
The study conducted in South Africa by Abrahams et al (2010) included 274 girls 
aged younger than 16 years, assessing adherence to a post-exposure prophylaxis (PEP) for 
HIV after rape with telephone counselling. Participants were randomized into an intervention 
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(n=136) and a control (n=138) group. The intervention group received the PEP along with 
standard care and telephone counselling. The control group received the PEP and only 
standard care. Measures of adherence included pill counts and liquid measure. There was no 
statistical difference or improvement in adherence to the PEP between the two groups 
(Abrahams et al., 2010).  
In 2015, Mbuagbaw et al. (2015) conducted a systematic review of interventions to 
improve ART across populations and age groups (Mbuagbaw et al., 2015). They identified 49 
RCTS on ART, of which three were focused on youths younger than 18 years old and 
caregivers (Abrahams et al., 2010; Berrien et al., 2004; Letourneau et al., 2012).  
Letourneau et al. (2012) have conducted a pilot RCT among 34 youth (aged 9-17 
years) in the United States and their caregivers to compare multisystemic therapy (MST) 
(Ellis, Naar-King, Cunningham, & Secord, 2006)with standard care plus one session of 
motivational interviewing (MI) (Miller & Rollnick, 2002). MST therapy was adapted in this 
intervention to target HIV-related problems at the level of the child, caregiver, family and 
broader community. The intervention involved intensive therapeutic support from trained 
therapists. Participants were seen on average twice a week at either their home, school or 
clinic over a six-month period. The control group received the standard care plus one session 
of MI. MI interviewing was provided by two trained therapists and aimed at increasing 
participants’ motivation and self-efficacy. Adherence was assessed via self-report measures, 
and clinical data on CD4 count and VL were obtained at baseline and post-intervention. 
There was no improvement in adherence or clinical outcomes in either of the groups 
(Letourneau et al., 2012).  
 
Stellenbosch University  https://scholar.sun.ac.za
  
63 
 
Research gaps 
Despite a growing body of qualitative literature identifying barriers and facilitators of 
adherence among children on ART in SSA, studies often include children across wide age 
ranges and at various developmental stages. Consequently, limited age-specific knowledge is 
available that may contribute to intervention development. Children younger than five years 
are largely excluded from qualitative research studies as interviewing and focus group 
methodologies are not a useful means of capturing treatment experiences directly from these 
children. Observational methods are needed to provide information-rich cases of children’s 
direct experiences. These methods have been useful among children younger than five years 
(Rochat et al., 2008). In addition, given the complexity and fluidity of caregiving among 
these children (Coetzee et al., 2015), a better understanding of household environments are 
needed, including how they may influence adherence to ART.   
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CHAPTER 3 
The research context 
Introduction 
The following chapter is organized into two parts. Part one describes the research 
context and provides information on the study location and the HIV programme. Part two 
describes the methodological overview of the research.   
KwaZulu-Natal, Umkhanyakude district (study area) 
The research was conducted in the Umkhanyakude district of Northern KwaZulu-
Natal, South Africa (Figure 3.1). KwaZulu-Natal, situated on the east coast of South Africa, is 
one of nine provinces in South Africa with 11 municipal and health districts. KwaZulu-Natal 
has the second largest population in the country, estimated at 10, 694, 400 in 2014 (Statistics 
South Africa, 2014). A large proportion of the population is Black African, and the primary 
language amongst residents of the area is isiZulu (Statistics South Africa, 2011). KwaZulu-
Natal is estimated to have the highest HIV prevalence rate in South Africa, estimated at 
27.0% in the age group 15-49 years at the end of 2012 (Department of Health South Africa, 
2013a). The Umkhanyakude district, the northern most district of KwaZulu-Natal, is 
predominantly rural and has five municipalities; Jozini, The Big Five False Bay, Hlabisa, 
Mtubatuba, Umhlabuyalingana.  
 
 
 
 
 
 
Figure 3.1. Map of South Africa and location of KwaZulu-Natal province   
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The Hlabisa sub-district (study location) 
This research took place in the Hlabisa sub-district within the Umkhanyakude district 
(Figure 3.2). The Hlabisa sub-district is predominantly rural, with 80% of the area under 
traditional authority (Hlabisa Local Municipality, 2013). The Hlabisa sub-district includes 
two large towns, Mtubatuba and Hlabisa, and one peri-urban area, KwaMsane. Residents of 
the area live in scattered and multigenerational households with an average of seven members 
per household (Tanser et al., 2008). Approximately 10% of the land is commercial farmland, 
and 6% is urban (Hlabisa Local Municipality, 2013). At the end of 2011, the Hlabisa sub-
district health services serviced a population of 220 000 individuals with 37.8% (83 160) of 
the population being children between the ages of one and 15 years old, and 2.4% of the 
population being infants less than a year old (Bland et al., 2013).  
  
  
 
  
 
 
 
Figure 3.2. Map of the study area (Hlabisa) within KwaZulu-Natal Province of South Africa 
Africa Centre for Health and Population Studies (Africa Centre)  
The research took place under the auspices of the Wellcome Trust-funded Africa 
Centre for Health and Population Studies (www.africacentre.ac.za), established in late 1997 
to monitor health and demographic change brought about by the rapid escalation of HIV in 
South Africa and the study area. The Africa Centre collects data from household members 
within the surveillance area (study area), known as the demographic surveillance area (DSA). 
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The DSA is 440 km2 and covers a population of 87 000, of which 75 000 are resident within 
11 000 households and predominantly isiZulu-speaking (Tanser et al., 2008). Based on data 
from the Africa Centre, the DSA shares characteristics similar to that of LMIC countries 
(Muhwava & Nyirenda, 2008). The area is characterized by high rates of unemployment, and 
families typically rely on state pensions and social grants (Tanser et al., 2008).  
Ethical permissions to conduct research. Since its establishment, the Africa Centre 
reached agreements with the local Department of Health (DoH) allowing researchers to 
conduct their studies in the study area and in primary healthcare clinics that fall within the 
DSA. Prior to undertaking research at any of the primary healthcare clinics within the DSA, 
researchers are required to obtain permission from the Hlabisa Hospital Management 
Committee as well as the permission of the Head Nurse at each facility. Since its 
establishment, the Africa Centre has built close ties with the surrounding members of the 
community. The Africa Centre established a community liaison office (CLO), which has for 
the past 12 years fostered close ties with the surrounding heads of the community. These 
community heads meet once a month in the form of a community advisory board (CAB) to 
review new research studies undertaken at the Africa Centre. Even in instances where a study 
receives ethical clearance from an institutional review board (IRB), researchers cannot begin 
data collection without approval from the CAB. 
Hlabisa HIV Treatment and Care Programme (HIV programme) 
Residents of the Hlabisa sub-district receive HIV-related healthcare under the Hlabisa 
HIV Treatment and Care Programme (HIV programme) (Bland et al., 2013; Houlihan et al., 
2011). Initially the HIV programme was a joint initiative between the Africa Centre and the 
local Department of Health, but since 2012 it has been entirely managed by the KwaZulu-
Natal Department of Health (Bland et al., 2013). By the middle of 2012, the HIV programme 
had initiated more than 20 000 PLWH onto ART across one 250-bed hospital (Hlabisa 
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Hospital), and 17 community-based primary healthcare clinics (Tanser et al., 2013). ART 
coverage has increased substantially since the roll-out of ART in the area in 2006, when only 
1800 people living HIV had been initiated (Bland et al., 2013). Six of the primary healthcare 
clinics fall within the DSA of the Africa Centre (Figure 3.3). The figure below shows the 
Africa Centre in relation to the 17 primary healthcare clinics in the Hlabisa sub-district, as 
well as the location of Hlabisa Hospital.  
 
 
 
 
 
 
 
 
 
Figure 3.3. Map of the Hlabisa sub-district within the Umkhanyakude district, Northern 
KwaZulu-Natal 
The Africa Centre provided 15 of the 17 primary healthcare clinics with park homes, 
funded by the President’s Emergency Plan for AIDS relief (PEPFAR), where patients receive 
HIV and TB services. At the end of 2011, ART treatment coverage of all HIV-infected 
individuals in the community had risen from 0% in 2004 to 31% in 2011(Zaidi, Grapsa, 
Tanser, Newell, & Bärnighausen, 2013).  
ART clinics in the HIV programme. Following the national roll-out of ART in 
South Africa in 2004, ART services were only available at Hlabisa Hospital. In 2005, ART 
services expanded to KwaMsane clinic, the largest clinic in the sub-district. At the end of 
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2006, an additional 6 clinics were providing ART services to clinic users and by the end of 
2007, all 17 clinics in the sub-district were providing ART services. The ART clinics 
operating within the Hlabisa sub-district are small, limited in terms of space and often short-
staffed, typical of rural facilities in South Africa (Bland et al., 2013).  
The HIV programme is largely nurse- and counsellor-led, with doctors visiting the 
clinics to initiate patients on ART and to follow up on clinical problems as they occur (Bland 
et al., 2013). At the end of 2008, the HIV programme had between 20 and 30 nurses, and 
approximately 60 adherence counsellors (Houlihan, Seigel, Buckley, Copelyn, & Lessells, 
2009). Each clinic has at least two HIV counsellors and up to four primary healthcare nurses 
overseeing and managing the services provided. Given the shortage of doctors in most LMIC 
countries, as well as within the Hlabisa sub-district, task-shifting in the form of ‘nurse-
initiation and management of ART (NiMART)’ allowed for nurses to initiate and manage 
patients stable on ART (Georgeu et al., 2012). Patient data from the clinics are uploaded onto 
the database known as ARTemis. The Africa Centre established the database and it contains 
all the clinical information of patients receiving treatment at the clinics 
(www.africacentre.ac.za).  
Clinic A. Clinic A was the primary recruitment site (Clinic B was also used in Phase 
2) for both phases of this study. Clinic A is the largest peri-urban clinic in the Hlabisa sub-
district. The clinic is situated within a large township, and in the early 2000’s a 
Reconstruction and Development Programme (RDP) development was added to it. The RDP 
was established following the first democratic elections in South Africa in 1994. The 
government stated that housing was a constitutional right to previously disadvantaged South 
Africans and initiated the RDP housing project. A typical house built under RDP regulations 
has an area of 36m2, and is built with cement bricks and mortar, with corrugated iron roofs 
and between two and three windows. The units are largely open-plan, this includes a 
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bedroom, kitchen and lounge. The lavatory area is built separately (Moolla, Kotze, & Block, 
2011).  
Clinic A manages around 10 000 individual patients (including HIV patients) a month 
(Houlihan et al., 2009). The clinic is the only clinic in sub-district that offers 24-hour health 
services (Muhwava, Nyirenda, Mutevedzi, Herbst, & Hosegood, 2008). The clinic is 
frequented by a physician from Hlabisa Hospital and, at the time of this study, a specialist 
paediatrician (Dr Ruth Bland) ran a Family Clinic for children on ART. Dr Bland established 
the Family Clinic in 2008, and by 2009 there were 41 infants less than a year old on ART 
(Cooke, Little, Bland, Thulare, & Newell, 2009). At the end of September 2013, 2390 
children were initiated onto ART across all clinics in the sub-district, with the majority of the 
children initiated at the Family Clinic.  
Children in the HIV programme. The HIV programme adheres to the South African 
HIV treatment guidelines (Department of Health South Africa, 2014), which reflects WHO 
recommendations for treatment and management of HIV in children (WHO, 2014). The 
South African government has made healthcare and medications (including ARV’s) free for 
children (Bland et al., 2013). According to the latest guidelines on ART initiation among 
infants, children and adolescents in South Africa, all children younger than five years old 
should be initiated on ART. The latest guidelines also state that social criteria necessary for 
initiation include that at least one person is identified as a caregiver and should be able to 
supervise all administration of the medication. Children between the ages of 5 and 10 years 
are eligible for ART if they meet the symptom criteria of WHO clinical stage 3 or 4 (WHO, 
2005) regardless of CD4 count, or if they have a CD4 count < 500 cells/ microlitre (cells/μl) 
(Department of Health South Africa, 2014).  
ART for infants and young children. There are currently nine antiretroviral drugs 
available to infants and young children on ART in South Africa. These are ABC, 3TC, d4T, 
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LPV/r, EFV, AZT, Didanosine (ddl), Ritonavir (RTV), and Nevirapine (NVP). Each of these 
drugs have specific dosing instructions (e.g. if administered in pill form whether the tablet 
may be crushed or chewed, or the capsule opened and diluted in water or mixed with 
something sweet), and some (d4T, LPV/r) have specific storage requirements (refrigeration or 
stored below <25°C).  
The above-mentioned drugs are available in triple combination as three treatment 
regimens, namely first-line, second-line and third-line ART regimens. Children are usually 
initiated on first-line ART. Second-line and third-line regimens are recommended following 
consistent indications of raised VLs or, in rare cases, drugs may be changed after adverse 
reactions (Department of Health South Africa, 2014).  
First-line regimen. The first-line regimen is usually a combination of three ARVs, 
although some fixed-dose combinations for children do exist. Two first-line regimens exist; 
namely, a PI -based regimen, and non-nucleoside reverse transcriptase inhibitor (NNRTI)-
based regimen. 
For children under three years (< 10 kgs), a first-line regimen is a combination of 
ABC, 3TC and LPV/r. This combination constitutes a first-line PI-based regimen. All three of 
these medications are available as liquid formulations, and dose changes vary depending on 
the weight of the child. Caregivers are required to measure the millilitres prescribed for each 
medication (usually ranging between 1ml and 5ml) and administer it to the child. The 
guidelines do not provide specific instructions on how caregivers should measure and 
administer the doses.  
For children between three and 10 years old (>10kg), a combination of ABC, 3TC and 
EFV is recommended. This combination constitutes a first-line NNRTI-based regimen. The 
guidelines state that children should be taken off liquid medications and switched to tablets 
and capsules as soon as possible. Recent evidence from a randomized trial on paediatric ART 
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monitoring and treatment strategies amongst children in Uganda and Zimbabwe on ART 
showed that children under three years are able to take tablets and that caregivers preferred 
administering tablets to liquids (Nahirya-Ntege et al., 2012). Furthermore, the latest 
guidelines state that LPV/r should be stored in a cool place (<25°C). For children on ART, 
routine monitoring includes VL testing at six months, one year on ART and then every 12 
months.  
Second-line regimen. A second-line regimen is recommended to children who have a 
VL > 1000 copies/millilitre despite reports of optimal adherence. Children failing first-line 
PI-based regimens are switched to second-line regimens based on consultation from an 
expert. Children failing first-line NNRTI-based regimens are switched to second-line 
regimens usually consisting of a combination of AZT, 3TC and LPV/r (for those previously 
on ABC, 3TC and EFV) or AZT, ABC and LPV/r (for those previously on d4T, 3TC and 
EFV).  
Third-line regimen. All children failing a second-line regimen are referred to an 
expert to recommend ARVs for a third-line regimen. According to Department of Health 
guidelines (Department of Health South Africa, 2014), before initiating a child on ART, a 
primary caregiver is required to undergo three HIV education sessions. The sessions are 
conducted on three separate occasions to provide the necessary knowledge and understanding 
of HIV and treatment administration. At the time of writing, most of the children receiving 
ART in South Africa received three separate ARV drugs, available in tablet or liquid form for 
younger children. Drug doses are dependent on a child’s weight. The drug’s liquid 
formulations require precise measurements by the caregiver. Once initiated on treatment, 
caregivers are expected to attend monthly clinic visits to collect pharmacy refills and consult 
the HIV counsellor. Often persons receiving ART need to travel to the clinic more frequently 
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than once a month if there are drug shortages. If drugs are available, and patients are deemed 
stable by their doctor, they may receive a two months’ supply of medication. 
Children failing on first-line ART in the area. In 2014, scientists from the Africa 
Centre sought to characterize acquired drug resistance amongst HIV-infected children on 
ART, and failing first-line regimens in the HIV programme (Pillay et al., 2014). Pillay et al. 
(2014) have collected plasma samples from 101 children (under 15 years old) identified as 
failing first-line. Of the 101 children (79 on a NNRTI-based regimen and 16 on a PI-based 
regimen) enrolled into the study, these authors were able to successfully genotype the DNA 
from 89 children. They found that at least 80% of the children on an NNRTI-based regimen 
had mutations in their DNA that cause resistance to ARV’s (resistance mutations). They 
found only one child on a PI-based regimen to have a major resistance mutation. Pillay et al. 
(2014) have expressed concern about the prevalence of high-level resistance mutations 
amongst this cohort and argued that it is an indicator of the prolonged time that children spent 
on a failing regimen. They highlighted the need for timely identification of children failing 
the first-line regimen, better adherence counselling and patient follow-up.  
Conclusion 
The research context used for the data collection of this thesis was well suited to 
address the research questions and to meet the overall objectives and aims of this thesis. The 
Hlabisa sub-district is characteristic of other impoverished areas in South Africa and has one 
of the highest HIV rates in the world. At the time of writing, children on ART in the Hlabisa 
sub-district are beginning to show possible signs of drug resistance. Drug resistance is 
problematic in the context of limited ART regimens available to CLWH in South Africa.  
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Methodological overview  
In keeping with the worldview and traditions of qualitative research I undertook a 
focused ethnography in order to answer the research question and sub-questions in two 
phases. Focused ethnography has emerged as a useful method to study very discrete subjects 
in certain cultures, sub-cultures or settings and has been used in health research, and more 
specifically in nursing research (Knoblauch & Schnettler, 2012; Venzon Cruz & 
Higginbottom, 2013). Focused ethnography has its origins in traditional ethnography. The 
method is appropriate for use amongst individuals believed to share common experiences and 
behaviours.  
Due to the flexibility and wide variety of data collection tools available for use within 
a focused ethnography, the design allows the researcher to gain an understanding of the 
phenomenon directly from their participants (emic view) whilst also incorporating their own 
understanding of the phenomenon into the study (etic view) (Venzon Cruz & Higginbottom, 
2013). Focused ethnography differs from traditional ethnography in that instead of studying 
an entire social field, it is only concerned with a specific aspect within a field. The scope of 
the investigation is pre-determined and does not evolve in the open context and nature of 
traditional ethnography (does not become adapted along the way) (Venzon Cruz & 
Higginbottom, 2013). Focused ethnography provided the best possible description of the 
research design used for this study. Under this umbrella term I was able to include and justify 
the various data collection methods used, and the time period in which I was engaged with 
data collection. 
In order to make clear how each of my objectives were addressed, I have tabulated the 
objective and respective qualitative data collection methods and tools used below (Table 3.1). 
The study was conducted in two phases. Phase 1 consisted of interviews and focus group 
discussions (FGDs) with key stakeholders in the treatment and care of children on ART and 
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was used to structure and inform the observations undertaken in Phase 2. Phase 1 was 
conducted between August and December 2012, and Phase 2 was conducted between January 
2013 and March 2014.  
Table 3.1  
Objectives of the Study Matched to the Data Collection Method 
Phase 1   
Objective Data collection method Materials and tools 
   
1 In-depth interviews Interview flyer (Appendix A) 
 
Doctors 
Informed consent –doctor/nurse 
(Appendix B) 
 
Nurses 
Doctor-nurse interview schedule 
(Appendix C) 
  Audio recorder 
   
 Semi-structured focus groups Focus group flyer (Appendix D) 
 Caregivers of children ≤ 5 years on 
ART 
Informed consent (Appendix E) 
  Caregiver focus group guide 
(Appendix F) 
   
 Adherence counsellors Informed consent (Appendix E) 
  Counsellors focus group guide 
(Appendix G) 
   
 Traditional healers Informed consent (Appendix E) 
  Traditional healer focus group guide 
(Appendix H) 
  Audio recorder 
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Table 3.1 (continued) 
Phase 2     
Objective Data collection method Materials and tools 
2 
Naturalistic observation using 
observation schedules, video and 
field notes 
 
 Caregiver-child dyads Caregiver consent form (Appendix I) 
 
 Home visit 1 observation schedule 
(Appendix J) 
 
 Home visit 2 and 3 observation 
schedule and video recorder (Appendix 
K) 
 Participant journals A4 college exercise book and pen 
   
3 
Naturalistic observation and field 
notes 
 
 
Caregiver-child-counsellor 
interaction 
Counsellor consent form (Appendix L) 
  
Counselling observation schedule 
(Appendix M) 
  Stop-watch 
    Field notes 
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CHAPTER 4 
Phase 1 - Methods 
Objective  
In an effort to explore caregivers', doctors', nurses', HIV counsellors', and traditional 
healers' perspectives of the barriers and facilitators to the administration of medication to 
children under five years by their caregivers, I conducted semi-structured interviews with 
doctors and nurses that provide treatment and care to children younger than five years on 
ART. In addition, I conducted focus groups with HIV counsellors, traditional healers and 
caregivers of children younger than five years on ART.  
Sample design and sampling methods 
Sampling and procedure. I used purposive sampling methods to recruit participants 
for Phase 1 of the study. Purposive sampling is a non-random sampling technique that allows 
the researcher to select key informants based on the contribution that their knowledge will 
add to the understanding of the phenomenon being investigated (Bernard, 2011).  
Individuals who were considered key stakeholders in the treatment and care of 
children below five years receiving ART were invited to take part in either an in-depth 
interview or focus group. I subsequently invited doctors, nurses and counsellors working in 
the Hlabisa HIV Treatment and Care Programme to participate in interviews. I furthermore 
invited individuals identified as primary caregivers of children younger than five years and 
attending clinic A to take part in a focus group discussion. And lastly, I invited traditional 
healers with experience in consulting with persons living with HIV to take part in FGDs.  
Recruitment and data collection. In-depth interviews with doctors and nurses. 
Interviewing is the most commonly used method of qualitative data collection due to the 
flexibility and ease with which the interview can be arranged compared to other methods 
such as observation (Willig & Stainton-Rogers, 2007). Doctors and nurses were selected for 
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individual in-depth interviews that were conducted at their earliest convenience to minimize 
time taken away from attending to their work responsibilities.  
Doctors were approached via e-mail and verbally onsite during clinic visits in the 
“gaining entry”-phase (discussed below). Nurses were approached face-to-face at the clinic 
and/or hospital and were asked to indicate which days at the clinic were less busy for them. I 
then arranged to be at the clinic on those days and was accompanied by an isiZulu-speaking 
interpreter (for participants who wished to conduct the interview in isiZulu).  
Despite the relative ease with which an interview may be arranged, the method itself 
required that I had good interviewing and note-taking capability, which are skills I had gained 
during my honours and masters degree training. More importantly, in order to gain a rich 
description of the data it was necessary to establish sufficient rapport with each of the 
participants. Rapport-building started with my initial introduction to each of the participants, 
and the subsequent acknowledgment of the importance of time constraints for staff.  
Interviewing as a method does not go without some criticism from the research 
community. For example, some authors (Potter & Hepburn, 2005) have asserted that 
interviews do not acknowledge relevant contextual factors such as interviewer-participant 
interaction that may be important for considering the type of information elicited. Interview 
guides and note-taker forms were used to record and include field notes and setting 
descriptions in the transcriptions of the interview data.  
Interviews were semi-structured and guided with the use of an interview schedule 
(Appendix C), lasting 30-60 minutes. The interview schedule contained demographic 
questions such as, “Can you state your occupation?” and experience questions such as, “Can 
you tell me about your experience in treating children under younger than five years living 
with HIV”. The schedule also contained other open-ended questions like “What do you think 
are some of the difficulties that caregivers have with administering ART?”  
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In order to facilitate a rich description of the data, probes were used such as “Can you 
tell me more?”, and “What else do you think?” to steer the conversation in a way that would 
elicit more information about a specific question. The interviews were audio recorded so that 
verbatim transcripts could be produced for further analysis.  
Focus groups with counsellors, caregivers and traditional healers. Focus groups 
have emerged as a useful way to collect vast amounts of information in a relatively short 
amount of time (Willig & Stainton-Rogers, 2007). Focus groups are typically held with 
individuals who share a common experience or knowledge about a similar issue. Thus, focus 
groups allow for participant options and beliefs to be obtained in a manner that may be 
considered as culturally grounded (Krueger & Casey, 2000). The advantage of focus groups 
lies in the facilitator becoming aware of instances where participants agree, noting those who 
are most verbal versus those who remain quieter, and noting how participants respond to one 
another. Adequate monitoring of the information elicited from participants during the focus 
groups ensures that a rich description of the underlying phenomenon is obtained. Focus 
groups are intended to generate data that have higher ecological validity than interviews as 
participants are subjected to less formality than would be experienced in an interview (Willig 
& Stainton-Rogers, 2007). Focus groups were an appropriate method as the participants were 
thought to have similar experiences and were likely to share more about their experiences in 
the company of others who experienced similar situations. 
In all three instances the focus groups were facilitated by one of two isiZulu speaking 
doctoral candidates (NM and TZ) and moderated by me. Each facilitator had met with me 
prior to the focus group to go through the focus group schedule and to establish whether 
questions were clear and concise. Facilitators were encouraged to mostly act as mediators 
between participants and to present the group with an initial stimulus to allow the 
conversation to progress based on participants’ responses to one another.  
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Counsellors’ focus group. I approached senior clinical staff working at the Africa 
Centre who had direct contact with the HIV counsellors working at the various clinics within 
the sub-district. At the time of this focus group the counsellors who were working at the 
clinics had been appointed by Africa Centre with PEPFAR funding. Counsellors met once a 
month at the Africa Centre for a meeting. I then arranged to conduct a focus group interview 
with the counsellors after their monthly meeting in September 2012. All counsellors gave 
written informed consent. The focus group was conducted in English, as all counsellors were 
fluent in English, and lasted 75 minutes. The focus group interview took place in a private 
meeting room at the Africa Centre, and participants were provided with lunch and 
refreshments to thank them for their time. Following the focus group, the note-taker and I met 
immediately afterwards to discuss the focus group and to debrief. The debriefing involved a 
discussion of some of the key themes that emerged from the focus group and whether any 
conflicts or tensions were noted during the discussion.  
Caregivers’ focus group. Caregivers to children younger than five years on ART and 
attending Clinic A were invited to take part in a focus group by their doctor (RMB), as well 
as by the Africa Centre nurse based at Clinic A. Caregivers were purposively recruited on the 
following basis: 
1. Caregivers of children younger than five years on ART with suppressed VLs 
(≤400 copies per millilitre after one year on ART) 
2. Caregivers of children younger than five years on ART with unsuppressed VLs 
(≥400 copies per millilitre after one year on ART) 
3. Caregivers of children newly initiated on ART (on ART for less than one year) 
Caregivers were asked to attend the focus group at the clinic in November 2012 and 
all provided written informed consent. The focus group was conducted in isiZulu in a private 
room at the clinic and lasted 120 minutes. Participants were reimbursed for travel costs, and 
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the caregivers and children were provided with lunch and refreshments to thank them for 
their time. After the focus group ended, the facilitator (NM) and I had met to debrief. We 
followed a similar procedure as outlined above.  
Traditional healers’ focus group. The CLO at the Africa Centre assisted with the 
recruitment of the traditional healers. One of the doctoral students at the Africa Centre (TZ) 
had met with a group of traditional healers a few months prior to my arrival and still 
remained in contact with many of them. She telephoned 10 healers who had agreed to take 
part in my study and they attended the focus group at the Africa Centre in November 2012. 
All provided written informed consent to participate in the study. The focus group took place 
in isiZulu in a private meeting room at the Africa Centre, and lasted 135 minutes. The 
traditional healers were reimbursed for travel costs and were provided with a cooked lunch at 
the Africa Centre canteen.  
Ethics 
Ethical approval. I moved to Mtubatuba (from Cape Town, South Africa), one of the 
three towns in the Hlabisa sub-district, in August 2012 to commence the data collection phase 
of my research. At the time of the move I had received ethical clearance for the research from 
the Stellenbosch Health Research Ethics Committee (HREC) (S12/05/135), as well as 
reciprocity with the University of KwaZulu-Natal (UKZN) (Appendix N). 
Ethical considerations. Gaining entry to the field. In keeping with the qualitative 
methodology, I undertook a brief period of engaging with the context and becoming familiar 
with the recruitment site. I had met with the CAB of the Africa Centre in September 2012 to 
present the study and obtain their permission to enter the setting. The CAB granted 
permission for the study to proceed. Following permission from the CAB (CAB approval 
letter Appendix O), I attended a meeting at Hlabisa Hospital to meet with the Hospital 
Managers where I presented the aims and objectives of my research, and was granted 
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permission to approach staff and clients at the primary recruitment site for inclusion into the 
study.  
Once all necessary approval was obtained to enter the field and to approach the 
relevant participants, I spent time becoming familiar with the primary recruitment site –the 
Family Clinic. As mentioned previously, Dr Bland, one of my doctoral supervisors, had 
established the Family Clinic. She held this clinic every Friday, until December 2012, after 
which one of the Hlabisa doctors took over. Over a period of a month I attended the family 
clinic with Dr Bland and observed how things operated at the clinic and how caregivers 
interacted with the doctors and counsellors. More importantly, I was introduced to staff and 
caregivers, whom I subsequently approached for inclusion in Phase 1. These insights proved 
useful, especially for Phase 2 in being able to decide how to approach caregivers and to 
understand the clinical route they followed when attending their monthly clinic appointments. 
I also accompanied Dr Bland to the paediatrics ward at Hlabisa Hospital and shadowed a 
clinical rotation. I was then also introduced to paediatricians with experience in treating 
children on ART.  
Data analysis  
Participant characteristics. Demographic information such as age, gender, marital 
status, level of education, and income were obtained from caregivers who took part in the 
caregiver focus group. Only partial demographic information (such as job description and 
gender) was available from the other respondents. Descriptive statistics (such as mean age 
etc.) were computed using the Statistical Package for the Social Sciences version 19 (Field, 
2005).  
Transcription. All the interviews and focus group interviews were audio-recorded 
and transcribed verbatim using ATLAS.ti version 7 (Scientific Development Software 
[ATLAS.ti], 2003). Data collected in isiZulu were outsourced to a transcribing company who 
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transcribed the transcripts in isiZulu and translated them into English. For each transcription 
the transcribing company signed a confidentiality agreement to ensure that the data remained 
secured and adhered to the ethics required for this study. Both versions of the transcripts were 
then given to the Zulu-speaking facilitators of the focus groups for quality checking against 
the audio recording. Both facilitators were reimbursed for their time. The transcripts and field 
notes were uploaded to ATLAS.ti version 7 for data analysis. The data analysis methods is 
discussed in the next section of this chapter.  
Rigour. In an effort to ensure rigour and transparency of the data analysis within the 
thesis I had chosen to use ATLAS.ti qualitative data analysis computer software. The 
programme, currently in its seventh version, assists with qualitative data analysis by 
providing its user with functions to support a robust analysis.  
The programme developers modelled the software on grounded theory methods, 
allowing users the option to create free codes and to visualize their coded work in a network 
space. Computer-aided qualitative data analysis (CAQDAS) has been available since the 
early 90’s to assist researchers with the management and analysis of text-based data that later 
went on to support analysis of image-based, audio, and video data (Friese, 2014). Software 
programmes such as ATLAS.ti allow researchers to confidently analyse data according to the 
methodological strategy best suited to answer their research questions. Various methods of 
qualitative data analysis exist and inductive thematic analysis was chosen to analyse the data 
for Phase 1 as well as Phase 2.  
Inductive thematic analysis. I conducted thematic analysis according to the 
guidelines set out by authors Virginia Braun and Victoria Clarke (2006). In their experience 
and during their review of the literature pertaining to thematic analysis, the authors found a 
large discrepancy between what thematic analysis is and how to go about conducting it. For 
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the purposes of maintaining scientific rigour and transparency I chose to conduct my analysis 
in keeping with their recommendations (Braun & Clarke, 2006).  
Braun and Clarke (2006) have provided a six-phase “theoretically-flexible approach” 
(p.2) that produces a comprehensive and holistic reflection of the data. An inductive thematic 
analysis differs from a theoretical thematic analysis in that themes identified are closely tied 
to the data themselves, as opposed to being fitted to a pre-existing coding frame.  
Although I used Bronfenbrenner’s EST (Bronfenbrenner, 1979) to organize themes 
that emerged from the data, the data were not coded or bound by the concepts related to the 
theory. The theory provided a suitable lens through which to interpret and make sense of the 
findings. Semantic themes, which merely described the data, evolved into latent themes, 
which allowed interpretation of the themes within a broader theoretical context. The six 
phases are shown in the Figure 4.1 below. The figure also shows how ATLAS.ti was used to 
facilitate each of the steps.  
 
 
 
 
 
 
 
 
Figure 4.1. Six phases of thematic analysis, adapted from Braun and Clarke 2006 as used 
within ATLAS.ti v7 
 
Phase 1: Getting to 
know the data
Phase 2: Developing an 
initial list of codes
Phase 3: Looking for 
themes
Phase 4: Refining and 
reviewing themes
Phase 5: Giving 
appropiate names to 
themes
Phase 6: Writing up the 
results
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Phase 1. Once the data had been collected, I started to familiarize myself with the 
information that had been collected. Part of this entailed reading and re-reading through the 
transcripts to search for meanings and patterns throughout the data, and recognizing potential 
codes to use for the formal coding phase. I imported all the transcripts into ATLAS.ti (as 
primary documents) and began to collect ideas for initial codes using the memo function of 
the software as I read through the transcripts. Within ATLAS.ti the user can create free codes 
from a list using the memo function (Friese, 2014).  
Phase 2. Once I had collected initial ideas for codes, I reviewed some of the codes for 
redundancy before importing them for use within ATLAS.ti. Friese (2014) recommends 
creating as much structure to the code list as possible early on to reflect transparency in the 
coding of the data. Semantic codes (descriptive codes) were used initially to describe the 
quotation of interest in a meaningful way. Saldana (2012) has offered ideas for other types of 
codes to include to facilitate coding, such as emotion codes (to code for feelings), attribute 
codes (to code for age, gender, occupation etc.), and versus codes (to highlight contrasts) 
(Saldana, 2012). Friese (2014) encourages the use of multiple layers of coding, as coding in 
such a way allows for the use of advanced functions of ATLAS.ti, for example, the code-
occurrence table and the query tool. Coding in itself is an iterative process and requires 
constant back and forth until there is an overall satisfaction with the codes generated.  
Phase 3. Once the data had been coded initially and a long list of codes had been 
produced, the analysis had to be refocused at the broader level of themes. During this phase, 
latent codes were developed and codes with inter-related meanings or ideas were sorted and 
grouped into potential themes. In ATLAS.ti this was done by grouping codes into families. 
Not all codes grouped into a family necessarily represented a separate theme. As Braun and 
Clarke (2006) explain, “A theme captures something important about the data in relation to 
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the research question, and represents some level of patterned response or meaning within the 
data set” (Braun & Clarke, 2006, p. 10). 
Phase 4. This phase involved a refinement of the themes developed in phase 3. 
During this phase, I was able to decide which themes were actual themes and contained 
enough data to support them, and which themes were similar and could thus be merged into 
other suitable themes. In ATLAS.ti the network view function was used to facilitate the 
decisions made for themes. This phase also means going back to the level of the data and 
reading through all data segments that warrant inclusion in the theme. In the network view 
and through the use of appropriate filters, I was able to read all the data segments pertaining 
to a theme to decide whether there was an overall fit. 
Phase 5. Following the satisfactory establishment of themes that represent the data 
collected throughout, I went about giving each theme an appropriate name. At this stage I 
used another level of refinement and considered theme names based on theory and data. For 
example, one particular theme would be named Microsystem, and the extended name of the 
theme would be based on the data collected. This is clarified in the results that follow. During 
phase 4 and 5, memo writing was used to reflect on the content of the themes and used to 
synthesize the overall meaning pertaining to the theme. Memos developed in ATLAS.ti were 
attached to the relevant networks.  
Phase 6. Phase six involves the presentation of the results of the data. This is done in 
the results section below.   
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CHAPTER 5 
Phase 1 - Results 
Participant characteristics 
A total of 40 respondents took part in the interviews and focus group discussions 
(Table 5.1).  
Doctors. Five doctors took part in interviews. Three doctors received their medical 
training abroad, and two in South Africa. Four of the doctors were predominantly English-
speaking, and one doctor spoke isiZulu. The English-speaking doctors used isiZulu-speaking 
interpreters (usually counsellors) during patient consultations. Three of the doctors were 
female, and two were male. The doctors were mainly clinic-based (and representative of all 
of the clinics in the DSA – see Figure 3.3), with two of the doctors being permanently based 
at the hospital (Table 5.1).  
Nurses. Four nurses took part in interviews, all of whom were professional nurses 
with ART training. All were female, and based at the clinics (representative of three of the 
clinics in the DSA) (Table 5.1). 
Counsellors. Ten counsellors took part in the counsellor focus group, all of whom had 
been trained as HIV counsellors, and were based at the clinics (representative of six of the 
clinics in the DSA) where they provided HIV counselling and testing, as well as routine 
adherence counselling to ART users. Nine of the counsellors were female, and one was male 
(Table 5.1). 
Caregivers. All of the caregivers (n=11) who took part in the caregiver focus group 
were female. Seven of the caregivers were the biological mothers of the child on ART, three 
were grandmothers, and one was the child’s aunt. Nine of the caregivers were single, one of 
the caregivers was widowed, and one was married. Seven of the caregivers had attended high 
school but did not complete it, two had achieved a Grade 12 level of education, one had no 
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formal education and one had a tertiary level education and was, at the time of the interview, 
a retired teacher (Table 5.1). Nearly all (9 out of 11), had received the pre-ART education 
sessions before the child was initiated onto ART. All stated that they were unemployed and 
seven of the caregivers were receiving a child support grant (CSG), which at the time of the 
focus group was worth 280 ZAR (USD= 22.98) per month (Table 5.2). 
Traditional healers. All the traditional healers (n=10) who took part had received 
training from Amref Health Africa (www.amref.org) (Table 5.1). Amref is an international 
African organization based in Nairobi, Kenya that trained 80 Traditional Health Practitioners 
(THP) between 2004 and 2007 in the Umkhanyakude district. Since 2007 the project was 
scaled up by the Department of Health and at the time of writing they continue to train THP’s 
in the area. Seven of the traditional healers were male and three were female. All of the 
healers practised in the surrounding community and defined their roles as either a herbalist, 
faith healer/prophet, sangoma or a combination of two. According to Truter (2007), a 
herbalist has a broad knowledge of curative herbs and predominantly uses herbs for treating 
diseases. Herbalists normally choose the profession, unlike other healers who ostensibly 
receive a calling to the profession (Truter, 2007).  
According to Truter (2007), a faith healer/prophet is normally a Christian belonging to 
mission churches. Faith healers predominantly heal through prayer, holy water and ash. A 
sangoma is generally considered the most senior of traditional healers. According to tradition 
sangomas are known to receive a calling to the profession. Sangomas, also known as 
diviners, are known to interact with the supernatural world to diagnose anomalies, especially 
with ancestors (Truter, 2007).  
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Table 5.1 
Participant characteristics  
Respondent  Respondent characteristics 
Doctors  
Doctor 1 
Medical officer and clinical researcher, trained abroad, male, clinic-
based, English-speaking 
Doctor 2 
Medical officer and clinical researcher, trained abroad, female, clinic 
and hospital-based, English-speaking 
Doctor 3 
Medical officer, male, trained locally, hospital-based, English and 
isiZulu speaking 
Doctor 4 
Medical officer and clinical researcher, trained locally, female, clinic-
based, English-speaking 
Doctor 5 
Medical officer, female, trained abroad, hospital-based, English-
speaking 
Nurses  
Nurse 1 
Professional nurse with ART specialization, female, clinic-based, 
English and isiZulu speaking 
Nurse 2 
Professional nurse with ART specialization, female, clinic-based, 
English and isiZulu speaking 
Nurse 3 
Professional nurse employed as a research nurse, female, clinic-based, 
English and isiZulu speaking 
Nurse 4 
Professional nurse with ART specialization, female, clinic-based, 
English and isiZulu speaking 
Counsellors  
Counsellor 1 HIV counsellor, female, clinic-based, English and isiZulu speaking 
Counsellor 2 HIV counsellor, female, clinic-based, English and isiZulu speaking 
Counsellor 3 HIV counsellor, female, clinic-based, English and isiZulu speaking 
Counsellor 4 HIV counsellor, female, clinic-based, English and isiZulu speaking 
Counsellor 5 HIV counsellor, male, clinic-based, English and isiZulu speaking 
Counsellor 6 HIV counsellor, female, clinic-based, English and isiZulu speaking 
Counsellor 7 HIV counsellor, female, clinic-based, English and isiZulu speaking 
Counsellor 8 HIV counsellor, female, clinic-based, English and isiZulu speaking 
Counsellor 9 HIV counsellor, female, clinic-based, English and isiZulu speaking 
Counsellor 10 HIV counsellor, female, clinic-based, English and isiZulu speaking 
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Table 5.1 (continued) 
Respondent  Respondent characteristics 
Caregivers  
Caregiver 1  
Single, mother, 24 years old, Grade 12, no pre-ART sessions, child has 
suppressed VL 
Caregiver 2 
Single, mother, 23 years old, Grade 8, received pre-ART sessions, child newly 
initiated 
Caregiver 3 
Single, mother, 33 years old, Grade 12, received pre-ART, child has suppressed 
VL 
Caregiver 4 
Single, mother, 22 years old, Grade 8, received pre-ART, child has 
unsuppressed VL 
Caregiver 5 
Single, grandmother, 51 years old, Grade 10, received pre-ART, child has 
suppressed VL 
Caregiver 6 Single, aunt, 27 years old, Grade 8, received pre-ART, child newly initiated 
Caregiver 7 
Married, grandmother, 55 years old, no education, received pre-ART, child has 
unsuppressed VL 
Caregiver 8 Single, mother, 21 years old, Grade 8, no pre-ART, child has suppressed VL 
Caregiver 9 
Widowed, grandmother, 65 years old, retired teacher, received pre-ART, child 
has suppressed VL 
Caregiver 10 
Single, mother, 23 years old, Grade 8, received pre-ART sessions, child has 
suppressed VL 
Caregiver 11 
Single, mother, 18 years old, Grade 8, received pre-ART sessions, child newly 
initiated 
Traditional 
healers 
 
Traditional 
healer 1 
Herbalist, male 
Traditional 
healer 2 
Sangoma and prophet, male 
Traditional 
healer 3 
Sangoma and prophet, male 
Traditional 
healer 4 
Faith healer and herbalist, male 
Traditional 
healer 5 
Faith healer and herbalist, female 
Traditional 
healer 6 
Faith healer and herbalist, female 
Traditional 
healer 7 
Herbalist and sangoma, male 
Traditional 
healer 8 
Herbalist, male 
Traditional 
healer 9 
Faith healer and sangoma, male 
Traditional 
healer 10 
Herbalist, female 
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Table 5.2 
Characteristics of the Caregivers  
Characteristics n=11 
Age of Caregiver (Mean (Std. Dev) years) 32.9 (16.3) 
Caregiver’s relation to child  
Mother 7 
Grandmother 3 
Relative 1 
Gender of child  
Male 3 
Female 8 
Caregiver marital status  
Single 8 
Married or living in a permanent union 2 
Widowed 1 
Highest level of education of caregiver  
No formal education 1 
Attended high school but did not complete Grade 12 7 
Completed Grade 12 2 
Graduated from university, college or technikon 1 
Employment  
Unemployed 11 
Income  
No income 1 
Less than R12000 per month 3 
More than R12000 per month 1 
Grant R280 per month 4 
Grant more than R280 per month 2 
Received paediatric pre-ART HIV education  
Yes 9 
No 2 
VL status of child  
Suppressed a 6 
Unsuppressed b 2 
New enroller c 3 
Note. a) VL < 400cps/ml after 12 months on ART; b) VL > 400 cps/ml less 
than 12 months on ART; c) On ART < 6 months - not yet received first VL 
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Results from the thematic analysis 
The themes that emerged from these data reflected a “patterned response” (Braun & 
Clarke, 2006, p. 10), not only due to the frequency with which the response emerged 
throughout each data set, but also according to investigator judgment as to whether it 
captured an idea important in answering the research question. The above process resulted in 
the identification of a composite list of semantic themes from each of the respondent groups. 
Table 5.3 shows the semantic themes derived from each respondent group, representing the 
themes derived at after Phase 3 and Phase 4 of the thematic analysis. 
The above-mentioned themes were then interpreted through the lens of 
Bronfenbrenner’s EST. Thus, latent themes were arrived at that represent doctors, nurses, 
counsellors, traditional healers and caregivers’ reflections on barriers and facilitators to 
adherence amongst children receiving ART via a caregiver. These are presented in Table 5.4 
below, and represent Phase 5 of the thematic analysis. 
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Table 5.3 
Semantic Themes Derived at after Phase 3 and Phase 4 of Thematic Analysis 
Traditional healers (n=10) Doctors (n=5) Nurses (n=4) Counsellors (n=10) Caregivers (n=11) 
Grandmothers as caregivers 
Caregiver definition 
Language barriers Caregiver definition Multiple caregivers 
Older versus younger 
children 
Trained versus untrained 
healers Clinic experience Frustration Grandmothers as caregivers Palatability 
Clinic experience  Multiple caregivers 
Positive affirmation towards 
caregivers Palatability Caregiver guilt 
Disclosure 
Grandmothers/moth
ers as caregivers Social grants Disclosure 
Caregiver-child 
relationship 
Multiple caregivers 
Caregiver-child 
relationship Financial insecurity 
Adjustment to daily routine 
(morning versus evening) 
Knowledge of 
importance of 
medications 
Financial insecurity 
Traditional 
medicines Overburdened households Religious beliefs Caregiving experience 
Pill swallowing 
Overburdened 
households Clinic experience Fathers Traditional medicines 
Palatability Food insecurity Caregiver-child relationship Clinic experience 
pre-ART education 
sessions 
Sweet taste distractor Pill swallowing Multiple caregivers Older versus younger children Use of reminder tools 
Biological mothers 
Large volumes of 
medicines Palatability Caregiver-child relationship Disclosure 
Social grants Palatability Side effects Side effects 
Visible outcomes of 
treatment adherence 
 
Doctor-caregiver 
relationship Pill swallowing  Clinic experience 
 
Adherence 
counselling Older caregivers  Financial insecurity 
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Table 5.3 (continued) 
Traditional healers (n=10) Doctors (n=5) Nurses (n=4) Counsellors (n=10) Caregivers (n=11) 
 
pre-ART education 
sessions Sweet taste distractor   
 Caregiver ill health 
Adjustment to daily routine 
(morning versus evening)   
 Disclosure Food vouchers   
 
Adjustment to daily 
routine (morning 
versus evening)    
 Older caregivers    
 
Beliefs about 
medication    
 Fathers    
 
Creativity in 
treatment 
administration    
  
Sweet taste 
distractor       
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Table 5.4 
Themes and Sub-themes Derived after Phase 5 Thematic Analytic Procedures 
System Description Theme Sub-theme  
Micro-
system 
Characteristics of 
the members of 
the microsystem 
that acted as 
determinants of 
adherence to ART Child characteristics Pill burden 
   Palatability 
  
Parent/caregiver 
characteristics Caregiver-child interaction 
  
 
Disclosure of the child’s 
HIV status to the caregiver 
   Denial of HIV 
  
Household characteristics 
Overcrowded households 
and food insecurity 
   Stigma and disclosure 
  
Healthcare worker 
characteristics Interaction with child 
  
Traditional healer 
characteristics Interaction with child 
Meso-
system 
Interactions 
between members 
of the micro-
system that acted 
as determinants of 
adherence to ART 
Caregiver-stakeholder 
interactions Language barriers 
   Multiple caregivers 
Exo-
system 
Influence of the 
healthcare context 
on adherence to 
ART 
Adherence counselling and 
training  
  Caregiver clinic experience  
  Child clinic experience  
Macro-
system 
Cultural and sub-
cultural factors 
that act as 
determinants of 
adherence to ART Traditional medicines  
    Religious beliefs   
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Microsystem 
Ecological Systems Theory (EST), as explained in Chapter 2, places the child within 
the microsystem. Alongside the child and within the context of this study, are all the members 
that directly participate in and influence treatment and care of the child. Thus the child is 
situated alongside his or her parent (s), caregiver (s), and household members, as well as 
alongside healthcare workers and traditional practitioners that interact with the children 
during consultation.  
Two over-arching themes were representative of the microsystem in this study, 
namely (1) characteristics specific to the child that influenced adherence to ART, and (2) 
characteristics specific to the key stakeholders (parents/caregivers, household members, 
healthcare workers, traditional healers) that influenced adherence to ART.  
Child characteristics. The age group of children represented in this study was 
children younger than or five years old. Respondents reported that children in this age group 
seldom knew why they were taking medications, and as such I did not include children 
themselves as respondents. Instead, doctors, nurses, counsellors, traditional healers and 
caregivers reported on barriers and facilitators that children in this age group experience with 
ART.  
Pill burden. The analysis indicated that respondents shared similar as well as 
differing views about what characteristics related to the child influenced adherence to ART. 
For example, doctors, nurses and counsellors had similar views on pill burden and reported 
that children struggled with taking large volumes of medication. They explained that children 
would sometimes be on ART and TB medication simultaneously, and that swallowing pills 
was problematic for children. One of the doctors (Doctor 5) stated that, “Exactly cause its 
liquids and especially if they are also affected by TB and possibly malnutrition, then you are 
looking at the ARV medication, your TB medication, your extra multivitamins and Bactrim 
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(an antibiotic used to treat infections) [and] that is a lot” (P5). Similarly, one of the adherence 
counsellors (Counsellor 2) stated, “Then this medication from the babies is more than the 
adult. It’s a lot of medication especially Efavirenz there is 200 and also 500 milligram and 
there is also the syrups, so maybe it is too much” (P8). One of the doctors (Doctor 3) stated 
that in his experience some caregivers of children on ART were uncomfortable with the 
number of medications the child received, and were often reluctant to administer the 
medications, especially when the child was ill. He stated that: 
. . . sometimes they [caregivers] look at the amount of medication that the child is 
getting. You find that, like on a prescription there’ll be about five to six drugs on top 
of the ARVs. So the mother feels as if this is too much for the child and so even on 
their face you could actually see that they think it’s a burden to the child to be given 
such medications, [it’s] too much. And most especially if the child is very ill then 
they’re a bit reluctant in giving medication because the child might vomit it and 
whatsoever. (P3) 
Conversely, caregivers themselves did not report on pill burden. However, two 
caregivers reported that TB medications were easier to administer due to the shorter duration 
(only given for 6 months) and the better palatability of TB treatment versus life-long ART.  
Doctors, nurses, counsellors and traditional healers stated that caregivers tried to 
mitigate issues of pill burden and facilitate treatment administration by opening medication 
capsules and dissolving tablets in water. For example, one of the traditional healers 
(Traditional healer 1) reported that a caregiver opened up the treatment capsules and 
dissolved it in water, making it much easier to administer to the child. The traditional healer 
stated, “One lady mentioned that the child was refusing to drink the medication so she just 
opened the capsules’ and diluted them and the child now drinks without any problems” (P10).  
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Palatability. A more prominent concern expressed by all respondents was the taste of 
LPV/r. There was consensus amongst respondents that LPV/r, one of the protease-inhibitor 
drugs, and a first-line regimen for young children was strongly disliked by children. 
Respondents also explained that this drug is bitter and in many instances the only way to get 
a child to swallow the medicine was by masking the taste with something sweet.  
Doctors reported that they normally advised caregivers to administer LPV/r together 
with something sweet such as the multivitamin usually prescribed to children or with a sweet 
alternative such as sugar, yoghurt, peanut butter or juice if they were able to afford it. As one 
of the doctors (Doctor 2) stated:  
I think particularly with LPV/r. It tastes very bitter, so one of the suggestions we make 
is if the child likes peanut butter to give them a spoon of peanut butter before giving 
the LPV/r…Obviously you could give a spoon of jam or something like that. Many 
families don’t have that so what many families do is give a spoon of sugar water or 
sugar because many families do have sugar in the house. I know that’s not particularly 
healthy, but that’s often what’s available to people. (P2) 
Two caregivers reported adopting a specific strategy to administering the medication 
in an attempt to alleviate the unpleasant taste. For example, Ngengi (caregiver 7), the 55-
year-old grandmother and caregiver of a child with an unsuppressed VL reported that she 
would start by administering the bitter-tasting medication to the child first, followed by the 
other, more palatable medications. Ngengi stated that: 
I used to start with the sweet medicine and let the child drink that first, [and] then I 
would finish with the bitter one. And then I changed and started with the bitter one 
first then finish with the sweet one. The child used to be very sick before I found out 
what was wrong at the clinic but now the child is better. (P9) 
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The unpleasant taste associated with LPV/r was closely tied to side effects such as 
vomiting and spitting out of medications. As Maggie (Caregiver 9), the 65-year-old 
grandmother and caregiver to a child with a suppressed VL, explained: 
I had a problem with the bitter medicine because the child was vomiting it and then I 
came back here and told them that the child does not want the medicine because she is 
vomiting it and they said I must continue with it. (P9)  
Nurses, doctors and counsellors were aware of the poor palatability and vomiting 
caused by LPV/r. They stated that caregivers were generally advised to re-administer 
treatment within an hour to ensure that the medicine was absorbed. In instances where 
caregivers were forced to re-administer medicine, some would run out of medications 
faster than others, resulting in caregivers having to travel to the clinic more than once a 
month to collect a refill.  
In instances where sweet alternatives (flavouring agents) were not commonplace 
in the household during treatment administration, encouragement and positive 
reinforcement contributed to motivating children to take their medication. A nurse (Nurse 
1) with some experience of the benefits of positive affirmation stated, “Yeah praises, the 
mother has to praise the child [and the] child just takes the medication” (P13). 
Characteristics specific to the key stakeholders that influenced adherence to 
ART. Parent/ caregiver characteristics. Caregiver-child interaction. The relationship of the 
caregiver to the child, (grandmother, mother, father or relative) influenced the extent to which 
caregiver responsibilities were met. Doctors, nurses, counsellors and traditional healers stated 
that the caregiver responsible for bringing the child to the clinic/consultation was often their 
grandmother. This fact was not reflected in the caregiver focus group as seven (out of 11) 
caregivers were biological mothers who were unemployed, three were grandmothers and one 
was an aunt (mother’s sister) (see Table 5.1). Respondents indicated that grandmothers were 
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mostly the caregivers of young children whose mothers had died or were working far away. 
One of the doctors (Doctor 2) who had several years of experience in seeing both children 
and their caregivers at the clinic and in the hospital setting stated that the interaction she 
observed between the caregiver and child was usually positive. She stated that she suspected 
that tension between the caregiver and child might arise when the child was struggling to take 
his/her medications. In such a situation the caregiver might feel an urgency to be strict with 
the child to ensure the medicine would be taken. She stated: 
…if there is any tension or any fear between the child and the caregiver, any kind of 
threats used, it can really make it quite difficult for little children to kind of 
swallow…but you can understand the caregivers point of view, if they’re terrified, 
they want the child to do well and to live and it’s really difficult for the caregiver if 
the child doesn’t take medicine…And I can understand the caregiver really, really 
must just feel at the end of their tether when that happens. (P2) 
Nurses and counsellors shared several concerns they had experienced in dealing with 
the grandmothers as caregiver. One concern was the inability to understand and follow dose 
and schedule adherence. For example, an HIV counsellor (Counsellor 3) stated: 
…and these days we know that most of the children - the caregivers are their grannies 
who do not understand, you know, the measurement [of the treatment doses] and 
especially with children another thing is that as the children gain weight, the dosage 
has to change. (P8) 
Others counsellors agreed with this counsellor during the focus group, reporting that 
they experienced much difficulty in communicating effectively with older caregivers. 
Counsellors thus felt strongly that the pre-ART education sessions offered to caregivers of 
children should be attended by more than one member of the household. Doctors, nurses, 
counsellors and traditional healers reported that other characteristics associated with the 
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caregiver, such as caregiver ill health, guilt over vertical transmission, old age and the 
number of dependents in a particular household, were also thought to influence adherence to 
ART.  
Disclosure of the child’s HIV status to the caregiver. All of the grandmothers and one 
aunt who participated in the caregiver focus group stated that the biological mothers of the 
children in their care did not initially disclose the child’s HIV status to them. These 
caregivers shared similar accounts of how the child came to be in their care and how they 
discovered the status of the child. The caregivers reported that the status of the child was only 
discovered once the child became ill, thus requiring a clinic visit. These caregivers expressed 
a deep sense of disappointment in their own children for failing to disclose the status of the 
child to them and subsequently compromising the health of the child. Maggie (Caregiver 9), a 
65-year-old widowed grandmother to a child with a supressed VL, said the following with 
regard to her caregiving experience: 
In January 2011 [child’s name] mother brought the child here and said she is going 
back to school so I took [child’s name], but we could see that she was not in a healthy 
state of wellbeing…It was also difficult for me when I found (out) that the child has 
this problem, but at the clinic they helped me a lot and it was people that I was used to 
and also this lady I go to church with who is also taking ARV’s and she also advised 
me and told me that everything is going to be okay and so I continued but my heart 
was still in pain but I continued to give her medicine and when I saw her starting to 
get better, I became happy and the other children didn’t ask that much about why I am 
giving her medication and I think it was because they saw how she was before. (P9)  
Maggie’s account of her caregiving experience adequately reflects the sentiments 
shared by the other grandmothers in the focus group. 
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Denial of HIV. The failure of biological mothers to disclose the status of the child to 
the person in whose care she had left them suggests a form of denial of the status of the child 
on the part of the mother. However, biological mothers were not the only members of the 
microsystem considered unable to accept the status of the child. Doctors, nurses, counsellors 
and traditional healers indicated that they were aware of instances where the biological 
fathers of these children also acted as barriers to adherence in that they would deny the HIV 
status of their child, thus forcing female caregivers to be secretive with the treatment. 
The respondents explained that they were mostly made aware of these instances by 
the reports of caregivers who attended the clinic, as fathers (and males in general) were less 
likely to attend clinic visits compared to females. One of the male doctors (Doctor 3) 
explained that in the Zulu-speaking community the man usually has the final say, and stated: 
Yes because in the Zulu culture the man is the head of the house. Sometimes when the 
father is around when the mother takes the child home with the medication you’ll find 
that the father will refuse the child taking medication. So it becomes a barrier between 
your child’s health and mother giving the medication to the child because the father 
would totally refuse and say my child is not sick so they shouldn’t be getting this 
ARV medication. So it becomes a stumbling block. (P3) 
One of the traditional healers (Traditional healer 6) also stated: 
Like …one [caregiver] came to me saying that she does not know how to tell the 
father that the child is positive, I told her to try and tell him because the child is in 
trouble. He needs to know. (P10)  
Most of the caregivers (9 out of 11) were single and living with other adults and 
children at their homesteads. The caregivers had reported that all the members of the 
household were aware of the status of the child, and none had specifically reported on the 
fathers of the children acting as barriers to ART. One of the caregivers reported that 
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disclosing the child’s HIV positive status to family members made treatment administration 
easier. The elderly caregiver (Caregiver 5) described how disclosure to household members 
facilitated adherence to the regimen: 
I made sure that I don’t forget the times so I put a reminder on my phone and asked 
the kids who I stay with to remind me and not forget and I made them read it so that if 
anything happens to me since I am a senior citizen they can help me. (P9) 
Household characteristics. Overcrowded households and food insecurity. Caregiving 
responsibilities were not an easy task to manage, especially in the context of overcrowded 
households in which many of the children and their caregivers resided. For example, 
respondents indicated that one caregiver was often responsible for many children. One 
doctor (Doctor 2) stated: 
That’s another [thing], yes often these grannies… it’s not just that they’re caregivers 
to [one child], there’s one granny whom I know who is caregiver to 12 grandchildren. 
I think three of them, I can’t remember how many, are on HIV treatment, and one of 
the children is handicapped. So you know, it’s a huge burden. (P2) 
An HIV counsellor (Counsellor 1) shared a similar account: 
We have a granny who’s looking after five children who are HIV positive. There are 
two of them not taking the treatment and three of them they are taking the treatment. 
So it’s hard for that granny to look after these children … (P8) 
All the caregivers participating in the focus group were unemployed, and almost all of 
the caregivers received a CSG worth ZAR280 (equivalent to $26). Two received a grant 
worth more than ZAR280 from the government (see Table 5.2). This money seldom 
supported the family for an entire month. The availability of other income, and thus ability to 
buy food, often determined whether medication would be administered. A doctor (Doctor 2) 
stated: 
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So last week I had a lady at the clinic and (the) child had a raised VL. (I) couldn’t get 
to the bottom of it. (The child was) definitely taking the tablets but in the end I asked 
her to go see someone in particular. One of the good counsellors was at the clinic and 
it turns out they tend to run out of money from about the 20th of each month so 
basically for about a third of the month, the child, who is an older child, refuses to 
take medicine if there is no food. (P2) 
One of the doctors (Doctor 3) also stated that a healthy child threatened the financial 
stability of many households, as an improvement in appetite meant that more food was 
necessary: 
Sometimes when the child is on ARV treatment they start gaining appetite. They are 
growing up fast. They’re quite active so in terms of food supply then it becomes a 
problem to their home. They don’t have enough food to give the child because then 
suddenly the child has too much appetite so that also becomes a problem for them. 
(P3) 
Food insecurity was thus identified as a major barrier to medication-giving with 
unanimity among respondents that caregivers were reluctant to administer treatment to a 
hungry child.  
One counsellor (Counsellor 1) stated: 
It’s a problem when there is no food to give to the child. You would find most parents 
deciding rather not to give a child medication because there is no food and they fear 
that children might experience even more complications because they’re taking 
medications with (out) that food. (P8) 
Caregivers themselves indicated the importance of having food available and one 
suggested that food vouchers would relieve some of this burden. One of the caregivers 
(Caregiver 6) stated:  
Stellenbosch University  https://scholar.sun.ac.za
  
104 
 
Why can’t they like give us a voucher for the kids to get food because our kids want 
the healthiest of food and we can’t afford to buy all of them. We are mothers who are 
not working so we could use some help because the grant money that we get doesn’t 
help us that much and we don’t work. (P9) 
Stigma and disclosure. Doctors, nurses and counsellors stated that children in the 
study area often resided within a household where there are some children on treatment 
and others not. In such instances the issues of stigma and disclosure would affect 
adherence to ART. Tina (Caregiver 3) reported that children did not like to be called away 
from their friends for medication times and even ran away when treatment time approached. 
As Tina (Caregiver 3), a single mother and caregiver to a child with a suppressed VL stated, 
“I think so because our kids is not like they’ve got all the things to play with at home. They 
are usually out with friends and then now they have to be called to come and take the 
medication” (P9).  
The other caregivers agreed with Tina’s statement. One of the counsellors reported 
that she had once counselled a young child who was mocked by her friends who nicknamed 
her “Pills” because she was always being called to come and take her pills. As Lydia 
(Counsellor 1) stated: 
Like when they call them for treatment, if the granny says come it’s time for the pills, 
it can make the discomfort for the child. Like the other one … he said he don’t like 
(to) take the treatment anymore because the friends are calling him ‘Pills’ now. (P8) 
Caregivers reported that the children in their care did not know why they were taking 
treatment, and some of the children had begun asking questions. Counsellors reported that 
children, even those of five years and younger, knew the difference between being on TB 
treatment versus being on ART and that caregivers reported difficulties disclosing to children. 
In some instances caregivers provided children with inaccurate and conflicting messages 
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about their treatment. One of the traditional healers (Traditional healer 4) reported on the 
conflicting messages that children received about their treatment and stated: 
You know kids are playful. A child asked what the pills were for and they [caregivers] 
told the child that is was to make him clever at school. The child said but at the clinic 
they told me these are pills for AIDS, and that is why I am always sick. (P10)  
Child interaction with healthcare workers. In order to understand the extent to 
which the relationship between the child and the various other role players influenced 
adherence to ART, the analysis was directed at understanding the experience each stakeholder 
had when treating or working with children on ART. For example, doctors reported having far 
less interaction with the children compared to nurses, caregivers and counsellors. Doctors 
reported that the interaction they did have would often be when a child was ill, or needed to 
be switched to a different regimen. Nurses and counsellors also reported fairly limited 
interaction with children in this age group. One of the counsellors (Counsellor 2) stated that 
caregivers themselves often left the child outside of the consultation room. She stated: 
Sometimes we see the caregiver comes with the child and leaves the child outside 
playing and comes alone in the consulting room. Perhaps there is no need, it’s like we 
feed the caregiver with the information and we don’t talk to the child…(P8)  
Communication between a child younger than five years and the healthcare workers 
was thus very limited, and most information was relayed via a caregiver.  
Child interaction with traditional practitioners. Traditional healers reported that 
they did provide traditional healing services to children on ART, and much like healthcare 
workers, verbal communication with the child was infrequent and communication was mostly 
done via the caregiver.  
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Mesosystem 
In the context of this study, the mesosystem considers the interactions between the 
members of the microsystems and the resulting impact of these interactions on the child’s 
adherence to ART. The over-arching theme representative of the mesosystem in this study 
was the interactions between the caregivers, healthcare staff and traditional healers.   
Caregiver-healthcare worker interaction. Language barriers. Doctors, nurses, and 
counsellors stated that language barriers made it difficult to communicate with caregivers 
about difficulties regarding medication administration. Four of the five doctors interviewed 
were predominantly English-speaking. Doctors explained that during their consultations an 
isiZulu speaking translator would be present, and it would usually be one of the adherence 
counsellors. One doctor (Doctor 1) reported the difficulty he experienced with 
communicating with the help of a translator. He explained that communicating via a 
translator limited rapport-building with the patient and also limited the extent to which he 
was able to probe patients for difficulties experienced with adherence to the regimen. He 
stated: 
So there’s a lot that’s lost in the translation for sure, and a lot of the complexity and 
the nuances of trying to explore adherence and things is obviously…the language is 
important. So it’s very difficult to explore in some of that complexity through a 
translator and ja, just building that confidence for somebody to truly tell you what the 
problems are is obviously very difficult without the language being the same. (P1) 
Although nurses and counsellors were able to communicate with caregivers in isiZulu, 
they reported that caregivers struggled to understand important information about the 
treatment such as changes in dose amounts. As one of the counsellors (Counsellor 2) stated: 
It shows that yes she was listening but couldn’t understand, which means at home 
she’ll do another thing. And it’s usually common because it’s like those caregivers 
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most time they are giving the syrups and then they come with an empty bottles at any 
time, [and say] oh it’s finished now. It means that they don’t understand. (P8)   
Multiple caregivers. Although a grandmother was considered the primary caregiver 
by the majority of respondents, other household members would also bring the child to the 
clinic for their monthly consultation. Doctors stated that having different persons 
accompany the child to clinic appointments disrupted continuity of care. One of the 
doctors (Doctor 4) explained, “So they’re coming in on their own, their caregivers have 
changed and the new caregiver doesn’t know that this child is taking medication …” (P4).  
One of the nurses (Nurse 4) explained how the irregularity of individuals attending 
clinic visits on behalf of the child on treatment disrupted her ability to monitor the child’s 
progress on ART. She stated: 
You find that some children their mothers died long ago so they are brought by 
different people. This month you see this one, next month you see that one so that 
becomes a problem because what you have talked with this person next month the 
child is brought by another who doesn’t know what have you talked [about] last time. 
Like, for instance, when I’m asking the caregiver to bring the child maybe for the 
bloods and telling them how to take the treatment, next time that one doesn’t know 
how to give the child the treatment. Something like that so it becomes a problem 
when coming to children. The medication is not taken properly. (P12)  
One of the doctors (Doctor 4) placed the irregularity of caregiver attendance at the 
clinics into perspective when she explained that when an older person such as the child’s 
grandmother is the primary caregiver, attending the clinic every month is physically 
challenging for her. In such instances where the mobility of the caregiver was restricted, 
younger children were sent to attend clinic visits instead. She stated: 
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… it’s the same person that’s usually giving the treatment [at home] but occasionally 
you have, for example, a granny at home who did the first three classes, who is the 
one who would be administering the medication, but bringing the toddler to clinic will 
be maybe an auntie or an older sibling, because they’re the one that is mobile and can 
jump in and out of taxis with a toddler... that can cause a difficulty because you are 
talking to someone who is not the person who is giving the medication at home 
…(P4) 
The problem of irregular caregiver attendance at the clinic is exacerbated when 
treatment-specific information provided to the person attending the clinic is not 
communicated to the person administering the medication. Further, doctors and counsellors 
explained that in some instances they were unsure as to whether the person bringing the child 
in was aware of the child’s status, and thus to what extent they were able to communicate 
with the person without disclosing the child’s status. One of the doctors (Doctor 4) explained 
that the uncertainty of whether disclosure had taken place delayed treatment initiation for the 
child. The doctor stated: 
…like I’m not always sure – should I disclose to this grandmother when the mother 
hasn’t done that herself or to call the mother back. So usually I say okay fine I’m 
running these investigations [inaudible 25:24] and then please come back to see me 
with the mother on another day. I haven’t initiated anybody where it’s not the person 
who is supposed to come, who, it’s not the primary caregiver coming to the clinic. 
(P4)  
Exosystem 
In the context of this study the exosystem considers the interactions of the members of 
the micro-, and mesosystems by placing the interactions in context, in this case, the 
healthcare context. The over-arching themes representative of the exosystem in this study 
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were adherence counselling and training and the experiences of the caregiver and child when 
attending their clinic visits.  
Adherence counselling and training. Doctors stated that in their experience 
adherence counsellors were seldom able to demonstrate an ability to question patients with 
the aim of eliciting information about difficulties with treatment. The doctors explained that 
the poor level of counselling skills reflected the poor quality of the training that adherence 
counsellors received. One doctor (Doctor 1) recalled an instance of poorly conducted 
training: 
I mean I’ve heard very bad things about the training, that there’s some place in 
[inaudible 0:27:41.2] that runs the training and it’s supposed to be a tutor training, sort 
of 10 full days or something and I hear that usually on the 3rd day or something the 
tutor just says ‘Oh, I think we’ve done enough. Just let them finish it. (P1) 
Another doctor (Doctor 2) stated that counsellors were neglected in their role and 
received no debriefing, minimal supervision, and once-off training sessions that were in some 
instances poorly conducted. The doctor explained that in her experience counsellors often 
asked closed questions to patients and seldom possessed the skills required to elicit more in-
depth information from patients. She also explained that counsellors were more likely to 
develop these skills if they were supervised by more skilled personnel. The doctor stated: 
Often when I’ve heard counsellors, you know, they ask a lot of closed questions 
which are not going to, in the five to ten minutes they’ve got with these patients, 
unearth these difficulties… Because if they have ten minutes per patient, there’s an 
awful lot you can do in ten minutes, and I feel these problems could have been 
unearthed a lot, lot sooner than they have been. So I would say that one of the real 
ways to turn this round would be to really, really put effort into the counsellors. But 
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that means you’ve got to have good counselling supervisors who are skilled and who 
are well-trained and who can debrief. (P2)  
One of the doctors (Doctor 4) explained that adherence counsellors lacked clearly 
defined roles and that in essence the healthcare system demanded a certain role from them, 
but one which they were ill-equipped for. She stated: 
Ja, I think the counsellors see their job as their session 1, 2, 3 and then additional 
adherence counselling they just try to figure out if the patient is taking their 
medication as they tell them to take the medication. But it’s almost like we expect 
them to be psychologists you know what I mean but that’s – there – I don’t think they 
do their role as that [inaudible 17:33]. I think they have a different understanding of 
what they are supposed to be doing as ARV Counsellors and we’d have a different 
expectation of what we think they should be doing as ARV [inaudible 17:45] 
Counsellors.(P4) 
Regarding the ‘sessions 1,2,3’ referred to by the doctor in the previous quote, doctors 
stated that the pre-ART HIV education sessions were conducted over two days at the primary 
healthcare clinics and on a single day at the hospital. The doctors agreed that it was 
emotionally and cognitively burdensome for a caregiver to receive counselling within two 
days, accept the child’s HIV diagnosis, and be expected to commence treatment immediately. 
For an illiterate caregiver these challenges would be even greater. 
A doctor (Doctor 1) explained:  
… it is a lot of information to process, and in the clinic the disadvantage is, it [HIV 
education sessions] takes a lot more time…. While here [at the hospital] you know 
they test positive, we take their CD4, their results are back, the next day all classes are 
done and we might actually be starting them within one or two days. And it’s a big 
Stellenbosch University  https://scholar.sun.ac.za
  
111 
 
thing being diagnosed with HIV or your child being diagnosed with HIV and having 
to understand this whole thing and the treatments. (P1) 
The intensity of information over a short period of time is likely to lead to poor 
caregiver knowledge of treatment administration practices. Doctors reported that some 
caregivers lacked basic knowledge about HIV and critical aspects of treatment 
administration, such as using a syringe for the measurement of liquid formulations. As one 
doctor (Doctor 4) described: 
So the knowledge is what to give and when, but the skills are how to draw the 
medicine up in the syringe, how to measure 5 ml or 8 ml or 6 ml or whatever the child 
is getting, (and) how to break a tablet in half and crush it and dissolve it and give it to 
the child. Because if you’ve not been shown those things you could be doing what 
you think is the right thing and it’s actually very different from what we think that 
caregiver is doing. (P4) 
Counsellors too felt that caregivers required more training sessions, as one counsellor 
(Counsellor 1) stated, “So I don’t know what we are going to do as counsellors. Maybe we 
need to… maybe the people need to come and do more sessions, maybe three or more… (P8). 
Despite doctors, nurses and HIV counsellors agreeing that the HIV-education sessions 
were rushed, and that more effort was needed to improve the skills of the counsellors, 
caregivers who participated in the focus group that had received the HIV education sessions 
reported that they were more than sufficient.  
One caregiver (Caregiver 3) explained: 
Me for myself, I am also positive and I think 2 classes are enough because I already 
know about HIV. I didn’t know how to drink the medication and that is what I wanted 
to know so 2 classes for me are enough. (P3) 
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Two caregivers were ill and unable to attend the sessions, and they reported that 
another family member attended the sessions on their behalf. The two caregivers explained 
that the family members had then shown them how to administer the medications and they 
then took over from them.  
The caregiver’s experience at the clinic. Respondents shared differing views about 
what they thought the experiences of caregivers attending the clinics in the DSA were. For 
example, one of the doctors (Doctor 1) stated that the experience of attending clinics was 
fairly ‘agricultural’, suggesting that clinic attendees were still very much controlled by the 
healthcare system rather than being empowered to take responsibility for themselves. He 
stated:  
I would imagine it’s fairly agricultural. I would say, that you’d come in and you’ve 
kind of heard it around the clinic and told to queue for your file and then once you’ve 
got your file, told to queue to see the counsellor or whatever and here you queue at the 
pharmacy or whatnot. I mean it’s very much still ‘we’re in control of you’ rather than 
that the patient’s caregivers or whatever are empowered to take responsibility 
themselves. It’s still you are the clinic and you will do this and you will like it or not 
that you have to queue for six hours. (P1) 
One of the other doctors (Doctor 2) explained that regular caregivers at the clinic 
actually found comfort in the routine that the clinic visit offered, and stated:  
I find that with increasing time, the children and caregivers actually settle down quite 
a lot. They know exactly what is going to happen when they come to clinic. They 
know, they’ve got an idea of what I am like, so they kind of know how to deal with 
that and certainly from [name of the clinic]. (P2)  
One of the traditional healers (Traditional healer 3) stated that perceived stigma 
prevented people from visiting certain clinics. He stated that some people in the surrounding 
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community were reluctant to visit certain clinics as they feared that others would think they 
were living with HIV. He stated: 
I am from [name of area]. As far as I know people from there not many people like to 
go to the clinic there because like for example if you go test and you are tested 
positive for HIV then you will hear it somewhere else. So people are going to clinics 
in other places because of this. Even when you go to the clinics you will find that 
everyone knows the line for HIV positive people are in their own line as a result 
people end up just keeping quiet and not getting any treatment. (P10)  
Caregivers in the focus groups reported positive experiences of attending the clinic. 
One caregiver (Caregiver 2) stated: 
Well I have never had a problem with the clinic, actually speaking, those people who 
work there motivate you and they advise you. Some people get offended but at the 
end they realize that they are getting good advice at the clinic. (P9)  
The child’s experience at the clinic. Respondents agreed that children were fearful 
of clinic visits in that they expected to get injections. However, they also agreed that clinics 
that fostered child-friendliness (often in the form of play leaders that facilitate various 
activities with children while awaiting their consultation) went a long way to improving their 
experiences at the clinic. One doctor (Doctor 2) explained: 
Parents or caregivers are often a bit nervous. The children are certainly nervous 
because they have often had blood tests done and the thought of coming to clinic is 
often quite worrying for them, because they don’t know what is going to happen. 
They (are) not used to the routine. I think the children quite enjoy coming because 
they’ve got play therapy and the atmosphere of the clinic. (P2) 
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Macrosystem 
In the context of this study the macrosystem includes the influence of culture and 
religion and their impact on the treatment and care of a child on ART in this area. The over-
arching themes representative of the macro-system in this study were the use of traditional 
medicines and religious beliefs.  
Traditional healing and traditional medicines. The traditional healers who took 
part in the focus group had all been trained to identify symptoms of HIV and make 
appropriate referrals to health facilities. The healers explained that there were still many 
healers in the area who did not acknowledge the existence of the virus. One healer 
(Traditional healer 3) stated, “They do not have the knowledge and the training. We were also 
like that in the beginning before the training and they are just blank basically” (P10). 
The healers went on to describe the impact of HIV training on their livelihoods. 
They stated that community members seeking help and advice from healers were unhappy 
with healers who had been trained and believed that their ancestral spirits were no longer 
communicating through them and that all they were doing was “referring them to the 
clinic”. A healer (Traditional healer 4) stated: 
When this training started it was a huge thing where our patients were being told that 
we are no more healers. We just send people to fill clinics and draw blood. We think 
we are better and I would meet some and ask them and they would say they found out 
that we are no more healers. One healer actually took four children and tried to heal 
them. When they came to me I could see that they were very ill so I referred to the 
clinic because I could see that they were very ill. (P10) 
Despite being trained to identify symptoms of HIV and make appropriate referrals, 
one of the traditional healers (Traditional healer 3) stated that he was confused about the 
extent to which their patients were able to use their herbal remedies. Other healers shared his 
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concerns and stated that a better integration between traditional healers and healthcare 
providers was needed in their area. One healer (Traditional healer 3) stated: 
As we were trained we were told that the child who is infected had a high risk of 
infections while using the enema (herbal enema) so if it was explained in a good 
manner not just to say don’t use the enema. I think if we were working together they 
would be able to explain it better to the mothers. (P10) 
The healers reported that they would still prescribe herbal remedies and enemas to 
patients on ART, but that they would advise them to take the remedies after their ARVs. A 
healer (Traditional healer 6) stated: 
Yes we do give them medication but we ask the caregiver on the times when they give 
them the ARVs and allow 1 hour and 30 minutes for them to take the traditional 
medication so not to interrupt the process of the ARV’s working on the child’s 
system. (P10) 
One of the doctors (Doctor 2) explained why traditional remedies were problematic 
for children and stated: 
No. It’s not ok generally for child health. Some of the enemas that are given, 
particularly those that include traditional plants like Aloes, can actually kill the 
children. So in the hospital we have many children who are admitted because they had 
a herbal enema and some of them can cause kidney and liver failure and the child 
dies. (P2) 
Only one caregiver in the focus group had consulted with a traditional healer about 
difficulties with treatment. Traditional healers, however, stated that they were frequented by 
caregivers, but that it was difficult to engage with them about medication adherence as 
caregivers were reluctant to disclose the child’s HIV positive status to them. 
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Religious beliefs. The HIV counsellors shared their concern about the role of the 
church in the fight against HIV. Caregivers of children with HIV and other PLWH had told 
counsellors that they believed that if they were prayed for they would be cured. As one 
counsellor (Counsellor 1) stated: 
The other thing, although it’s not so common, is the family belief disturbs sometimes 
on the adherence [family beliefs disturb adherence]. Like the family believes that if 
we take the child in a [in to] church and they will pray for the child she’s cured... 
They say oh we believe in that pastor, he’s doing a good job. (P8) 
Counsellors were the only respondents that referred to the influence of religion on 
ART adherence amongst children. Caregivers made no mention of religious or other beliefs 
that influenced adherence to ART.  
Summary of findings  
During Phase 1 I conducted nine interviews and three focus groups with individuals 
considered key stakeholders in the treatment and care of children younger than five years on 
ART living in the study area. Following a six-phased thematic analysis, a comprehensive list 
of themes and sub-themes was produced that summarized important information regarding 
barriers to and facilitators of paediatric adherence to ART in rural KwaZulu-Natal. The 
analysis highlighted agreements and disagreements between participants, and provided 
relevant quotes to contextualize each theme and sub-theme. 
The results reflected that the following barriers existing within the microsystem (i.e. 
the interactions between the child and all of his/her closest connections): Child 
characteristics, parent/caregiver characteristics, household characteristics, healthcare worker 
characteristics and traditional healer characteristics. Respondents were unanimous about the 
difficulty children had with taking large volumes of medications and swallowing medications 
that were unpleasant. Facilitators such as mixing the medications with a sweet alternative as 
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well as using positive affirmation were suggested to improve medication-taking by the child. 
In the mesosystem the results showed several interactions between the caregivers of children 
and healthcare staff that acted as a determinant of adherence to ART. Health workers 
emphasized that language barriers restricted rapport building and limited the extent to which 
information could be obtained from caregivers. The results indicated that barriers to 
paediatric adherence to ART were particularly salient when caregiving responsibility was 
shared and communication amongst those involved in the treatment and care of the child was 
lacking or poor.  
The results showed that factors within the exosystem, such as adherence counselling 
and training, influenced the extent to which counsellors were able to engage with caregivers 
regarding medication difficulties. In other words, the results indicated that adequate training 
of adherence counsellors with regular supervision, training and debriefing was a necessity in 
ensuring timely identification of problems with caregivers. Several caregivers reported 
positive experiences at the clinic, while other respondents indicated that a fear of being 
identified as HIV positive was still a concern amongst residents of the area. Respondents 
reported that children generally did not enjoy coming to the clinic out of fear of having their 
bloods taken, but that child-friendly facilities helped to mitigate much of this barrier. 
Traditional healers reported that they still prescribed herbal enemas to children (whether on 
ART or not). Traditional healers explained that the effects of their remedies on ART were 
poorly understood by them and that this called for better engagement with healthcare staff in 
the area. The analysis thus provided a broad range of perspectives expressed by the key role 
players in the treatment and care of children on ART. The first phase of this study served as a 
descriptive phase and the knowledge obtained provided a context and understanding of the 
factors influencing adherence amongst CLWH and their caregivers within this community. 
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The information obtained provided the necessary insight for the observational methods 
undertaken in Phase 2.  
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CHAPTER 6 
Phase 1 – Discussion  
Introduction 
The findings of the interview and focus group data demonstrated how key 
stakeholders in the treatment and care of children younger than five years understood the 
factors influencing paediatric adherence to ART within this context. The findings revealed 
that adherence to ART is influenced and shaped by the interactions between the child-
caregiver dyad and the family, in addition to the interactions between the child-caregiver 
dyad and healthcare system. In keeping with Bronfenbrenner’s EST (1979), the present 
chapter is organized to discuss the findings at the level of the micro-, meso-, exo- and 
macrosystem (Bronfenbrenner, 1979). 
Microsystem determinants of paediatric adherence to ART 
As per Bronfenbrenner’s EST (1979), the microsystem refers to the immediate 
environment in which the child lives and moves. In the context of this study, the system is 
dynamic and driven by the key interactions of the child with all those directly involved in 
their treatment and care. Two over-arching themes were representative of the microsystem in 
this part of the study, namely, characteristics specific to the child that influenced adherence to 
ART, and characteristics specific to each of the key stakeholders that influenced adherence to 
ART.  
Child characteristics. Child characteristics influencing adherence to ART were 
mostly in accordance with the literature (Haberer & Mellins, 2009; Simoni et al., 2007; 
Vreeman, Wiehe, Pearce, et al., 2008). Thus, respondents were unanimous about the 
difficulty children had with taking large volumes of medication and swallowing medications 
that are unpleasant. In particular, respondents stated that children struggled with LPV/r as the 
bitter taste often caused vomiting, which disrupted dosing when the syrup was not re-
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administered after vomiting. Palatability difficulty for children with LPV/r poses several 
concerns. Firstly, at present first-line ART regimens that include LPV/r are more effective 
than other available first-line regimens at suppressing VL (Ciaranello et al., 2015). Secondly, 
third-line treatment options are not readily available in South Africa and require referral to a 
specialized team, which poses concerns about future treatment options in the face of 
emerging drug resistance, especially amongst children residing in this study area (Pillay et al., 
2014). Lastly, in the absence of re-administration of the dose following an episode of 
vomiting, children are likely to experience periods of treatment interruption. A common 
reason for missed doses among infants and young children is vomiting without re-
administration of the dose (Reddi et al., 2007). Fixed dose combinations are not yet the norm 
and there is still a pervasive shortage of paediatric formulations, including more palatable 
formulations, in resource-limited settings (Bagenda et al., 2011). Similar to the findings of 
other studies, facilitating actions such as mixing the medications with a flavouring agent, and 
positive affirmation from caregivers were suggested to improve medication-taking by the 
child (Fetzer et al., 2011; Wrubel et al., 2005). Some authors (e.g. Bunupuradah et al., 2006) 
have shown that masking the taste of ARVs facilitates treatment administration to children. 
However, it remains uncertain as to whether masking the taste of ARVs improves overall 
adherence to ART in children (Bain-Brickley et al., 2011).  
Caregiver characteristics. With the devastating effects of HIV on the South 
African youth (15-35 years old) (Statistics South Africa, 2012), many children have been 
left orphaned (3.7 million) and care has increasingly shifted to grandparents or elderly 
caregivers (Mokgatle & Madiba, 2015). In this context, the Hlabisa HIV programme has 
dramatically improved the overall health and expected lifespans of HIV-infected women 
and children in the study area (Ndirangu, Newell, Tanser, Herbst, & Bland, 2010). Thus, 
more children are growing up with at least one biological parent present in the household 
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– usually the biological mother (Rochat, Arteche, Stein, Mitchell, & Bland, 2015). 
Despite these successes, there are still a number of children who live with an older 
caregiver, especially when biological mothers migrate to other areas for work (Hosegood 
et al., 2007; Makusha & Richter, 2014).  
Findings from this study showed that biological mothers often did not disclose the 
HIV status of the child to the caregiver in whose care she left them. Therefore, as was 
also found in other findings from South Africa (e.g. Sikstrom, 2014), caregivers only 
became aware of the status of the child once the child had become ill and required 
medical attention. Children in the care of older caregivers have been shown to access 
treatment and care much later in their illness trajectory than those living with their biological 
mothers (Ahmed, Gugsa, Lemma, & Demissie, 2013; Mokgatle & Madiba, 2015). Further, 
children initiating ART at an advanced disease stage are at a heightened risk for morbidity 
and mortality (Davies et al., 2009; Davies, 2015; Fenner et al., 2010).  
In the context of poverty, elderly caregivers who absorb young children into their 
care (especially children in need of chronic care and attention) are particularly challenged by 
their age, financial instability and level of education as they attempt to meet the caregiving 
needs of the child (Mokgatle & Madiba, 2015; Skovdal et al., 2011; Ssengonzi, 2007). 
Poverty also complicates and often diminishes the quality of caregiving a young child is 
likely to receive, as caregivers are likely to experience increased stress which makes it 
difficult to respond to the sensitive and stimulating care required by the child (Richter, 2004; 
Rochat et al., 2008). Caring responsibilities thus become shared among available household 
members. The results showed that irregular attendance of caregivers at the clinics was 
problematic for healthcare workers. There is evidence to suggest that children living with 
elderly caregivers usually have more than one person taking the child to clinic visits (Coetzee 
et al., 2015; Ferrand et al., 2010), and that the presence of multiple caregivers is associated 
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with poor adherence to ART (Fassinou et al., 2004). The problematic nature of caregiver 
irregularity at clinic visits in this study is discussed further on.  
In the setting where the study was conducted, marriage rates are low and 
biological fathers seldom residing with their children (Hosegood et al., 2007; Makusha & 
Richter, 2014). The demographic profile of this study area shows that the majority of 
children live with their biological mothers, not with their fathers (Hill, Hosegood, & 
Newell, 2008). The absence of Black fathers in the lives of children in South Africa 
occurs largely as a consequence of apartheid. Yet, despite the abolition of the apartheid 
laws, the effects are still evident today with men separated from family life and from 
involvement in the care of their children (Makusha & Richter, 2014). Very few studies 
have explored the involvement of men in the care and treatment of CLWH, apart from studies 
that emphasise the financial contribution that men offer to support the child and the family’s 
needs (Hosegood & Madhavan, 2010, 2012; Makusha & Richter, 2014).  
Nevertheless, available evidence from this study and others (Wachira et al., 2012) 
seems to suggest that within the context of HIV, where male involvement in caregiving and 
interaction with health services is substantially less than that of females, a biological father 
may act as a barrier to adherence to ART. For example, in the study by Wachira et al. (2012), 
females were found to be reluctant to disclose the status of the child to their male partners out 
of fear of being stigmatized and losing their financial support. In this study the findings 
showed that some fathers were not convinced that their child was HIV positive, which meant 
that female caregivers had to be secretive about the treatment. As shown in the literature, 
concealing the status of the child is likely to cause stress on the part of the caregiver in having 
to hide medications and maintain secrecy of the illness while also needing to access social 
and financial support, which requires openness with and disclosure to others (Hejoaka, 2009).  
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Stigma and disclosure. Although the appropriate age at which to disclose a child’s 
HIV status to them is not clear from the literature (Vreeman et al., 2013), respondents stated 
that children younger than five years were curious about their treatment and even aware that 
some treatment courses (like those for TB) come to an end, while theirs did not. The results 
show that even at this age, children experience discrimination from other children when 
called away from their friends to take medications. Studies from South Africa repeatedly 
report that many caregivers feel that children are too young to know about their status 
(Moodley et al., 2006; Kagee et al., 2006). Similar to other studies (Vreeman et al., 2010), 
caregivers then provide inaccurate information and often lie to children about their illness. In 
Brazil (Marques et al., 2006), HIV-infected adolescents emphasised the importance of 
receiving accurate and complete information about the nature of their illness.   
Food insecurity and overcrowded households. A study from KwaZulu-Natal 
showed that rural households survive on less than ZAR12 (1.14USD) per day (D’Haese et 
al., 2013). Many caregivers reported that they receive the government funded CSG. The 
CSG, which is currently worth R300 (28.12 USD) (participants in our study referred to 
the amount allocated before this, i.e. R280 (26.25 USD)) per month, was an initiative of 
the government to support the nutritional and other health needs required for a growing 
child (South African Government Services, 2013). Caregivers in this study mostly relied on 
government support grants received on behalf of the child to support all family members. 
Doctors stated that as children regained their health because of ART adherence, their 
appetites improved. Some doctors explained that a child’s improved appetite would threaten 
the financial stability of the household, as more food would have to be given to the child. In a 
study by Nagata et al. (2012) among adult ART users in Kenya almost all of the respondents 
(87%, n=67) reported that they experienced an improvement in their appetites following 
initiation on ART. Several participants reported that they would skip meals in the morning as 
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‘hunger pangs’ were worse at night. However, this did not necessarily stop them from taking 
their medication (Nagata et al., 2012).  
Caregivers in this study stated that children have to take food with medications. The 
availability of food often determined whether medication would be administered to the child, 
as food is needed to mitigate the side effects of medication, such as nausea and vomiting. 
Similar findings have been reported elsewhere (Biadgilign et al., 2009; Fetzer et al., 2011). 
Caregivers in this study stated that food vouchers would help to alleviate some of the burden, 
as the vouchers would only be used to buy food and not other household amenities. The HIV 
epidemic has placed a large burden on families in SSA over the past three decades, many of 
which also face several other social, economic and political challenges. Thus, the HIV 
epidemic has compromized and threatened the ability of many families to care for and 
support children infected and affected by HIV. Despite the burden of absorbing an additional 
family member into a typical rural household, empirical studies consistently show that most 
aﬀected families and households in SSA adapt and continue to provide for the needs of 
children (Hosegood & Madhavan, 2010).  
Healthcare worker characteristics. De Civita et al. (2004) have argued that within 
the context of paediatric healthcare, successful adherence to medication regimens to a large 
extent requires a triadic partnership between the child, caregiver and medical team. These 
authors postulate that within the context of complex regimen requirements (such as ART), 
meaningful exchanges between each of the partners should occur within the context of 
developmental, contextual and disease characteristics.  
Children are often excluded from the decisions made during medical consultations 
(Schwartz & Axelrad, 2015; Tates & Meeuwesen, 2000). Doctors, nurses and traditional 
healers reported that they often had very little communication with children during 
consultations and counsellors reported that children were occasionally excluded from their 
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counselling sessions. For caregivers of CLWH, exclusion of children from the medical 
consultation may occur as a result of fear of disclosure of the child’s HIV status to the child 
(Vreeman et al., 2013). However, studies have shown that children who are given 
responsibility and are made part of the treatment process respond better to their treatment and 
are better able to integrate treatment into their daily lives (Fetzer et al., 2011; Hammami et 
al., 2004).  
Mesosystem determinants of paediatric adherence to ART 
In the context of this study, the mesosystem considers the interactions between the 
members of the microsystems and the resulting impact of these interactions on the child’s 
adherence to ART. The over-arching theme representative of the mesosystem in this study 
was the interactions between the caregivers with healthcare staff and traditional healers.   
In the South African paediatric HIV healthcare context, and especially in the context 
specific to this study, the ART programme is typically led by doctors, nurses, and counsellors 
(Bland et al., 2013). Given the influence of culture and the use of herbal remedies in rural 
South Africa (Appelbaum Belisle et al., 2015), traditional healers may also be considered part 
of the medical team. The information that caregivers of children on ART receive from their 
healthcare providers contributes a large proportion of the skills and knowledge available to 
them to ensure the child’s optimal adherence to ART (DiMatteo, 2004).  
Findings from this study demonstrates several factors that disrupt the potential to form 
healthcare partnerships between caregivers and healthcare workers necessary to overcome 
barriers to adherence to ART in children’s mesosystems. Among these factors were limited 
interaction and communication between doctors, caregivers and children, predominantly as a 
result of language barriers. Doctors in the study were largely English-speaking and consulted 
with patients via translators. Consequently, language barriers took away the opportunity for 
the doctors to establish meaningful relationships and build sufficient rapport with the 
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caregivers. Penn et al. (2011) have found language barriers to complicate patients’ knowledge 
and understanding of ART among ART users in South African public healthcare facilities 
(Penn, Watermeyer, & Evans, 2011). Poor knowledge of ART among caregivers has 
repeatedly been associated with poor adherence to ART (Arage et al., 2014; Olds, Kiwanuka, 
Ware, et al., 2015; Wachira et al., 2012).  
The opportunity for rapport-building was similarly disrupted with the irregularity of a 
single consistent caregiver attending clinic visits on the child’s behalf. In this study, the 
unavailability of a single caregiver in some cases disrupted the continuity of care as doctors 
were unsure whether appropriate communication amongst the individuals who were 
responsible for the child took place after the clinic visit. As mentioned earlier, the evidence 
of the impact of multiple caregivers on paediatric adherence rates is unclear (Haberer & 
Mellins, 2009). Yet, some evidence from South Africa shows that confusion between 
multiple caregivers responsible for administering ART to the child was among the most 
salient reasons for missed doses among children (median age of 5.7 years) on ART (Reddi 
et al., 2007).  
The findings from this study suggest that irregularity of clinic attendance among 
caregivers is a consequence of orphanhood and maternal migration for work purposes. 
Elderly caregivers who are more likely to be immobile and suffer age-related illnesses 
rely on other household members to attend clinic visits on their behalf. Although it did not 
emerge from this data, the irregularity of doctors in primary healthcare settings also limits 
rapport-building. Doctors in the primary healthcare settings are known to rotate between 
clinics and patients may not consistently see the same doctor for consultation (Biadgilign et 
al., 2009; Bland et al., 2013). Inconsistency in doctors and caregivers, coupled with limited 
interaction with children during consultations, highlighted the difficulty of developing and 
sustaining meaningful healthcare partnerships in this setting.  
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Exosystem determinants of paediatric adherence to ART 
In the context of an expanding ART programme in South Africa and the shortage of 
healthcare workers, task-shifting has become one way to manage the sheer volume of patients 
accessing primary healthcare facilities. Task-shifting was originally put forward by the WHO 
(2008) to allocate specific tasks to health workers with lower level qualifications in order to 
increase HIV services at decentralized healthcare facilities. The new cadre of health workers 
engaged to facilitate this process are known as adherence counsellors or lay/peer counsellors 
or community health workers (CHWs) (McPake & Mensah, 2008).  
Lay counsellors typically do not hold professional or paraprofessional qualifications, 
and are known to receive short periods of unstandardized training (Dewing et al., 2015; 
Petersen et al., 2014). Some training programmes last only one week, while others may 
last up to one year (Remien et al., 2013). For example, at the time of writing this research 
report, in the Western Cape, lay counsellors trained by the Western Cape AIDS Training and 
Information Counselling Centre (ATICC) received a month of training, after which they are 
left to respond to problems with patient adherence on their own (Remien et al., 2013). 
Following training, counsellors are required to provide a number of services, including 
psychosocial support services to ART users in the form of adherence counselling. The limited 
training that counsellors receive places them at a relative disadvantage to engage with 
patients in a supportive manner (Dewing et al., 2015; Kagee, 2013). 
Doctors in this study stated that adherence counsellors were largely neglected in their 
role, and received little support in the form of regular supervision and debriefing. In many 
ways, doctors felt that the healthcare system demanded a certain role from adherence 
counsellors, but one that they are ill-equipped for. Given the varying periods of 
unstandardized training provided to adherence counsellors in the South African public 
healthcare system, some studies have specifically focused on providing lay counsellors with 
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counselling skills with the aim of improving psychosocial services to ART users (Kagee et 
al., 2013; Dewing et al., 2015). However, a recent systematic review showed mixed results 
regarding lay counsellors’ ability to provide behaviour change counselling with the aim of 
improving adherence to ART (Petersen et al., 2014). Findings from the review showed that 
adherence counsellors adapted behaviour change interventions according to their own needs, 
and often chose to advise patients on adherence issues in their own manner and not according 
to client-centred models (such as Egans’s client-centred model) (Dewing et al., 2012). 
Further, the review showed that counsellors felt excluded from the medical hierarchy largely 
due to the unclear nature of their roles within the healthcare system (Petersen et al., 2014). In 
the context of the exosystem, the unstructured training sessions and lack of follow–up with 
and debriefing of counsellors are factors beyond the control of the counsellors themselves, 
but they nonetheless influence the level of psychosocial support and behaviour change 
counselling that counsellors are able to offer patients during routine counselling sessions. 
As the ART initiation criteria continue to change, more people access public 
healthcare facilities and have to be initiated onto ART. Given the urgency to provide health-
seeking individuals with treatment in an already overburdened healthcare system, pre-ART 
education sessions often occur over very short periods of time (Bland et al., 2013). Doctors in 
this study stated that pre-ART education sessions received by patients at the clinic and at 
hospital were usually conducted either over two days at the clinics, or a single day at the local 
hospital. Doctors stated that this was too much information to receive over such a short 
period of time, and that for an illiterate caregiver this was especially cognitively and 
emotionally burdensome. Counsellors, in particular, stated that they had difficulty in 
communicating with elderly caregivers regarding treatment changes. The rushed nature of 
these education sessions and irregular clinic attendance may explain why communicating 
with elderly caregivers is problematic. Given the absence of effective communication 
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amongst key role players in the treatment and care of children on ART in this study, rushed 
information-giving coupled with an illiterate caregiver and a poorly skilled adherence 
counsellor is likely to affect the relationship the child has with his or her treatment and the 
healthcare facility.  
Despite the obvious concerns that healthcare workers had regarding adherence 
counselling and pre-ART education sessions, caregivers reported that the pre-ART 
counselling sessions they received were sufficient for their needs. This discrepancy may 
reiterate the problematic nature of the state of adherence counselling services provided to 
caregivers of children on ART. Caregivers may not be aware that they lack important 
knowledge regarding the treatment as this information was not communicated to them by a 
family member or healthcare provider. 
Several caregivers reported positive experiences at the clinic, while traditional healers 
indicated that a fear of being identified as HIV positive was still a concern amongst residents 
of the area. Stigma still persists as one of the most important factors influencing linkage to 
care. It contributes to delayed treatment initiation among HIV infected infants and young 
children (Boender et al., 2012). Respondents reported that children generally did not enjoy 
coming to the clinic out of fear of injections, but that child-friendly facilities helped to 
mitigate many of these barriers. Other studies have also demonstrated the importance of 
child-friendly services at healthcare facilities (Fairlie, Sipambo, Fick, & Moultrie, 2014; 
Mkwanazi, Rochat, Coetzee, & Bland, 2013).  
Macrosystem determinants of paediatric adherence to ART 
The influence of traditional medicines on adherence to ART. African communities 
are still largely influenced by traditional healers and traditional medicines (Appelbaum 
Belisle et al., 2015; Bland, Rollins, Broeck, & Coovadia, 2004; Schenk, Kiragu, Murugi, 
& Sarna, 2014). Studies from KwaZulu-Natal have shown that traditional healers are 
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often patients’ first contact with healthcare (Appelbaum Belisle et al., 2015; Carton, 
Laband, & Sithole, 2008). Similarly, in Kenya traditional healers are often patients’ first 
access to healthcare as it is affordable, accessible and less stigmatising than clinic or 
hospital visits (Schenk et al., 2014). 
Despite the influence of traditional healers in this community, caregivers in this 
study stated that they did not typically consult with healers regarding ART difficulties 
with children in their care. Only one caregiver in the FGD had consulted with a traditional 
healer about difficulties with treatment. Traditional healers, however, stated that they were 
consulted by caregivers, but that it was difficult to engage with them about medication 
adherence as caregivers were reluctant to disclose the child’s HIV positive status to them. In 
the study by Appelbaum Belisle et al. (2015) traditional healers reported that patients sought 
their care as they were considered trustworthy. However, stigma associated with being HIV 
positive limited the extent to which traditional healers were able to engage with caregivers 
and children on ART. 
Despite having received training on identifying the symptoms associated with 
HIV, traditional healers in this study remained largely unaware of the contra-indications of 
their herbal remedies when used in conjunction with ART. Traditional medicines remain 
largely uncontrolled (poorly regulated and unregistered) and in the case of children, the 
uses of traditional medicines such as herbal enemas have resulted in chi ld deaths (Bland 
et al., 2004). Similar to the findings of other studies (Appelbaum Belisle et al., 2015) 
traditional healers reported that they prescribed herbal enemas to children whether they are 
on ART or not. Traditional healers explained that the effects of their remedies on ART were 
poorly understood by them and stated that better engagement with healthcare staff in the area 
was needed. The use of traditional medicines within the context of HIV treatment and care 
remains contentious (Appelbaum Belisle et al., 2015). Recent evidence on the use of 
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traditional medicines among Zulu ART users in KwaZulu-Natal demonstrated that 
traditional healers supported concurrent use of traditional remedies and ART and believed 
they played a very important role in the treatment and care of PLWH. Healthcare 
providers were not open to engaging traditional healers in the care of PLWH (Appelbaum 
Belisle et al., 2015).  
The influence of religious beliefs on adherence to ART. Only adherence counsellors 
in this study mentioned the potential influence that religion had on adherence to ART. The 
counsellors stated that they were aware of instances where ART users had reported to them 
that HIV could be cured through prayer. Another study in South Africa has also implicated 
some charismatic religious leaders as barriers to adherence to ART (Coetzee et al., 2011). 
However, these findings contradict other research studies investigating the influence of 
religion on adherence (Park & Nachman, 2010). For example, in an earlier study by Park et 
al. (2010), the authors investigated the relationship between religious beliefs and adherence to 
ART. The authors sampled 18 HIV-infected youth members aged between 14 and 22 years. 
The authors found that youths who reported elevated rates of involvement in religious 
practices more often had excellent adherence (defined as no missed doses in the past three 
days for more than one medication) compared to those with lower rates. The authors 
attributed religious beliefs to a form of social support. Social support has been shown to 
increase adherence amongst ART users (DiMatteo, 2004; Katz et al., 2013; Olds, Kiwanuka, 
Ware, et al., 2015).  
Limitations and strengths 
The findings represent the perspectives of healthcare providers, traditional healers and 
caregivers of children younger than five years on ART in rural KwaZulu-Natal. The study 
therefore provides a broad range of perspectives expressed by the key role players in the 
treatment and care of children on ART. However, due to the small sample size and geographic 
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location of the participants, the findings cannot be generalized beyond the study. However, 
the findings may be transferable to other caregiver-child dyads living in the study area.  
The study included parental as well as non-parental caregivers of children on ART, 
local as well as non-local doctors, and considered the perspectives of traditional healers. Very 
few studies have incorporated traditional healers’ perspectives regarding barriers and 
facilitators of paediatric ART. By limiting the research specifically to children younger than 
five years on ART the research provides specific age-related knowledge that may contribute 
to intervention development. The perspectives of female caregivers were largely solicited in 
this research. Given the dearth of studies including male perspectives on paediatric HIV, 
future research might benefit from purposively recruiting biological or social fathers’ 
perspectives on factors influencing paediatric ART. By including children with varying 
virological outcomes, this research allowed for comparisons that highlighted factors that may 
contribute to disease progression among infants and young children on ART. The findings 
demonstrate that attempts to improve paediatric adherence to ART in this setting should 
consider the complexity of the socioecological environment in which adherence among 
children and their caregivers in this area occurs. 
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CHAPTER 7 
Phase 2 - Methods 
Objectives 
In order to determine what information caregivers received during their adherence 
counselling session at the clinic, I observed and documented the adherence counselling 
session caregivers received during a routine monthly visit to the clinic. 
To determine the barriers and facilitators of treatment administration practices by 
caregivers to children younger than five years with different virological outcomes on ART, I 
video-recorded and documented the administration of medication to children younger than 
five years by their caregivers during one morning and one evening visit at their homesteads.     
Sample design and sampling methods 
Employment of a field assistant. Phase 2 of the research commenced in March 2013. 
Prior to this, I employed a full-time, isiZulu-speaking, research assistant (RA; Ms Mgenge). 
The RA had previous experience in the field, as she had been appointed as a data collector at 
the Africa Centre prior to becoming involved in my study. She had also previously worked as 
a data capturer and had experience in interviewing women and adolescents living with HIV. 
Ms. Mgenge has been a resident in the Hlabisa sub-district all her life and had valuable 
knowledge of the rural area. Her knowledge aided navigation of the field in areas where street 
names and proper roads are non-existent.  
The RA assisted with recruitment of caregiver-child dyads, served as an interpreter in 
the field during home visits and counselling sessions, and assisted with rapport building with 
families. The RA kept a field journal in which she recorded her reflections on home visits. I 
included the field notes of the RA in the analysis.  
Sampling design and criteria. Purposive sampling was used to select and recruit 
children younger than five years into the study. Viral load status at the time of recruitment 
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was used to differentiate three groups of children invited to take part in the study (Table 7.1). 
Children on ART for more than a year with a VL ≤400 copies per millilitre (cps/ml) were 
considered virally suppressed. A suppressed VL was considered an indicator of good 
adherence. Children on ART for more than a year with two consecutive VLs of ≥400 cps/ml 
were considered virally unsuppressed. An unsuppressed VL was considered to be an indicator 
of poor adherence. Children on ART for less than a year with no VL data were new enrollers. 
New enrollers were included in order to understand how caregivers incorporated treatment 
administration and clinic adherence into their daily routine. I aimed to recruit 10 caregiver-
child dyads based on each criteria group.  
Table 7.1 
Sampling Criteria of Children on ART 
  Time on ART (years) VL (copies per millilitre)  
Unsuppressed VL ≥1 ≥400 cps/ml (X2)* 
Suppressed VL ≥1 ≤400cps/ml 
Newly initiated ≤ 1 No VL** 
Note. * = Unsuppressed following two consecutive raised VLs ≥400 cps/ml. ** 
= Newly initiated children had not yet had a VL taken since enrolment on ART. 
 
Recruitment. Recruitment took place at two primary healthcare clinics (one peri-
urban clinic [clinic A], and one rural clinic [clinic B]) in the Africa Centre’s DSA. Clinic A 
was the same clinic we had used during Phase 1 of the study. Recruitment began at clinic A 
and clinic B was added to complete the sample size/ensure enough caregiver-child dyads 
were recruited for each criteria group.  
Dr Ruth Bland, paediatrician to all the children on ART attending clinic A and B, 
approached the Africa Centre database scientist with the criteria for the study sample as 
outlined earlier. A password-protected output based on these criteria generated a list of 
caregiver-child dyads and expected date of clinic attendance. At the clinic, the list was 
provided to one of the adherence counsellors (who had agreed to assist with recruitment) 
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based in the filing room at the clinic. The filing room was the patients’ first point of entry 
when they came to the clinic, and was therefore a suitable point at which to engage with and 
invite caregivers. I asked the adherence counsellor to invite caregivers attending the clinic on 
the child’s behalf to meet with me and my RA in a private room after their clinic visit. At 
clinic B I used the same recruitment strategy. The RA, in the presence of the principal 
investigator (BC), explained each objective of the overall study to participants in their first 
language, isiZulu. All participants gave written informed consent. 
Figure 7.1 shows the number of caregiver-child dyads recruited from clinic A and 
clinic B and the numbers that withdrew from the study. The final sample consisted of 10 
children newly initiated on ART and their caregivers, 12 children with suppressed VL’s and 
their caregivers, and 11 children with unsuppressed VL’s and their caregivers. Thus, 33 
caregiver-child dyads took part in this study. Detailed participant characteristics are presented 
in the next section. 
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Figure 7.1. Recruitment numbers at clinic A and clinic B 
 
Newly initiated (n=10) 
Final sample clinic A (n=8) Final sample clinic B (n=2) 
13 recruited from clinic A and B (n=13) 
2 withdrew (Both moved out 
of the DSA) 
1 child passed away 1 month 
after recruitment 
Suppressed VLs (n=12) 
22 recruited from clinic A and B 
8 lost to follow-up after home 
visit 1 
2 withdrew as father refused 
home visits 
Final sample clinic A (n=12) Final sample clinic B (n=0) 
Unsuppressed VLs (n=11) 
17 recruited from clinic A and B 
3 withdrew 
2 relatives did not want home 
visits 
1 Caregiver-child dyad moved out of 
DSA 
Final sample clinic A (n=10) Final sample clinic B (n=1) 
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Procedure. I observed caregivers during their counselling session, as well as during 
two to three visits at their homes. I asked each caregiver for permission to use a video camera 
during the household visit. However, those who declined were not excluded from the study. 
Only caregivers who had previously stated that members of the household were aware that 
the child was receiving medications were recruited for the study. All caregivers provided 
written informed consent.  
Counselling session. Once a caregiver and child had been recruited, my RA and I 
accompanied them to a counselling session approximately one month after recruitment. We 
were present at the clinic on the date of each caregiver’s next clinic visit. However, we did 
not call caregivers beforehand to remind them of their visits. Caregivers who were not 
present at their next clinic date were then telephoned the following day to determine the 
reason.  
A semi-structured observation schedule (see Appendix M) was used during each 
adherence counselling session. When caregivers arrived at the clinic on their next clinic date, 
we met with them at the filing room and waited with them in line for their counselling 
session. The observation schedule elicited the following information: the length of the 
counselling session, caregiver and counsellor mood, presence of the child in the session, and 
content of the counselling session. The counselling sessions were mostly conducted in 
isiZulu, and captured via my RA’s field notes. These field notes were translated by my RA 
into English and used by me for analysis. Once the counselling visit was concluded, we 
scheduled the first home visit (home visit 1) within a week following the counselling visit. 
Household visits. Following the counselling session, participants were observed at 
their households three times.  
Home visit 1. Home visit one (which typically lasted between 45 and 60 minutes) was 
the first time that we met with the caregiver and child at home. The purpose of this first visit 
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was to establish initial rapport with the family, to map out exactly where participants lived (so 
that we could arrive on time for the medication event on home visit 2), and to observe and 
document the type of dwelling, occupants and resources (see Observation schedule for Home 
visit 1 - Appendix J).  
Home visit 2 and 3. Following home visit 1, my RA and I were present at the 
caregiver and child’s home during one morning and one evening field visit (which typically 
lasted between 20 and 60 minutes each) in order to document and observe ART 
administration and management as it occurred naturally in the household. The morning home 
visit occurred no later than a month after home visit one. We conducted all the morning home 
visits during the period May 2013 to October 2013. No home visits occurred during 
November and December 2013 due to heavy rainfalls and families migrating or receiving 
family members during the festive season. Evening home visits were conducted during the 
period January 2014 to March 2014. 
On the day of either the morning or evening home visit we arrived at the household 
some time before the treatment event (administering of ART to the child) took place. 
Caregivers had indicated to the RA the time that ART was "normally" administered to the 
child and we arrived before this time to document the moment-to-moment occurrences 
before, during and after the administration of the ART (See observation schedule for Home 
visit 2 and 3 – Appendix K).  
My RA and I identified obvious obstacles that caregivers faced and the methods or 
structures that were in place to facilitate the administration of medication. We identified the 
individuals involved in the administration of the medication, observed the interaction 
between the child and the caregiver and used a video-recording device to facilitate these 
observations. During home visit 2 literate caregivers were given a book and pen and asked to 
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document their daily routine. Illiterate caregivers nominated a literate household member to 
write in the journal on their behalf.  
Participant food parcels. Following each home visit participants were handed a food 
parcel to the value of R150.00 as a token of my appreciation for their willingness to 
participate in this research.  
Natural observation as a data collection method 
Unlike our natural observations of the world around us and our ability to make sense 
and offer judgements about things, observation for research purposes is systematic and 
focused on formal processes that characterize daily life (Angrosino, 2007). Observation may 
thus be defined as, “…the act of noting a phenomenon, often with instruments, and recording 
it for scientific purposes” (p. 72). Naturalistic observation differs from participant 
observation to the extent to which the researcher engages in the action. Angrosino (2007) has 
summarized four kinds of roles that a researcher conducting ethnographic work may adopt 
during the data collection process as established by Gold (1958).  
The first role is that of the “complete observer” (p72). In this role the observer 
remains entirely covert and is never seen or noticed by the participants. The “complete 
observer” role lends itself to ethical concerns in the form of deception of participants. The 
second role is that of the “observer-as-participant” (p72). In this role the researcher conducts 
short periods of observation and is known to and often interacts with the study participants, 
but only in his/her capacity as a researcher. The third role is that of the “participant-as-
observer” role (p73). In this role the researcher becomes as much a friend to participants in 
the study as an objective and neutral researcher. Thus, participants remain aware of the 
intentions of the role of the researcher during the data collection period. Finally, the fourth 
role is that of “complete participant” (p73). In this role the researcher becomes completely 
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immersed in the lifestyle of the participants to the extent that the research agenda remains 
largely unknown to participants.  
Based on these distinctions of the various observer roles, I considered my role in this 
research to be that of “observer-as-participant”. Observing participants through naturalistic 
observation provided me with the unique opportunity to collect data from individuals 
embedded in their natural context (Paterson, Bottorff, & Hewat, 2008). As far as possible I 
tried to remain unobtrusive, but this was difficult given the predominantly rural and Black 
inhabited surrounding community and my presence as a young white female. Initially I had 
used a marked Africa Centre vehicle for home visits, but experienced field workers suggested 
that an unmarked vehicle would make the neighbours of my participants less curious. I thus 
decided to change the field car to an unmarked rented vehicle for the remainder of the data 
collection period. Despite my concerns, my presence at the households received little 
attention from the neighbours of the participants, possibly due to the timing of our visits. The 
first visit to each participant was usually conducted during early afternoon (between 11am 
and 4pm), followed by a very early morning home visit 2 (between 5am and 9am), and late 
afternoon/evening home visit 3 (between 4pm and 8.30pm).  
Video-recording as a data collection method. Video-recording has emerged as a 
valuable tool for qualitative studies (Knoblauch & Schnettler, 2012; Knoblauch, 2012). It has 
been used extensively in social anthropological studies and is a useful tool for research in the 
sociological, psychological and health sciences (Heath, Hindmarsh, & Luff, 2010). The use of 
video, augmented by field work, allows for access to the fine details of participant behaviour 
and interaction (Heath, Luff, & Sanchez Svensson, 2007). I used Heath, Hindmarsh and Luff 
(2010) as my main source and guide for collecting, organizing, transcribing, and analysing 
the video data. For the purposes of this research, video was used to capture a very specific 
process as it occurred naturally within the households of my participants that may otherwise 
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not have been documented as accurately by observation schedules alone. There are both 
advantages and disadvantages to using video as a data collection tool, and these have 
important implications for the kind of data generated from this work. For example, video 
allows for the observed event to be viewed more than once and be subjected to a fine-grained 
frame-by-frame analysis of the phenomenon being investigated. However, using a video-
recording device in the presence of participants invites bias as participants may react in a way 
that is contrary to their normal behaviour (Heath et al., 2010). Reactivity bias and its 
implications in this study are discussed later on.  
Participant journals as a data collection method. Journals as a method of data 
collection are not frequently utilized as they require a level of commitment and adherence 
(the very phenomenon being investigated in this study) amongst the participants. However, 
participant journals are useful in circumstances where long periods of observation are not 
practical (Jacelon & Imperio, 2005). Therefore, without imposing too much constraint on 
participants’ daily routines, it was suggested that they try to keep the diary for at least a week. 
Participants were encouraged to merely document their day as it proceeded, with relevant 
times if possible. None of the diaries had any content that appeared to be psychologically 
distressing to participants.   
Methodological considerations 
Position of camera in the household. Although my overall methodology remained 
the same during this process, considerations such as where to place the camera, whether it 
should be handheld or placed on a tripod changed as the research progressed. When the 
camera was handheld, following the actions of participants, especially in the context of 
limited space to move within a household, it became obvious that the actions were intrusive. 
Thus, I decided a tripod was a far less intrusive method. Since most of the morning visit data 
had been recorded using the handheld method, I struggled with the idea of not following the 
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action and not being up close to the action. Furthermore, using a handheld camera meant that 
I was able to zoom in during measurements and administration, whereas using the tripod 
meant that I recorded from a small distance away from the action.  
Reactivity bias. The presence of the researcher in a household undoubtedly invokes 
questions as to what extent researcher presence affects natural behaviour. Furthermore, 
concerns exist regarding whether the behaviour that is observed in a seemingly natural 
environment is representative of everyday behaviour (Gardner, 2000). There was initial 
concern about how reactivity bias would influence the research as my presence within the 
household undoubtedly created bias amongst respondents. In some instances the bias was 
clear, while in others it was less clear. For example, in some instances during the video-
recording participants are seen looking directly at the camera during the observed event. 
There are also instances where the camera is moved around several times and forced to 
follow participants’ actions very closely due to the sheer restriction of space in the household.  
I tried to ascertain whether the behaviour I observed during my visits to the household 
was representative of normal behaviour. I did so by conducting an initial, unobtrusive (no 
video) home visit followed by the morning visit and evening visit to the household, both of 
which were video-recorded. Visiting the site more than once may reduce reactivity bias 
amongst participants (Heath et al., 2010; Knoblauch & Schnettler, 2012).  
Another way to ascertain whether the behaviour I observed during my visits to the 
household was representative of normal behaviour was the inclusion of the participant 
journals. In the journals participants documented their daily activities, which included 
(amongst other things) who administered treatment on a particular day and whether or not the 
child demonstrated any problematic behaviour during the medication-giving activity. 
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Reflexivity  
As mentioned previously, the study is located within the interpretivist paradigm, 
which acknowledges the subjectivity of the researcher and potential bias introduced by the 
individual life experiences and background of the researcher (Blanche et al., 2006; Creswell, 
2013). It is thus integral to the reader of this thesis to understand the extent to which my 
background has shaped the interpretation of the data. I am a 27-year-old, white South African 
female living in a middle-class residential area in Cape Town. For this thesis I relocated to 
KwaZulu-Natal. Prior to the start of this thesis I completed both an honours and masters 
thesis in structural barriers to adherence to ART amongst adults living with HIV. Following 
the completion of both these theses, I developed a modest baseline knowledge of the factors 
that influence adherence amongst ART users living in circumstances much poorer than the 
context in which I grew up in.  
However, the notion of adherence to medication and its importance is not unknown to 
my personal context. Both my brother and father live with chronic health conditions that 
require twice daily dosing with medications. My mother is the primary caregiver to both my 
brother and father as she is responsible for the monthly collection of their medications and 
the administration of their medications twice daily. In our context adherence is not limited by 
structural barriers to such an extent that it influenced adherence as is the case in the context 
of my participants.  
During my home visits to the participants in my study, I was sensitized to the 
challenges they faced due to the lack of the financial security necessary to buy food. For both 
the caregivers and children who took part in this study, food security by far determined daily 
adherence to medication taking. I recall one particular instance of a caregiver who began to 
cry during my visit due to the sheer helplessness she experienced from being unable to 
consistently provide her child with food. The direct confrontation with poverty as 
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experienced by my presence in these households, allowed for a deeper understanding and 
appreciation of the circumstances people living within a rural context face.  
Rigour 
Creswell (2014) has suggested eight ways of ensuring and maintaining scientific 
rigour in qualitative research and maintains that researchers should use a combination of at 
least two of these strategies (Creswell, 2014 p. 232-234). These are: 
1. Prolonged engagement. Prolonged engagement involves spending long periods in 
the field to obtain an in-depth understanding of the details of the study site and the 
participants. In this study I used prolonged engagement in the form of multiple 
field visits to increase the rigour and validity of the observations made.  
2. Persistent observation. Persistent observation involves focusing on key 
characteristics that may be relevant to the phenomenon being investigated, and 
exploring these in as much detail as possible. Observation of caregivers’ treatment 
administration practices was key to the research design and facilitated 
triangulation.  
3. Triangulation. Triangulation uses a combination of different data sources to justify 
the overarching themes arrived at after analysis. In this study I used interviews, 
focus groups, observation, field notes and participants journals to derive and 
justify key themes emanating from the data.  
4. Peer debriefing and support. Peer debriefing is used to enhance the accuracy of the 
information obtained by allowing someone (usually an expert), to review and 
question the study design and findings. Due to the sensitive nature of the data 
collected, the analysis of the data was done in consultation with both of my 
supervisors, Prof Ashraf Kagee (an expert on barriers to adherence) and Dr Ruth 
Bland (an expert on paediatric HIV, especially in rural settings). Both Prof Kagee 
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and Dr Bland reviewed a subset of the transcripts (without seeing the coded work) 
and their independent impressions were matched against the coded transcripts. 
They also provided conceptual input at the level of theme identification.  
5. Member checking. Member checking involves presenting the findings of the study 
to the participants and determining whether the findings are an accurate depiction 
of participants’ insights.  
6. Negative case analysis. Negative case analysis involves presenting discrepant or 
contrary information about a particular theme and adds to the credibility of the 
theme.  
7. Auditing. An external auditor, preferably someone not familiar with the research, 
may be used to provide an objective perspective throughout the research process 
and assess accuracy and interpretation of findings. External auditing in the form of 
conference presentations (Appendix P) of some of the findings pertaining to this 
research provided objective perspectives of the research.  
8. Reflexivity. Reflexivity allows for the researcher to clarify bias in the research 
process that may be as a result of present or past experiences. 
Trustworthiness 
According to Miles and Huberman (1994), trustworthiness in qualitative research can 
be established using four criteria, namely: 
1. Confirmability 
2. Dependability  
3. Credibility, and  
4. Transferability 
1. Confirmability refers to the accuracy of the information collected by the 
researcher, void of bias on the part of the researcher. One way to control for this is 
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to have multiple observers. I thus asked Ms. Mgenge, my RA, to participate in the 
observations of the counselling sessions and home visits, also using the semi-
structured observation schedules and writing her account of each visit in the form 
of field notes. After a particular home or counselling visit, Ms. Mgenge and I 
would compare field notes and eliminate any inaccuracies that may have been 
encountered by either one of us. The use of participant journals invited the 
participants’ voice into the analysis of data based on daily routine, which 
subsequently also added to the confirmability of the observations.  
2. Dependability refers to the extent to which the research process remained 
consistent over the course of the study period. I used semi-structured observation 
schedules to guide my observations during the counselling and home visits, which 
allowed for observations in a systematic fashion (Angrosino, 2007). I also used 
field notes to contextualize the observations and to document any deviation from 
the research process, if encountered.   
3. Credibility refers to the extent to which the conclusions of the study are a fair 
reflection of the data collected and of the participants. The data presented in this 
thesis were constantly checked with participants as they were collected. At each 
home visit the field notes and observations of the previous visit would be shared 
with participants in order to obtain their approval of the version of the accounts as 
captured by myself and my RA. All the data were analysed by me and checked 
with my supervisors for meaningful interpretation and clarity in the presentation 
of the results. Lastly, Phase 1 of the data has been published in a peer-reviewed 
journal, and thus reported to a wider audience. Phase 2 of the data has been 
presented at one feedback session to the Africa Centre, and also at a conference. 
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The data from Phase 2 will also be prepared for publication in a peer-reviewed 
journal.  
4. Transferability refers to the extent to which conclusions of the study are relevant 
to matters beyond the study. Transferability will be addressed in the concluding 
chapter of this thesis.  
Ethics 
Ethical approval. The study received ethical approval from Stellenbosch University 
(S12/05/135) and reciprocity with the University of KwaZulu-Natal.  
Ethical considerations. Gaining entry to the field. As mentioned previously, gaining 
entry into the field required approval from the CAB. In contrast to their willingness to 
approve Phase 1 of the study, CAB members stated that they were hesitant to approve Phase 
2. The board expressed concern as to who would have access to the data, and that this would 
be a crucial factor when informing participants of the study. The sensitive nature of the data 
meant that I had to conduct the review of the video-recordings and the analysis in 
consultation with my supervisors. As mentioned in Phase 1, the necessary approval was 
sought from the Hlabisa Hospital management to conduct this research at their clinics. 
However, before recruitment at the clinic commenced for Phase 2, the RA and I arranged to 
meet the head nurse of the clinic, as well as the Africa Centre ART nurse. We received verbal 
approval from both the head nurse and ART nurse to commence recruitment of participants.  
Anonymity and confidentiality. The sample included in this study consisted of 
children considered vulnerable persons, and measures were subsequently taken to firstly 
allow for such video-recording to be done in the households, and secondly to analyse the data 
securely in such a manner that the actions would be ethically acceptable. Pseudonyms were 
used to anonymize participants’ information and are used throughout the thesis, and image 
stills captured from the video data were censored to remove any identifying facial features. 
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Participants were informed that only members directly involved in the research (myself and 
my supervisors) would have access to the data. The video data were kept secure on a 
password-protected external hard drive in a locked drawer.  
Data analysis 
Counselling data. The source of the counselling sessions’ data was the written notes 
of my own as well as my RA observations of these sessions. The observations were structured 
using a semi-structured observation schedule (Appendix M). Thus, the average length of the 
counselling observations and whether the child attended the counselling session or not were 
calculated using statistical functions in Excel 2013. Textual data regarding the content 
addressed in the counselling sessions were coded using ATLAS.ti v7. Field notes were used 
to place the counselling sessions in context, to note whether the observations were done in the 
morning or later in the day when a counsellor may be expected to be more tired, and to 
document space in the counselling room, privacy and the occurrence of interruption.  
Household data. The sources of the household data were the video-recordings and 
data from the semi-structured observation schedules used during home visits one, two and 
three. Other sources of data included handwritten observational field notes taken by my RA 
and I during home visit one, two and three, as well as participants’ journals. Demographic 
data (such as age, marital status, level of education etc.) were entered and analysed using the 
SPSS v 22. Field notes and video data were imported into ATLAS.ti v 7.  
Video data. Video material, like other forms of qualitative data, is analysed and 
interpreted based on the researcher’s methodological needs and theoretical assumptions 
(Heath et al., 2010). I was guided by the methods provided by Heath, Hindmarsh and Luff 
(2011) in collecting, organizing, transcribing, and analysing the video data. These authors 
discuss three key steps when analysing video data from a sociological perspective, drawing 
on ethnomethodology and conversation analysis (CA) (pp. 61 – 85). Firstly, the video data 
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undergoes a preliminary review that entails cataloguing of the data corpus, with consistent 
labelling of the video file names and marking instances that may be important for further 
analysis. At the end of each home visit the video data were uploaded onto a password-
protected personal computer and reviewed before being imported into ATLAS.ti. Friese 
(2014) also encourage the use of “good data file names” (p.38) when working in ATLAS.ti. I 
subsequently labelled each video clip based on the following convention (Friese, 2014): 
HDV_0014_SUPP_1; HDV (High definition video_participant ID 
number_virological status of the child_age of the child). Following the preliminary review, 
Health et al. (2011) have suggested a substantive review of the data corpus that entails 
selecting and analysing the video instances marked during the preliminary review. They then 
discuss the ways in which ‘talk’ can be transcribed alongside sequence of events. Given that 
most of my video data lacked any verbal communication amongst participants (which 
subsequently became a sub-theme in the analysis), my review and transcription of the video 
data were mainly sequence-orientated. The video data were transcribed in ATLAS.ti and 
coded using principles of grounded theory as video data were analysed alongside 
observational notes and participant journals.  
The analysis approach is one of inductive thematic analysis that adopts similar 
strategies to grounded theory for analysing data (Braun & Clarke, 2006). It is important to 
state that this thesis is not embedded within grounded theory as a methodology as outlined in 
Charmaz (2006). Rather, the principles of the theory are used as an analytic guide for the 
analysis of the video data, observations, and field notes collected for this thesis. The analytic 
outline was continually revised based on each additional piece of data entered, with the 
process of open coding, axial coding, and selective coding (Charmaz, 2006). Open coding 
consists of identifying codes or themes in the original transcripts. Axial coding involves 
arranging the basic codes into inclusive categories or families. Selective coding is the process 
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of identifying overarching core categories at greater levels of abstraction to form a conceptual 
model that is the grounded theory. Thus based on the principles of grounded theory and data 
analytic steps suggested by Health et al., (2010), I analysed the data following the nine steps 
below to arrive at the themes and sub-themes presented in the next chapter.  
Step 1: Frame-by-frame transcription of video data in ATLAS.ti 
Step 2: Re-reading of transcripts and marking important processes 
Step 3: Generation of empirical codes and initial memo-writing 
Step 4: Re-reading of transcripts for conceptual clarity and refinement of code list 
Step 5: Import of field notes and participant journals 
Step 6: Reading of transcripts alongside field notes and participants journal 
Step 7: Using hyperlink functions in ATLAS.ti and additional empirical codes to 
compare and contrast the sequence of events across the three criteria groups 
Step 8: Re-examination of all the data to refine codes at a broader conceptual level 
Step 9: Organizing codes into themes and sub-themes 
Step 1. Transcription of the video was a necessary first step as it allowed frame-by-
frame documentation of the steps taken during treatment administration and ensured that 
coding was conducted as close to the action as possible. Thus, transcription allowed for a 
meaningful engagement with the video, over and above the initial cataloguing review 
discussed previously. It also allowed for the clear identification of process and sequence of 
events followed during the retrieval, preparation and administration of medications. 
Step2. Once transcription was completed, all the video transcripts were re-read. During 
the reading of the transcripts I marked (highlighted) instances across the transcripts that were 
similar (e.g. same geographical area in the house where medication was administered), and 
also instances that were different (e.g. change in person responsible for administering 
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medication to the child in the morning versus in the evening). The analysis was guided by the 
research objectives for Phase 2. Therefore, I marked instances that related to: 
 Where medications were stored 
 Whereabouts of the child during medication preparation 
 How medications were measured 
 How medications were administered 
 The person responsible for measuring and administering medication 
 The support of another household member during treatment measurement and 
administration 
 Difficulties during measurement and administration 
 Food availability before, during or after treatment administration  
 Interaction between caregiver and child 
Step 3. Following Step 2, I went back to all the marked instances and coded these 
with suitable descriptive level codes. As the names of the codes were likely to change as the 
analysis developed further, I kept a daily analytic memo in which I reflected on the 
appropriateness of various code names.  
Step 4. Once I had assigned code names to all the marked instances I re-read the 
transcripts for conceptual clarity and refinement of the code list. 
Step 5. Following Step 4, I imported the field notes and participant journals into the 
analysis and labelled them according to the same convention as the video data.  
Step 6. The multiview functionality (two or more windows containing different 
analytic material can be opened simultaneously) of ATLAS.ti allowed for coding video 
alongside field notes and participant journals to bring context into the conceptualization of 
codes. Furthermore, the multiview functionality of ATLAS.ti allowed for the comparison of 
treatment administration across the three groups.  
Stellenbosch University  https://scholar.sun.ac.za
  
152 
 
Step 7. I used hyperlink functions in ATLAS.ti to combine segments of the field notes 
and participant journals to explain observed events in the video data. I added new codes 
where necessary.  
Step 8. Following step 7 I re-examined all the data and refined the code list.  
Step 9. In the final step I organized codes into suitable themes and sub-themes using 
the ‘create family’ function in ATLAS.ti, and used the ‘query tool’ in ATLAS.ti to locate 
similarities and differences in treatment administration across the three criteria groups.  
Observational notes and participants’ journals. Textual data obtained from 
handwritten field notes and participant journals were re-written in a Word document and 
imported into ATLAS.ti for thematic analysis. I followed the same six-step thematic analytic 
procedure as outlined in Phase 1 to code and categorize the information obtained from these 
data. Furthermore, as part of the process of triangulation, these data were coded alongside 
video data to provide a basis for the constant comparison between what had been observed 
during household visits and what had actually happened. The results of the data analysis 
procedure are addressed in the next chapter. 
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CHAPTER 8 
Phase 2 - Results 
Participant characteristics 
Child characteristics 
Children with suppressed viral loads. Of the 12 children on ART with suppressed 
VLs, one child was aged one year, three children were aged two years, two were aged three 
years, three were aged four years and three were aged five years. The median age of these 
children was 3.5 years (IQR [2-4.75]) (Table 8.1).  
The majority of the children were female (8 out of 12) and more than half (9 out of 
12) had at least two caregivers. The biological mother was the primary caregiver of eight 
children and the grandmother of four children as the children’s biological mothers were living 
away from home. Most of the children’s biological fathers (8 out of 12), were also living 
away from home. None of the children’s biological parents were reported to be deceased. 
Nine children were receiving a first-line PI-based regimen consisting of ABC + 3TC + 
LPV/r, and one received a first-line PI-based regimen consisting of d4T + 3TC + LPV/r. Two 
children were on a first-line NNRTI-based regimen consisting of ABC + 3TC + EFV, and d4T 
+ 3TC + EFV, respectively. The average time on ART among children in this group was 27.9 
months (2.3 years). 
 Half of the children received their medications at 7am and 7pm daily. Andile’s 
caregiver, however, had changed his dose time from 7am/pm to 6am/pm to accommodate her 
crèche times (Table 8.1).  
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Table 8.1 
Sample Characteristics of Children with Suppressed VL’s  
Pseudonym 
Age 
(years) 
Gender 
Number 
of 
caregivers 
Primary 
caregiver 
Whereabouts 
of biological 
mother 
Whereabouts 
of biological 
father 
ART 
regimen 
Time on 
ART 
(months) 
Dose time 
at 
recruitment 
Dose time 
changed 
Thabisa 4 Female 2 Mother Living with 
child 
Living away 
from family 
ABC + 
3TC + 
LPV/r 
14 7am/pm No 
Sizwe 2 Male 1 Grandmother Living away 
from family 
Living away 
from family 
ABC + 
3TC + 
LPV/r 
27 8am/pm No 
Thenjiwe 3 Female 2 Mother Living with 
child 
Living with 
child 
ABC + 
3TC + 
LPV/r 
35 7am/pm No 
Lwazi 3 Male 2 Mother Living with 
child 
Living with 
child 
ABC + 
3TC + 
LPV/r 
35 7am/pm No 
Richard 4 Male 2 Mother Living with 
child 
Living with 
child 
ABC + 
3TC + 
LPV/r 
25 7am/pm No 
Mbali 1 Female 2 Mother Living with 
child 
Living away 
from family 
ABC + 
3TC + 
LPV/r 
21 8am/pm No 
Ayanda 5 Female 2 Mother Living with 
child 
Living away 
from family 
d4T + 
3TC + 
EFV 
42 7am/pm No 
Andile 2 Female 2 Mother Living with 
child 
Living away 
from family 
ABC + 
3TC + 
LPV/r 
25 7am/pm Yes(6am/6pm) 
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Table 8.1 (continued) 
Pseudonym Age 
(years) 
Gender Number 
of 
caregivers 
Primary 
caregiver 
Whereabouts 
of biological 
mother 
Whereabouts 
of biological 
father 
ART 
regimen 
Time on 
ART 
(months) 
Dose time 
at 
recruitment 
Dose time 
changed 
Tholakele 5 Female 1 Grandmother Living away 
from family 
Living away 
from family 
d4T + 3TC 
+ LPV/r 
50 6am/pm No 
Nandi 4 Female 2 Grandmother Living away 
from family 
Living away 
from family 
ABC + 
3TC + 
LPV/r 
20 6h30am/pm No 
Sizani 2 Female 1 Grandmother Living away 
from family 
Living away 
from family 
ABC + 
3TC + 
LPV/r 
22 6h30am/pm No 
Sibusiso 5 Male 2 Mother Living with 
child 
Living with 
child 
ABC + 
3TC + 
EFV 
19 6am/pm No 
Note. Liquid ARVs - ABC (Abacavir), 3TC (lamuvidine), LPV/r (Lopinavir/ritonavir). Tablet ARVs - d4T (Stavudine), EFV (Efavirenz), AZT 
(Zidovudine), CPV (Capravirine) 
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Children with unsuppressed viral loads. Of the 11 children on ART with 
unsuppressed VLs, one child was aged one year, one was aged two years, three children were 
aged three years, one child was aged four years and five children were aged five years. The 
median age of these children was four years (IQR [3-5]) (Table 8.2). 
The majority of the children were male (6 out of 11). At least eight children had more 
than one caregiver with five having two caregivers, and three having as many as three 
caregivers. Caregivers were identified as persons responsible for both treatment 
administration daily as prescribed and/or monthly clinic attendance. Five children had their 
biological mother as their primary caregiver, while two had their grandmothers as their 
primary caregiver, and the remaining four had an aunt as their primary caregiver (Table 8.2).  
The biological mothers of three children were deceased. Two biological mothers lived 
away from home and the remaining six biological mothers lived with their children. 
However, of the six biological mothers who lived with their children, only one (Dingane) was 
not identified as the primary caregiver of the child. One of the children’s biological fathers 
was deceased, seven were living away from home, and three were living at the same 
homestead. Six children were receiving a first-line PI-based regimen consisting of ABC + 
3TC + LPV/r, and three a first-line PI-based regimen consisting of d4T + 3TC + LPV/r. Two 
children were on second-line regimens consisting of AZT + 3TC +LPV/r, and AZT + ABC + 
3TC + CPV respectively. The average time on ART among children in this group was 33.7 
months (2.8 years). More than half of the children (7 out of 11) received their medications at 
7am and 7pm daily. Dingane’s aunt, however, changed her medication from 9am/9pm to 
6am/6pm as Dingane was due to start school soon (Table 8.2).  
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Table 8.2 
Sample Characteristics of Children with Unsuppressed VL’s 
Pseudonym 
Age 
(years) 
Gender 
Number of 
caregivers 
Primary 
caregiver 
Where-
abouts of 
biological 
mother 
Where-
abouts of 
biological 
father 
ART 
regimen at 
last home 
visit 
Time on 
ART 
(months) 
Dose time 
at 
recruitment 
Dose time 
changed 
Samu 3 Male 3 Aunt Living 
away from 
family 
Living 
with child 
ABC + 
3TC + 
LPV/r 
28 7am/pm No 
Phila 5 Female 3 Grand-
mother 
Deceased Living 
away from 
family 
AZT + 
ABC + 
EFV+ 
CPV/r  
54 6am/pm No 
Nathi 2 Male 2 Mother Living 
with child 
Living 
with child 
ABC + 
3TC + 
LPV/r 
17 7am/pm No 
Muzi 5 Male 2 Aunt Deceased Living 
away from 
family 
d4T + 
3TC + 
LPV/r 
51 7am/pm No 
Kwanele 5 Female 3 Mother Living 
with child 
Living 
away from 
family 
d4T + 
3TC + 
LPV/r 
23 7am/pm No 
Dingane 5 Female 2 Aunt Living 
with child 
Deceased 3TC + 
AZT + 
LPV/r 
46 9h00am/p
m 
Yes 
(6am/6p
m) 
Busisiwe 5 Male 2 Aunt Deceased Living 
away from 
family 
d4T + 
3TC + 
LPV/r 
57 7am/pm No 
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Table 8.2 (continued) 
Pseudonym Age 
(years) 
Gender Number of 
caregivers 
Primary 
caregiver 
Where-
abouts of 
biological 
mother 
Where-
abouts of 
biological 
father 
ART 
regimen at 
last home 
visit 
Time on 
ART 
(months) 
Dose time 
at 
recruitment 
Dose time 
changed 
Duduzile 1 Female 1 Mother Living 
with child 
Living 
away from 
family 
ABC + 
3TC + 
LPV/r 
18 6am/pm No 
Jabulile 3 Male 2 Grand-
mother 
Living 
away from 
family 
Living 
with child 
ABC + 
3TC + 
LPV/r 
32 6am/pm No 
Khethiwe 4 Female 1 Mother Living 
with child 
Living 
away from 
family 
ABC + 
3TC + 
LPV/r 
29 7am/pm No 
Siyabonga 3 Male 1 Mother Living 
with child 
Living 
away from 
family 
ABC + 
3TC + 
LPV/r 
16 7am/pm No 
Note. Liquid ARVs - ABC (Abacavir), 3TC (lamuvidine), LPV/r (Lopinavir/ritonavir). Tablet ARVs - d4T (Stavudine), EFV (Efavirenz), AZT 
(Zidovudine), CPV (Capravirine) 
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Children newly initiated on ART. Of the 10 children newly initiated on ART, one 
was aged below one year (four months), and one was aged one year. Four children were aged 
two years, and four children were aged five years. The median age of these children was two 
years (IQR [2-5]) (Table 8.3). 
The majority of the children were female (6 out of 10). Six children had more than 
one caregiver with half of the primary caregivers being a biological mother. Three caregivers 
were grandmothers, one caregiver was an aunt and one caregiver was a biological father. The 
biological mothers of two children (Tina and Thandiso) were deceased. Two biological 
mothers lived away from home. Almost all (9 out of 10) biological fathers were living away 
from the family. Seven children were receiving a first-line PI-based regimen consisting of 
ABC + 3TC + LPV/r, and one child was on a first-line PI-based regimen consisting of d4T + 
3TC + LPV/r. Two children were receiving a first-line NNRTI-based regimen consisting of 
ABC + 3TC +EFV. The average time on ART among children in this group was 4.4 months 
(0.4 years). Half of the children received their medications at 6am and 6pm daily and none 
had changed their dose times during the course of the study (Table 8.3).  
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Table 8.3 
Sample Characteristics of Children Newly Initiated on ART 
Pseudonym 
Age 
(years) 
Gender 
Number of 
caregivers 
Primary 
caregiver 
Where-
abouts of 
biological 
mother 
Where-
abouts of 
biological 
father 
ART 
regimen at 
last home 
visit 
Time on 
ART 
(months) 
Dose time 
at 
recruitment 
Dose time 
changed 
Thembe 5 Female 1 Aunt Living 
away from 
family 
Living 
away from 
family 
ABC + 
3TC + 
EFV 
4 6am/pm No 
Lungile 5 Female 2 Grand-
mother 
Living 
away from 
family 
Living 
away from 
family 
ABC + 
3TC + 
EFV 
7 7am/pm No 
Luyando 1 Male 2 Mother Living 
with child 
Living 
away from 
family 
ABC + 
3TC + 
LPV/r 
9 6am/pm No 
Zoliswa 5 Female 2 Grand-
mother 
Living 
with child 
Living 
away from 
family 
ABC + 
3TC + 
LPV/r 
1 6am/pm No 
Tina 5 Female 2 Father Deceased Living 
with child 
d4T + 
3TC + 
LPV/r 
6 7am/pm No 
Hlengiwe 2 Female 1 Mother Living 
with child 
Living 
away from 
family 
ABC + 
3TC + 
LPV/r 
6 9h00am/p
m 
No 
Amanda <1(4 
months) 
Male 2 Mother Living 
with child 
Living 
away from 
family 
ABC + 
3TC + 
LPV/r 
1 7am/pm No 
Thandiso 2 Male 2 Grand-
mother 
Deceased Living 
away from 
family 
ABC + 
3TC + 
LPV/r 
6 6am/pm  
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Table 8.3 (continued) 
Pseudonym Age 
(years) 
Gender Number of 
caregivers 
Primary 
caregiver 
Where-
abouts of 
biological 
mother 
Where-
abouts of 
biological 
father 
ART 
regimen at 
last home 
visit 
Time on 
ART 
(months) 
Dose time 
at 
recruitment 
Dose time 
changed 
Siyasizwe 2 Male 1 Mother Living 
with child 
Living 
away from 
family 
ABC + 
3TC + 
LPV/r 
2 6am/pm No 
Thondeka 2 Female 1 Mother Living 
with child 
Living 
away from 
family 
ABC + 
3TC + 
LPV/r 
2 8am/pm No 
Note. Liquid ARVs - ABC (Abacavir), 3TC (lamuvidine), LPV/r (Lopinavir/ritonavir). Tablet ARVs - d4T (Stavudine), EFV (Efavirenz), AZT 
(Zidovudine), CPV (Capravirine) 
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Caregiver characteristics 
The age of the caregivers ranged from 22 to 67 years. A greater proportion of 
caregivers to children with suppressed VLs (7 out of 12) were married and/or living with a 
significant other in a permanent union compared to the other two groups (2 out of 11 – 
unsuppressed, and 2 out of 10 – new enrollers). Furthermore, a greater proportion of 
caregivers to children with suppressed VL’s had completed high school (5 out of 12), 
compared to the other two groups (2 out of 11 – unsuppressed, and 1 out of 10 – new 
enrollers). Most of the caregivers (27 out of 33, 82%) were unemployed and were receiving 
either a CSG or disability grant from the South African government. More than half of the 
caregivers (19 out of 33, 58%) were also ART users. Only 24 (73%) had received the pre-
ART HIV education sessions before the child was enrolled on treatment (Table 8.4).  
Several caregivers (25 out of 33, 76%) indicated that they were not solely responsible 
for treatment giving or for attending clinic visits (11 out of 33, 33%), but shared this 
responsibility with another member of the household, usually an older sibling. Caregivers 
reported that all members of the household were aware that the child was on treatment. 
However, it was not fully ascertained whether the household members knew this treatment 
was for HIV, especially in the case of other siblings in the household (Table 8.4). 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
  
163 
 
Table 8.4 
Caregiver Characteristics 
Variable Suppressed (n =12) Unsuppressed (n=11) Newly initiated (n=10) Total 
Age, years, median (IQR) 
[Range: 22-67] 
35 (27.5 - 48) 29 (24 - 40) 28.5 (25.5 - 51)  
Marital Status     
Single 5 9 7 21 
Widowed 0 0 1 1 
Married or living with a 
significant other in a 
permanent union 
7 2 2 11 
Living arrangement     
Live with children only 3 1 3 7 
Live with other adults and 
children 
9 10 7 26 
Education     
No formal education 0 2 1 3 
Attended primary school 
but did not complete 
0 1 1 2 
Completed primary school 2 3 2 7 
Attended high school but 
did not complete Grade 12 
5 3 4 12 
Completed Grade 12 5 2 1 8 
Graduated from 
university, college or 
technikon. 
0 0 1 1 
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Table 8.4 (continued)     
Variable Suppressed (n =12) Unsuppressed (n=11) Newly initiated (n=10) Total 
Employment     
Unemployed 10 11 6 27 
Employed full-time 0 0 2 2 
Student 1 0 1 2 
Retired 1 0 1 2 
Income     
Less than R12, 000 5 6 0 11 
Do not know 2 0 1 3 
CSG* 3 2 2 7 
>1 grant 2 2 4 8 
Disability grant 0 1 0 1 
R10, 0001-R40, 000 0 0 1 1 
Pension 0 0 2 2 
Language     
Zulu 11 11 10 32 
Portuguese 1 0 0 1 
Caregiver on ART, yes, 
no 
8 6 5 19 
Caregiver attend HIV 
education session, yes 
8 7 9 24 
Number of children 
looked after, mean, 
(range) 
3.5 (2-7) 2.9 (1-7) 2.7 (1-4)  
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Table 8.4 (continued)  
Variable Suppressed (n =12) Unsuppressed (n=11) Newly initiated (n=10) Total 
Only person bringing child 
to clinic, yes 
9 5 8 22 
Other clinic goer     
Aunt 2 1 2 5 
Sibling 1 1 0 2 
Father 0 2 0 2 
Mother 0 1 0 1 
Grandmother 0 1 0 1 
Only person who 
administers treatment, Yes 
4 1 3 8 
Other treatment giver     
Aunt 1 1 2 4 
Sibling 5 2 5 12 
Father 3 2 0 5 
Mother 0 3 0 3 
Grandmother 0 2 1 3 
Grandfather 1 0 0 1 
Disclosed to family 
members, yes 
12 11 10 33 
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Counselling observations 
The caregiver-child dyads recruited for the study were accompanied to one routine 
adherence counselling session at their first clinic visit after recruitment, and prior to home 
visit one. The purpose of conducting the counselling visit prior to the home visit was to 
document the information caregivers received during these sessions. Reasons for non-
attendance at the clinic visit were determined telephonically.  
ART clinic and counselling room setup 
Figure 8.1 below shows the typical setup of the ART section at clinic A. The setup at 
clinic B was similar. In the ART section, rooms were numbered one through ten, with 
patients’ exit point being the pharmacy where they collected their medications. During 
informal conversations with the head ART nurse at the time, she explained that the following 
activities took place in each room: 
Room 1: Prior to initiation patients are weighed in room one. Children are then 
weighed every month to determine whether dose changes have to be made.  
Room 2: Prior to initiation HIV infected adults and caregivers of HIV-infected 
children undergo three pre-ART group HIV education sessions. These sessions take 
place on two separate days over a two-week period.  
Room 3: Patients’ files are stored here. 
Room 4: Patients’ files are kept here before they are stored in room three. 
Room 5, 6 and 7: Routine patients usually started at room four where they receive 
their patient files. Once they have received their files they wait to see the adherence 
counsellors in either rooms five, six or seven.  
Room 8, 9 and 10: Patients then visit the ART nurse in either rooms eight, nine or ten. 
Room 11: Patients collect their monthly medication from the pharmacy at room 11, 
where they then exited the ART clinic.  
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Figure 8.1. The ART clinic setup at clinic A. 
Counselling observations 
During my observations events usually occurred in the following sequence. Once 
caregivers had collected their files at room 4, they queued outside the counselling rooms 
(room 5, 6, or 7), which were occupied on a ‘first-come-first-served’ basis. Figure 8.2 below 
shows the typical setup inside a counselling room, including the position of the adherence 
counsellor in relation to the caregiver and child, as well as where my RA (RA) and I (PI) 
stood and observed the sessions. The setup was similar in all counselling rooms at both clinic 
A and clinic B.  
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Figure 8.2. Typical counselling room setup  
Once caregivers had entered the room for counselling they were seated in the chair 
closest to the door, or opposite the counsellor. Counselling observations were recorded from 
the moment caregivers entered the counselling room to the moment they exited the rooms.  
Reasons for non-attendance  
My RA and I observed 25 adherence counselling sessions. Thus we observed 6of 10 
of the newly initiated children, 11 out of 12 of the suppressed children, and 8 out of 11 of the 
unsuppressed children (Table 8.5). Of the eight sessions that my RA and I were unable to 
observe, four caregivers stated that they were unwilling to wait in the long queues outside the 
counselling rooms, three caregivers stated that they were unable to get time away from work, 
and one stated that she was in school and unable to attend.  
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Length of counselling session 
The length of the counselling sessions varied across observations, with the average 
counselling visit across all observations lasting 8.1 minutes. The average length of 
counselling received by caregivers of children with unsuppressed VLs was 6.86 minutes. On 
average the time in counselling received by caregivers of children newly started on ART and 
those with suppressed VLs was 8.2 and 8.8 minutes respectively. Among the children with 
unsuppressed VLs, two counselling sessions lasted less than 10 minutes and the remaining 
were less than seven minutes. Among the children with suppressed VLs, six sessions lasted 
less than 10 minutes, and the remaining were less than seven minutes. Among children newly 
initiated on ART, three sessions lasted longer than 10 minutes, with the remaining sessions 
lasting less than five minutes. The variations in length resulted from the varied nature of the 
content addressed in the counselling sessions and is discussed further on.  
Presence of child in session  
Children accompanied their caregiver to the counselling session in 18 out of 25 
observations. Among the newly initiated children, one child (Siyasizwe) was unable to attend. 
The caregiver stated that the child was at home with his aunt. Among the suppressed children, 
five children (Thenjiwe, Lwazi, Sibusiso, Ayanda, Richard) were unable to attend the 
counselling session. One caregiver, a mother to twins on ART (Thenjiwe and Lwazi) reported 
that the children were at school. Reasons for non-attendance of the remaining three children 
were not elicited by the counsellors from the caregivers during the counselling sessions. One 
child with an unsuppressed VL (Dingane) was reported by the caregiver to be at school.  
Presence of primary caregiver 
Almost all (24 out of 25) caregivers who attended the counselling sessions were the 
primary caregiver of the child. One counselling session of a child newly initiated on ART 
(Thandiso) was attended by the child’s older sibling instead of his grandmother. In three 
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instances both the caregiver and child were counselled in the same session (Table 8.5). These 
instances contributed to longer counselling times.  
Privacy in counselling sessions  
In eight of the observations the counselling sessions lacked privacy. In three instances, 
two counsellors occupied one counselling room and saw patients simultaneously. In three 
instances counselling sessions were interrupted by other members of staff and in two 
instances the counselling sessions were interrupted by other patients (Table 8.5).  
The extract below from my field notes of the counselling session observed with Sizwe 
(suppressed two-year-old male) and his grandmother demonstrates the difficulty associated 
with an overcrowded counselling room.  
Field note extract: 
Two counsellors occupied one of the counselling rooms at the clinic. One of the 
counsellors did not work from a desk and balanced the patient’s file on her knees or 
pressed on a stack of files on a chair. The other counsellor in the room was seated at 
the desk [P197]. 
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Table 8.5 
Counselling Observations across the Three Criteria Groups 
 Newly- 
initiated 
Supp-
ressed 
VLs 
Unsupp-
ressed VLs 
Total 
Number of observations 6 11 8 25 
Length of counselling session in 
minutes (mean, [range]) 
8.2 [5,10] 
8.8  
[4, 18] 
6.86  
[2, 14] 
8.1 
Presence of child in session 5 6 7 18 
Presence of primary caregiver 5 11 8 24 
Caregiver and child counselled in 
same session, yes 
1 1 1 3 
Number of interruptions during 
counselling sessions 
1 2 2 5 
> 1 counselling session taking place, 
yes 
1 0 2 3 
 
Content addressed in the sessions 
Table 8.6 shows the content of the counselling sessions with the caregivers across all 
three groups. Table 8.6 shows the number of times each of the activities was observed in the 
sessions across each criterion group.  
As mentioned previously, 10 of the counselling sessions lasted longer than 10 
minutes. Six of the sessions were longer as a result of administrative tasks that took place 
during the sessions. For example, five counselling sessions among children with suppressed 
VLs lasted longer than 10 minutes. In one session (Richard) this was because both caregiver 
and child were counselled in the same session. Time was spent doing a pill count of the 
caregivers’ medication. In two sessions (Ayanda, Mbali), time was spent replacing old file 
covers with new ones. In one session, counselling for two children (Lwazi, Thenjiwe) took 
place. In the session that lasted 18 minutes, 12 minutes was spent searching for the laboratory 
results of the child in the filing room next door to the counsellor’s room.  
In one session with a child newly started on ART (Amanda), the counsellor spent time 
searching for lab results. Thus, although it appeared as though children with suppressed VL’s 
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received longer counselling sessions, the difference in time was predominantly due to 
administrative tasks that took place during the session.  
As can be seen in Table 8.6, there were only two observed instances where caregivers 
had reported issues related to the child to the counsellor. One was an instance where the 
child’s eyes were hurting and the other was an instance where the caregiver reported bodily 
sores on the child. In both instances the counsellors had recommended that the caregiver take 
the child to see a doctor.  
During the counselling sessions, counsellors typically asked about the dose amounts 
of medication administered to the child (10 out of 25 observations), reported the child’s 
weight to the caregiver (4 out of 25 observations), reported the child’s CD4 count (4 out of 25 
observations) and VL results to the caregiver (7 out of 25 observations), and in one instance, 
a counsellor asked about the use of a reminder tool.  
In four observations counsellors had reported the VL status of an unsuppressed child 
to the caregiver. In two of these observations the counsellors had stated that the child was due 
to have their VLs tested again at the next clinic visit. In both of the other two sessions (Phila, 
Jabulile) the counselling lasted less than 10 minutes. During these sessions counsellors asked 
caregivers to name the medications that the child was receiving and to name the dose 
amounts. Both counsellors asked what times the caregivers were administering the 
medications to the child and emphasized that the timing was important.  
In both instances the caregiver of the child was their grandmother. Both caregivers 
were able to name the dose amounts. However, only Jabulile’s grandmother was able to name 
all of the medications he received. Although Phila’s grandmother was present in this 
counselling session, she reported previously that she was not solely responsible for clinic 
attendance and treatment administrations to Phila. She shared this responsibility with two of 
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Phila’s older siblings. Irregular clinic attendance by Phila’s grandmother may have 
contributed to her inability to name all of the medications Phila received.   
There were two instances (Siyasizwe, Thandiso - both children newly initiated on 
ART), where the counsellors had asked the caregivers to demonstrate how they measured the 
medications. In both instances the counsellor had presented the caregiver with a syringe and 
cup of water and asked the caregiver to demonstrate how much of a certain formulation (in 
both cases LPV/r) the caregiver administered to the child. Both caregivers had made accurate 
measurements.  
There were two counselling sessions (Nathi, Dingane- both unsuppressed children on 
ART) in which the counsellor attending to the caregivers had only signed the patients file for 
attendance. The extracts from my field notes of both instances below show how this was 
documented. Below is the field note extract from counselling session with Nathi (three-year-
old unsuppressed male) and his mother. 
Field note extract: 
Nathi’s mother walked into the counselling room and sat down on the chair nearest to 
the counsellor and handed the counsellor two files (one file was her own). The 
counsellor greeted both caregiver and child (as well as myself and RA) and began to 
page through the file. She repeated the file entry that was made last month, and dated 
and signed her entry. She handed the file back to the caregiver and said to Nathi, “I 
like your shoes boy”, but he did not respond. The counsellor then asked whether the 
child talks (child was standing behind his mother) and the caregiver nodded and 
replied, “yes”, and got up and exited the room. (Time in session: 9h47am – 9h55am) 
[P202].  
Below is the field note extract from the counselling session of Dingane (five-year-old 
unsuppressed female) and her aunt.  
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Field note extract: 
Dingane’s aunt stepped into the counselling room. The caregiver (Dingane’s aunt) sat 
down on the chair nearest to the counsellor. The caregiver had three files with her 
today (one of which was her own, and the other Dingane’s). The counsellor asked the 
caregiver, “Where is the child?” to which the caregiver replied, “at school”. The 
counsellor signed and dated all three files, and handed them to the caregiver. The 
caregiver then got up and exited the counselling room. (Time in session: 10h22am – 
10h24am) [P206].  
As seen from the extracts above, in one of the sessions the child had been present and in the 
other the child had not been present. Regardless of child’s presence, the counsellors did not 
engage in conversation with the caregivers. The content of the counselling sessions observed 
amongst caregivers in this study thus varied from caregiver to caregiver. There appeared to be 
no formalised approach to any of the sessions I observed, and as mentioned, in some sessions 
very little interaction took place between caregiver and counsellor. The majority of the 
counselling sessions took place in confidence, although it must be mentioned that the 
presence of my RA and I may have contributed to a lack of engagement between caregiver 
and counsellor.   
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Table 8.6 
Counselling Observations and Activities across the Three Criteria Groups 
  Newly initiated Suppressed Unsuppressed Total 
 Content covered in session Number of times occurred 
(out of 6 observations) 
Number of times occurred 
(out of 11 observations) 
Number of times occurred 
(out of 8 observations) 
Out of 25 
observations 
 Caregiver reported child’s eyes 
are hurting 
  1 1 
 Caregiver reported sores on 
child’s body to counsellor 
1   1 
 Counsellor asked caregiver about 
dose amounts 
5 3 2 10 
 Counsellor asked caregiver about 
dose times 
1  2 3 
 Counsellor asked caregiver about 
medication names 
 1 2 3 
 Counsellor asked caregiver about 
number of treatment givers 
1 1 1 3 
 Counsellor asked caregiver about 
reminder tools 
 1  1 
 Counsellor asked caregiver to 
bring child for blood tests 
1 1 2 4 
 Counsellor asked caregiver to 
bring child to counselling 
1 3  4 
 Counsellor asked caregiver to 
bring medication to clinic 
 1  1 
 Counsellor asked caregiver to 
demonstrate measurements 
2   2 
 Counsellor only signed and dated 
child’s file 
  2 2 
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Table 8.6 (continued) 
  Newly initiated Suppressed Unsuppressed Total 
Content covered in session 
Number of times occurred 
(out of 6 observations) 
Number of times occurred 
(out of 11 observations) 
Number of times occurred 
(out of 8 observations) 
Out of 25 
observations 
Counsellor reported CD4 
count to caregiver 
 
2 2 4 
Counsellor reported child’s 
weight 
2 1 1 4 
Counsellor reported VL to 
caregiver 
 
3 4 7 
Counsellor searched for lab 
results 
1 1 
 
2 
Counsellors asked caregiver 
how child was doing 
 
2 
 
2 
Counsellors asked the age of 
the child 
  
1 1 
Counsellors did caregiver's 
pill count 
1 1 
  
2 
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Household observations 
Household characteristics 
Following the counselling observations, my RA and I conducted home visit one. 
Home visit one was used to locate participant households, as well as to document the type of 
dwelling participants lived in, the number of occupants and resources. 
Household area. Most (13 out of 33) participants lived in an area known as Msane 
reserve (Area 1 – Figure 8.3) (Table 8.7). Msane reserve is part of the greater KwaMsane 
area, and is approximately 4km from clinic A. The roads leading from the national road to 
clinic A, Africa Centre, and clinic B are all tarred. Five participants lived in an area with a 
tarred road leading up to their homestead (those living in KwaMsane –Area 2). The 
remainder of participants had dirt roads leading to their homesteads. In areas such as Msane 
reserve (Area 1), Ndlovu village (Area 4), Bhoboza (Area 5) and KwaMshaya (Area 7), my 
RA and I often had to park our vehicle somewhere close to the homestead and walk the 
remainder of the way as there were no direct roads leading to these homesteads, only 
footpaths. Except for the two participants living in KwaMshaya (Area 7), most participants 
lived within a 5km radius of their clinic.  
Type of dwelling, occupants and resources. Twenty-two caregiver-child dyads 
resided in a RDP type house. Two caregiver-child dyads resided in wooden structures, two in 
rondawel’s (circular, single-roomed structures made of mud and mortar with thatched roofs), 
and seven resided in house structures made of brick and cement (Table 8.7).  
The median numbers of adults and children per household were three and three 
respectively. Given that the modal number of rooms per household was two, the households 
were mostly overcrowded with an average of six members per household. All of the 
households had electricity, and almost all had access to a refrigerator (30 out of 33, 91%). 
Water was mostly available via a communal water point (17 out of 33, 52%). All of the 
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caregivers indicated that if available, children were usually given food prior to being 
administered their ART (Table 8.7). 
 
Figure 8.3. Map of location of study participants in relation to both clinic recruitment sites 
(not to scale).  
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Table 8.7 
Household Characteristics 
Variable Suppressed (n=12) Unsuppressed (n=11) Newly initiated (n=10) Total 
(n=33) 
Household area     
Bhoboza 0 0 2 2 
Msane reserve 6 5 2 13 
Ndlovu village 0 3 1 4 
KwaMsane 4 1 0 5 
Opapasi 1 0 0 1 
KwaMshaya 0 0 2 2 
Ebaswazini 1 1 2 4 
Somkhele 0 1 1 2 
Type of dwelling      
RDP* house 7 8 7 22 
Wooden house 1 1 0 2 
Rondawel** 1 1 0 2 
Brick house 3 1 3 7 
Number of rooms per household(mode) 2 2 2 2 
Number of adults per household 
(median) 
2.5 3 2.5 3 
Number of children per household 
(median) 
4 3 3.5 3 
Water in household     
Inside tap 5 1 2 8 
Tap on property 4 3 1 8 
Communal water point 3 7 7 17 
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Table 8.7 (continued)  
Variable Suppressed (n=12) Unsuppressed (n=11) Newly initiated (n=10) Total 
(n=33) 
Electricity (yes) 12 11 10 33 
Refrigerator (yes) 11 10 9 30 
Food given before ART (yes) 12 11 10 33 
Note. * = RDP - Reconstruction and Development Programme house, typical size of two-roomed RDP structure - 30 m2 (Hunter & Posel, 2012) 
** = Rondawel - circular house made of brick and mortar with a thatched roof. 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
  
181 
 
Treatment administration observations 
Following home visit one, participants were visited at their homesteads during one 
morning (home visit two) and one evening visit (home visit three). As stated previously, 33 
caregiver-child dyads took part in Phase 2 of this study. My RA and I conducted a total of 86 
home visits over a period of 13 months [February 2013 – March 2014], visiting each 
caregiver-child dyad at their homes at least twice (i.e. at home visit 1 - initial visit to 
household, and home visit two - morning visit to household). However, only 20 caregiver-
child dyads were visited a third time (i.e. at an evening visit [home visit 3]). The reasons for 
not completing all evening visits are described below. 
Children newly initiated on ART. I was unable to observe treatment administration 
in the evenings of four of the children newly initiated on ART. Two of the children, Hlengiwe 
and Thondeka received their doses in the evening at 8pm and 9pm respectively. For safety 
reasons, my RA assistant and I did not conduct any field work later than 8pm in the township 
(Table 8.3).  
Although my RA and I had arranged and been to Tina and her father’s homestead 
before 7pm one particular evening to observe medication administration, we did not video 
record the treatment event. Tina’s father had arrived home late from work that evening and 
refused to administer medication to his child until supper had been prepared and eaten. By 
8pm that evening supper was still not ready, and treatment had still not been administered. 
My RA and I had left the homestead without recording treatment administration. Tina’s 
father, however, called my RA in the morning to state that he did administer treatment to his 
daughter, and that he had done so at 9h30pm. The importance that the caregivers in this study 
attach to administering food before medication is addressed again later in this thesis.  
Lastly, I was unable to conduct an evening home visit to Luyando and his mother’s 
homestead. The RA had called Luyando’s mother to arrange an evening visit. She stated that 
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they had moved households since our last visit and was not comfortable with us coming to 
their new home as the other members of the household were not aware of the child’s status.  
Children with suppressed VL’s on ART. I was also unable to observe treatment 
administration in the evening at four of the homes of children with suppressed VLs. Two of 
the children, Sizwe and Mbali, both received their second dose of medication at 8pm (Table 
8.1). As mentioned, no evening visits occurred after 8pm. Andile and her mother lived in very 
close proximity to their neighbours. At recruitment, Andile’s mother said that we were 
welcome to visit them in the morning, but that the evenings at their homestead were always 
busy and they did not wish to draw the attention of their neighbours. Lastly, Sizani’s 
grandmother informed my RA that Sizani no longer lived with her and was living with her 
mother in an area outside of the DSA.  
Children with unsuppressed VL’s on ART. Finally, I was unable to observe 
treatment administration in the homes of two children with unsuppressed VLs (Table 8.2). I 
was unable to observe treatment administration in the evening at Muzi’s home. Muzi’s aunt 
had informed us that he had gone with his aunt to a funeral in Mpumalanga and that she was 
unsure as to when they would return. We were also unable to observe treatment 
administration at Duduzile’s home in the evening as my RA was unable to schedule an 
evening that suited her caregiver. Dudu’s mother had begun working since our last visit and 
she struggled to give an exact time that she would be at home.  
In the next section I present the themes and sub-themes related to the observations of 
the treatment administration practices undertaken by caregivers at medication-giving times 
during the morning and evening home visits. The section incorporates the video data, 
observation schedules, field notes and participant journals to contextualize the treatment 
event and household circumstances. The themes and sub-themes are summarized in Table 8.9.  
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Length of morning and evening visits. The average time spent at the households in 
the morning was approximately half an hour across all three groups, and in the evening 
approximately an hour long across all three groups. The actual time it took to measure and 
administer the medication to the child during these visits was far shorter (Table 8.8).  
Table 8.8 
Length of Morning and Evening Visits 
  Newly initiated Suppressed VL Unsuppressed VL 
  
Morn-
ing visit 
(n=10) 
Even-
ing visit 
(n=6) 
Morn-
ing visit 
(n=12) 
Even-
ing visit 
(n=8) 
Morn-
ing visit 
(n=11) 
Even-
ing visit 
(n=9) 
Length of morning and 
evening visit in 
minutes[mean, min, max] 
32.7           
(19, 54) 
58.63 
(26,14) 
37.25         
(19, 55) 
55.00       
(37, 79) 
36.00         
(17, 65) 
55.81       
(20, 90) 
Length of treatment 
administration in minutes 
[mean, min, max] 
3.85 
(1.45, 
9.11) 
3.03 
(1.00, 
7.53) 
4.12 
(0.56, 
5.54) 
6.83 
(1.59, 
12.25) 
4.99 
(1.02, 
14.55) 
5.99 
(2.43, 
9.32) 
 
Length of treatment administration. The average length of time it took to measure 
and administer medication in the mornings across all the groups was less than five minutes, 
and in the evening less than seven minutes (Table 8.8). Caregivers to children newly initiated 
on ART took an average of three minutes to measure and administer the medication, whereas 
caregivers of children with suppressed and unsuppressed VL’s took longer.  
The difference in the length of treatment administration time was largely attributable 
to the age/weight of the child as this determined the type of medication the child received. 
For example, six of the newly initiated children were younger than two years of age (Table 
8.3), compared to the majority of children in the suppressed (Table 8.1) and unsuppressed 
group, who were older than three years (Table 8.2). As per the Department of Health dosing 
chart for children (2013), children weighing more than 10kg typically receive tablets instead 
of liquid formulations. Thus, a larger proportion of children with suppressed and 
unsuppressed VLs received tablets/capsules as part of their regimen. Some of the tablets were 
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dissolved before being administered to the child, thus adding to the length of the treatment 
event. Issues specific to the way in which medications were administered and measured are 
discussed in detail in the section with the heading ‘Medication-related observations’.  
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Table 8.9 
Themes and Sub-themes across Observations 
    Barriers Facilitators 
Microsystem   Drug palatability Self-administration/ 
ownership of the 
medication 
 Child-related 
observations 
Side effects (refusal, cough, 
spit and vomit) 
 
  Pill burden (dissolving pills 
and opening capsules) 
 
Mesosystem     
 Context- 
related 
observations 
Medication workspace (house 
structure, number of 
occupants) 
 
  Medication storage  
  Caregiver beliefs about ART 
(Food given before treatment 
administration) 
 
 Medication-
related 
observations 
Caregiver knowledge of ART 
(medication measurement 
tools, measurement issues, 
dose checking, medication 
administration to child, 
missed doses) 
 
 Caregiver-
related 
observations 
 Caregiver strategies for 
remembering 
(Reminder tool) 
   Caregiver strategies for 
disguising medication 
taste (flavouring 
agents) 
   Adjustment to daily 
routine (organization, 
mornings vs evenings) 
   Caregiver consistency 
and treatment supporter 
   Strategies for 
managing pill burden 
(mixing medications) 
      Caregiver-child 
interaction 
(communication during 
treatment 
administration) 
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Context-related observations  
Medication workspace. As mentioned previously, households on average had up to 
six occupants in a dwelling consisting of one bedroom and one living area. Thus, 
overcrowded households were common amongst the participants in this study. In addition, the 
majority of household members were unemployed (Table 8.10). Overcrowded households 
coupled with unemployment fuelled various difficulties associated with treatment-giving that 
are discussed again further on. These difficulties include the inability to provide food before 
medication is given. In the context of this sub-theme, overcrowded households meant that 
some of the caregivers were limited in terms of space within the household to facilitate a 
smooth transition of medication-related activities in the morning and evening.  
Below is an extract from my field notes on the morning that we visited Khethiwe, a 
four-year-old girl with an unsuppressed VL. Khethiwe received her medication from her 
mother at 7am and 7pm daily. She received a combination of three liquid ARVs (ABC + 3TC 
+ LPV/r). Khethiwe’s mother prepared her medications for her by measuring the dose of each 
liquid using a syringe and injecting the contents of the syringe into three separate cups. In the 
mornings, Khethiwe’s mother also prepared packets of peanuts that she sold in town in order 
to provide an income for herself and her four children who reside with her in their one-
bedroomed house. On this particular morning, I observed how Khethiwe’s mother stepped 
over children asleep on the floor as she went about her morning routine. The extract 
demonstrates some of the discomfort associated with managing everyday activities in an 
overcrowded household: 
 
Field note extract: 
Walking into the household this morning I noticed family members (all children) 
asleep on the floor, and also on the bed in the lounge area and in the small bedroom 
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[…]. The caregiver stepped over one of her children asleep on the floor to get to the 
fridge. She opened the fridge and took out the small bottle of LPV/r. She stepped back 
over the child, and returned to the small table in kitchen area of the room. The 
caregiver checked her cell phone (presumably for the time) and then began to prepare 
the medication. [P188].  
Table 8.10 
Context-related Observations 
  Newly initiated Suppressed VL Unsuppressed VL 
  
Mornin
g visit 
(n=10) 
Evening 
visit 
(n=6) 
Morning 
visit 
(n=12) 
Evening 
visit 
(n=8) 
Morning 
visit 
(n=11) 
Evening 
visit 
(n=9) 
Medication 
workspace 
      
Lounge 5 4 9 6 2 4 
Bedroom 3 2 2 1 7 3 
Kitchen 2 0 1 1 2 2 
Medication storage       
In bedroom (hidden) 5 3 5 3 3 5 
In bedroom (not 
hidden) 
2 1 6 5 7 4 
In lounge (hidden) 3 2 0 0 1 0 
In lounge (not hidden) 0 0 1  0 0 
LPV/r refrigerated* 4 2 9 7 5 4 
Food given **  3 2 1 0 0 0 
Note. * = 27 children were receiving LPV/r as part of their regimen. ** = food given before 
treatment administration 
 
As previously mentioned, the modal number of rooms in the households was two 
(Table 8.7). The rooms were typically organized into an area for cooking (usually close to the 
refrigerator), a lounge area and a sleeping area (usually the second room). Based on these 
distinctions within the households, I coded the area in which the medication was measured 
and administered to the child.  
Throughout both morning and evening visits a larger proportion of children newly 
initiated on ART and those with suppressed VLs were observed to receive their medications 
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in the ‘lounge’ area, compared to those with unsuppressed VLs. Among children with 
unsuppressed VLs, 10 observations took place in a bedroom. The preferred area to administer 
medication was presumably where the caregiver and child had enough space to be seated next 
to one another (Table 8.10). The area in the house where the medication was administered 
was usually the same for morning and evening visits.  
In one particular instance the caregiver of a newly initiated child on treatment 
(Thembe) chose to administer medication to the child in the bedroom during the evening 
visit. I had observed Thembe’s aunt preparing and administering medication to Thembe 
during the morning visit in the kitchen area of their home. Thembe’s aunt reported that the 
kitchen area was convenient for her as she had a table where she could do her measurements 
and had access to any additional tools or materials that she needed in order to proceed with 
the activity. Thembe’s aunt stated that her brother, who lived and worked in an area several 
hours away from the family, was home for a short period due to illness. She stated that 
Thembe’s uncle refused to allow Thembe to be in the same room as his own children when he 
was at home. The field note extract below from my RA’s journal captures the sentiments 
shared by Thembe’s aunt about her brother on that day: 
Field note extract: 
The caregiver said that he even says that this child is sick and she must not be present 
where we are as a family. She must stay outside the room. He doesn't even want the 
child to touch any utensils, when she wants to drink water he doesn't want the child to 
take it herself from the bucket because that water will be drunk by everyone in the 
house [P187]. 
Thembe’s aunt stated that Thembe was aware of her uncle’s dislike of her and often 
stayed outside of the house when he was home. This was the only instance where we had 
encountered obvious discrimination against an HIV-infected child on ART. 
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Medication storage. Despite the lounge area of most households being the preferred 
area for treatment measurement and administration, nearly all of the caregivers stored the 
medications in the bedroom (Table 8.10). Abacavir and 3TC (both liquid ARV formulations) 
and tablets (such as EFV, AZT and d4T) do not require refrigeration and it was therefore 
appropriate to store these medications at room temperature. The directions for one of the 
medications, LPV/r, state that it should be kept refrigerated (Department of Health South 
Africa, 2013b). Although most caregivers (30 out of 33) had access to a refrigerator (Table 
8.7), not all caregivers stored LPV/r in the refrigerator. Of the 27 children (10/12 suppressed; 
9/11 unsuppressed; 8/10 newly initiated) receiving LPV/r, the medication was only seen 
removed from the fridge on 18 morning occasions and 13 evening occasions (Table 8.10). 
LPV/r was stored together with other medications, usually in the caregivers’ bedroom. 
Compared to children with suppressed VL’s, fewer caregivers of children newly initiated and 
with unsuppressed VLs kept LPV/r refrigerated.  
Medications stored in the bedroom were either hidden (when kept in plastic bags and 
stored in a cupboard in the bedroom) (see Figure 8.4), or not hidden (when kept on a table in 
the bedroom) (see Figure 8.5) (Table 8.10). At 16 observations (morning and evening) of 
children newly initiated on ART, medication was kept in the bedroom in 11 of the 
observations, of which eight were observed to be hidden and three not hidden (Table 8.10). 
Across 20 observations of children with suppressed VLs, medication was kept in the bedroom 
in 19 cases, of which eight were observed to be hidden, and 11 not hidden. At 20 observations 
of children with unsuppressed VLs, medication was kept in the bedroom in 19 cases, of 
which eight were observed to be hidden and 11 not hidden. Compared to children with 
supressed and unsuppressed VLs, more of the caregivers to children newly initiated on ART 
did not keep LPV/r in the fridge and preferred to store medications out of sight. Based on this 
observation it is possible that they were hiding the medications from small children, other 
Stellenbosch University  https://scholar.sun.ac.za
  
190 
 
household members or visitors. Figures 8.4 and 8.5 provide examples of medication that was 
presumably hidden and medication that was not hidden respectively.  
 
 
 
 
 
 
 
 
 
 
Food given before treatment administration. During home visit 1, all of the 
caregivers reported that they usually give food to the child before treatment administration in 
the mornings and evenings (Table 8.7). During both morning and evening visits to the 
household, we seldom saw children eating food before their treatment was administered 
(Table 8.10). When asked whether the child had eaten yet, caregivers responded by saying 
that they had already given food to the child before we arrived.  
There were only four morning (three newly initiated, and one suppressed VL) and two 
evening visits (both newly initiated) where we had seen a child eating before treatment was 
administered or had seen visible signs that food had been prepared and given (Table 8.10). 
We had not seen any indications of food given during our visits to the households of children 
with unsuppressed VLs. There was therefore a mismatch between what caregivers had stated 
during the initial home visit (home visit one) and what had been observed during the morning 
and evening home visits.  
Figure 8.5. Medication not hidden –  
illustrates medications kept on a table  
in the bedroom 
 
Figure 8.4. Medication hidden - illustrates  
caregiver holding a plastic bag  
containing medications.  
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However, although visible signs of food preparation and consumption were missing 
from most morning and evening household visits, entries from caregiver journals show that 
eating food was an important activity before medication was given, and that the lack of food 
presented a barrier to treatment administration for both the caregiver and child. In the 
sequence of extracts below I present individual entries from the journals of two caregivers of 
children with unsuppressed VL’s. In the journals of each of these caregivers, giving food to 
the child always preceded giving medication to the child. The extracts thus show the 
importance of food administration before medication administration in the daily routines of 
these caregivers and children. 
Extract from the journal of Phila’s (unsuppressed five-year-old female) grandmother: 
30 September 2013 
At 05h48am I wake up I prepare something so that Phila can eat it before she can take 
medicines then at 6am I gave her meds. At 10h40 I started cooking food for us to eat 
after lunch. At 1pm I take my lunch then I also take cold drink. When it was about the 
time for Phila to take treatment at 6pm I prepare meds for her after that I gave it to her 
but I started by giving her food because she can’t take meds on an empty stomach. I 
watched TV until 21h30pm then I went to sleep [P261]. 
Extract from the journal of Jabulile’s (unsuppressed three-year-old male) grandmother 
(written by an older sibling member): 
We wake up in the morning we take a bath eat our food and we went to school. 
Jabulile went to his car that takes him to school. When he came back from school he 
went to sleep then when granny came back she wake him up. We gave him food 
because we see that time for him to take treatment is closer after that he takes his 
treatment then take a bath [P263]. 
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In the extract below from the journal of Thondeka’s (newly initiated two-year-old 
female) mother, she illustrates the barrier that a lack of food in the household imposed on 
treatment administration. Thondeka’s mother sought support from her neighbours when she 
was unable to provide her child with food.   
Journal extract: 
18 February 2014 
I wake up in the morning. I washed dummies for my child. I made milk because there 
was no food that she will get when she wake up. Then I went to my neighbour to ask 
if they can help me with maize meal so that I can make porridge for her. […][P211].  
Medication-related observations 
Liquid formulations. Apart from one child with a suppressed VL (Ayanda five-year-
old female), all of the children received liquid ARV formulations as part of their regimen. 
These formulations included ABC, 3TC and LPV/r. Of children newly initiated on ART, nine 
received ABC, 10 received 3TC and eight received LPV/r as part of their regimen. Of 
children with suppressed VLs, 10 received ABC, nine received 3TC and 10 received LPV/r as 
part of their regimen. Of children with unsuppressed VLs, seven received ABC, seven 
received 3TC and nine received LPV/r as part of their regimen.  
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Table 8.11 
Medication-related Observations 
  Newly initiated Suppressed VL Unsuppressed VL 
  
Morning 
visit 
(n=10) 
Evening 
visit 
(n=6) 
Morning 
visit 
(n=12) 
Evening 
visit 
(n=8) 
Morning 
visit 
(n=11) 
Evening 
visit 
(n=9) 
Medication 
measurement tools 
      
Syringe 6 3 7 5 7 5 
Syringe + nozzle 4 2 4 3 1 1 
Measuring cup 0 1 1 0 3 3 
Measurement issues       
Bubble in syringe 1 0 2 1 1 1 
Dose checking       
ABC 2 3 2 0 4 3 
3TC 2 3 1 1 4 3 
LPV/r 3 3 8 6 6 7 
Medication 
administration 
(directly or 
indirectly)** 
      
Syringe (directly) 6 3 9 7 4 4 
Measuring cup 
(indirectly) 
4 3 2 1 7 5 
Missed doses 1 1 0 0 0 0 
Note. ** = Medication administration: Directly – medication injected directed into child’s 
mouth using syringe. Indirectly – medication transferred into a cup 
 
The majority of caregivers (observed 20 times during morning administration, and 13 
times during evening administration) used a separate syringe to measure and administer each 
dose (Table 8.11). One way to aid accurate measurements of liquid formulations using 
syringes is through the use of a syringe nozzle. Syringe nozzles are small plastic attachments 
that fit into the opening of medication bottles and are made especially for syringes. These 
devices are typically packaged with the medications ABC and 3TC. The medication LPV/r 
does not come with such a device. Syringe nozzles were underutilized amongst the caregivers 
(only used 15 times across 56 observations) (Table 8.11). Observation revealed that syringe 
nozzles were used more frequently by caregivers of children newly initiated (observed six 
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times) and suppressed on ART (observed seven times) compared to unsuppressed children on 
ART (observed two times). Fewer instances were observed among those with unsuppressed 
VLs as a large proportion was receiving LPV/r via syringe only.   
However, even with a syringe nozzle intact, caregivers who chose to use them used an 
angle to make measurements that sometimes compromized accurate measurements of the 
dose. In two instances where measurements were taken at a horizontal angle these 
measurements led to bubble formations in the syringe.  
Figure 8.6 and 8.7 show two different caregivers taking a measurement of 3TC with a 
syringe nozzle intact. Both caregivers were biological mothers, one was a biological mother 
to a suppressed child, and the other to a child newly initiated on ART. In both instances the 
caregiver is seen holding the bottle horizontally while the measurement is taken. In both these 
instances the angle at which doses were measured resulted in bubbles forming within the 
syringe, suggesting possible dose inaccuracy. The doses were not checked by the caregivers 
after measurements. Thus, it is likely that children were under-dosed in these examples.   
 
 
 
 
 
 
 
 
 
 
Figure 8.7. Dose measurement of 3TC – 
newly-initiated child on ART 
Figure 8.6. Dose measurement of 3TC –               
suppressed child on ART   
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In four other instances it was clear from the video data that a large bubble had formed 
in the syringe (Table 8.11). In neither of these instances was the bubble removed, indicating a 
possible under-dosing of that medication.   
To illustrate this, Figure 8.8 features a series of consecutive video frames (P226 – 
P228) taken from the recording of a typical morning medication measurement by Siyasizwe’s 
(newly initiated two-year-old male) mother, depicting the formation of an air bubble in 
syringe. In the first frame, the caregiver draws up an amount of medication from an orange 
cup using a syringe. In the second frame, the caregiver lifts the syringe upward and checks 
the dose amount from a downward/horizontal angle. In the last frame, the caregiver removes 
the syringe from the orange cup (with an air bubble in the syringe pointed out by the yellow 
arrow).   
 
 
 
 
 
 
Figure 8.8. Air bubble formation in syringe  
Similarly, Figure 8.9 shows a consecutive series of video frames (P230 – P232) taken 
from a recording of a typical medication measurement in the morning by Nandi’s (suppressed 
four-year-old female) grandmother, depicting the formation of a bubble in the syringe during 
the measurement of 3TC. The caregiver poured some of the liquid from the medication bottle 
into the lid before the measurement began. As seen in frame P230, the caregiver placed the 
syringe into the lid (at a slight horizontal angle) and began to draw up an amount of liquid. In 
frame P231, an arrow points to the air bubble in the syringe. In P232 the caregiver has placed 
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the syringe down (the air bubble was not removed). Thus, due to the large bubbles in the 
syringes in these examples, it is likely that the dose administered was insufficient.  
 
 
 
 
 
Figure 8.9: Air bubble formation in syringe  
Dose checking. As mentioned earlier, the majority of caregivers used a syringe to 
measure liquid formulations. Once a dose had been measured, I was able to code for whether 
the caregiver checked the amount that she had drawn up, and whether she made any 
adjustments to this amount. Across all three groups, caregivers made several adjustments to 
the measurements of LPV/r compared to the other liquid formulations (Table 8.11). 
Caregivers appeared to be more cautious and concerned with the accuracy of LPV/r and less 
so with the measurements of liquid ABC and 3TC. Furthermore, caregivers of children 
suppressed (observed 14 times) and unsuppressed on ART (observed 13 times) were observed 
to check the dosage of LPV/r more frequently than the caregivers of children newly initiated 
(observed six times) on ART (Table 8.11).  
To illustrate dose checking, Figure 8.10 features a sequence of images from a 
recording of a typical morning measurement of ABC by Khethiwe’s mother. In video frame 
P241 the caregiver draws up a dose amount (from a downward angle), followed by a minor 
dose adjustment in video frame P242. In video frame P243 the caregiver checks the dose 
briefly (at a horizontal angle). In video frame P244 the caregiver is seen transferring the dose 
to an alternative administering tool [medication cup]. This example illustrates the brief nature 
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of dose checking that occurred when doses of ABC (and 3TC) were measured. It is likely that 
these brief instances of dose checking resulted in inaccurate measurements. 
 
 
 
 
 
 
 
Figure 8.10. Dose checking 
Medication administration (directly or indirectly). Caregivers administered liquid 
ARV’s (like ABC, 3TC and LPV/r) to the child either directly (by injecting the liquid directly 
from the syringe into the child’s mouth), or indirectly (by injecting the liquid into a cup first 
and then letting the child drink from the cup) (Table 8.11). Caregivers to children newly 
initiated (observed nine times) and with suppressed VLs (observed 16 times) preferred 
injecting the liquid ARVs directly from the syringe into the child’s mouth (Table 8.11). On 
the other hand, caregivers to children with unsuppressed VLs (observed 12 times) preferred 
injecting the liquid into a medication cup first and then administering it to the child (Table 
8.11). Caregivers administered liquid medications directly to younger (younger than three 
years old) children.  
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Tablet formulations. All of the five-year-olds (three with suppressed VL’s, five with 
unsuppressed VL’s, and three newly initiated) in the study were on a regimen containing 
either pills or capsules in combination with a liquid ARV (usually LPV/r). Most children 
received their medication via direct administration (Table 8.11). The ARV’s in tablet and 
capsule form were prepared and administered differently from the liquid. As seen from Table 
8.12, tablets and capsules were either swallowed whole or dissolved in water or mixed with a 
taste distractor (drinking yoghurt). All the children with suppressed VL’s received their 
tablets/capsules directly and they were subsequently either swallowed whole or, as in the one 
instance with Tholakele, the contents of the capsule were poured out into her mouth. 
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Table 8.12 
Handling of Tablets and Capsules during Treatment Administration 
 
Person 
administering 
dose 
ART regimen 
Tablet swallowed 
whole/ dissolved 
in water 
Capsule swallowed 
whole/ capsule opened 
Residue 
Newly initiated 
 
   
 
Thembe Aunt 
ABC + 3TC + 
EFV (300mg) 
EFV swallowed 
whole 
NA  
Lungile Grandmother 
ABC + 3TC + 
EFV (200mg) 
NA 
EFV capsule opened and 
mixed with drinking 
yoghurt 
None 
Tina Father 
d4T (20mg) + 
3TC + LPV/r 
d4T mixed with 
other ARVs 
NA  
Suppressed      
Ayanda Mother 
d4T (20mg) + 
3TC (75mg) + 
EFV (300mg) 
d4T + 3TC + EFV 
swallowed whole 
NA  
Tholakele Grandmother 
d4T (20mg)+ 3TC 
(75mg) + LPV/r 
d4T swallowed 
whole 
3TC capsule opened, 
powder administered 
directly into mouth 
None 
Sibusiso Mother 
ABC (300mg) + 
3TC (150mg) + 
EFV (300mg) 
ABC + 3TC 
_EFV swallowed 
whole 
NA  
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Table 8.12 (continued) 
 
 
 
Person 
administering 
dose 
ART regimen 
Tablet swallowed 
whole/ dissolved 
in water 
Capsule swallowed 
whole/ capsule opened 
Residue 
Unsuppressed      
Phila Grandmother 
AZT (100mg) + 
ABC + EFV 
(200mg)+ CPV/r 
AZT dissolved in 
water 
Capsule opened and 
dissolved in water 
Yes 
Muzi Aunt 
d4T (20mg) + 
3TC (150mg) + 
LPV/r 
d4T + 3TC 
swallowed whole 
NA  
Kwanele Mother 
d4T (20mg) + 
3TC (75mg) + 
LPV/r 
d4T dissolved in 
water 
3TC capsule opened and 
dissolved in water 
Yes 
Dingane Aunt 
3TC + AZT 
(150mg) + LPV/r 
AZT dissolved in 
water 
NA Yes 
Busisiwe Aunt 
d4t (20mg) + 3TC 
(75mg) + LPV/r 
d4T dissolved in 
water 
3TC capsule opened and 
dissolved in water 
Yes 
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The tablets of 4 out of 5 children in the unsuppressed group were dissolved in water 
before being administered (Table 8.12). Dissolving tablets into solutions was problematic in 
cases where the residue of the tablets remained behind in the container (usually a cup) and 
was discarded by the caregiver when she rinsed out the medication cup. In all four instances 
where either a tablet or capsule had been dissolved in water, residue of the medications 
remained behind in glass/cup it was administered from. Once administered, the caregiver 
rinsed the administration tool and discarded the residue that remained left over.  
To illustrate the above phenomenon, the sequence of images from the recording of 
treatment administration to Phila (unsuppressed five-year-old female) is shown below (Figure 
8.11). Phila was on a second-line regimen and had never had a suppressed VL. Each of 
Phila’s tablet/capsule medications was dissolved in water and administered to her in a tall 
glass. In video frame P228, Phila’s caregiver measures 5ml of water and injects it into the tall 
glass. She then reaches for the bottle of pills [P289] and takes out a single capsule. She then 
opens the capsule and pours the powder contents into the water in the tall glass [P290]. She 
then proceeds to mix the contents together [P291]. After this, she administers the dose to the 
child.  
 
 
 
 
 
 
Figure 8.11. Dissolving tablets 
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Following administration of the medication to Phila, her caregiver discards the residue 
remaining in the glass. The actions of the discarding the residue are described in the extract of 
the video transcript below.  
Video transcript: 
Video transcript 7: video segment 6635 – 7084. The camera follows the caregiver to 
where she has poured water into the tall glass [white residue visible in the glass]. The 
caregiver swirls the mixture of residue and water around in the glass and walks 
towards the door. The caregiver disposes of the contents of the glass outside. The 
caregiver walks back into the room and picks up one of the syringes. She rinses it 
using the water in the blue plastic container. She then dries off the syringe and 
proceeds to rinse the next syringe [P7]. 
Missed doses. Only one caregiver had missed a dose of a particular medication (Table 
8.11). Siyasiwe’s (newly initiated two-year-old) mother stated she had been using ABC and 
3TC interchangeably as she thought they were the same medication.  
Caregiver-related observations 
Use of a reminder tool. All of the caregivers reported using a cell phone as a 
reminder device at home visit one. However, during my observations not all caregivers 
checked their cell phones for the time before preparing to administer the medication to the 
child (Table 8.13). In 15 (out of 33) morning and 14 (out of 20) evening observations, 
caregivers were seen checking their cell phones before dose administration (Table 8.13). 
Nearly all (8 out of 12 in the morning and 8 out of 8 in the evening) of the caregivers of 
children with supressed VLs had their cell phones with them and checked them for the time 
beforehand. However, there were only two instances (Table 8.13) across all video recordings 
where the sound of an alarm going off as a reminder was heard. Both instances were from the 
same caregiver during the morning and evening visit (Thenjiwe’s mother, see Table 8.1). So, 
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although caregivers reported using cell phones as a reminder device, only one had actually set 
an alarm on her cell phone. 
 
Table 8.13 
Caregiver-related Observations  
  Newly initiated Suppressed VL Unsuppressed VL 
  
Morning 
visit 
(n=10) 
Evening 
visit 
(n=6) 
Morning 
visit 
(n=12) 
Evening 
visit 
(n=8) 
Morning 
visit 
(n=11) 
Evening 
visit 
(n=9) 
Reminder tool 
(device seen/heard) 
      
Device seen and 
checked 
4 3 8 8 3 3 
Device seen and heard 0 0 1 1 0 0 
Organization* 2 1 6 4 4 6 
Caregiver 
consistency and 
treatment supporter 
      
Dose administration 
by primary caregiver 
9 8 11 7 9 6 
Dose administration 
by other household 
member 
1 2 1 1 2 3 
Note. * = methodical treatment preparation and administration. 
Amongst caregivers who visibly checked their cell phones for time, there were two 
instances (during Richard’s (suppressed) morning visit, and during Dingane’s (unsuppressed) 
morning and evening visit) of waiting periods between dose measurements and dose 
administrations. The waiting periods indicated the importance that these caregivers attached 
to administering the dose at the appropriate time.  
In the video transcript below, Dingane’s (unsuppressed female, five years old) aunt 
had already collected all the medications from her bedroom and the LPV/r from the fridge in 
the kitchen and had brought them into the lounge area where she prepared and administered 
the doses. Once she had placed all the medications down, she had sat down and checked her 
cell phone (presumably for time) several times before she began measuring and preparing the 
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dose amounts. The transcript extract demonstrates an instance where the caregiver waits for 
an exact time before proceeding with dose measurements.  
Video transcript extract: 
Video transcript 69: video segment 4801 – 5082: The caregiver sits with her elbows 
resting on her knees. The caregiver and child sit in silence [waiting period: 5.30s to 
8.00s]. The caregiver reaches for her cell phone. The caregiver picks up her cell 
phone, and looks at it [presumably checking the time]. She then places the cell phone 
down again [P69]. 
Organization. I coded for instances where organized and systematic dose preparation 
and administration took place. In each of the video recordings of treatment administration by 
these caregivers (12 mornings and 11 evenings), syringes and or medication cups were placed 
in a specific order before the medication was administered to the child. The order of 
medications involved administering LPV/r first, followed by the administration of the other 
liquids. Caregivers of children with suppressed (observed 10 times) and unsuppressed 
(observed 10 times) VLs were observed to organize treatment administration in this way 
more times compared to caregivers of children newly initiated on ART (observed three times) 
(Table 8.13).  
Treatment organization was most notable with the two mothers that each had two 
children on treatment. Thus, Thenjiwe and Lwazi’s (suppressed three–year-old unidentical 
twins) and Khetiwe’s (older sibling also on ART) mothers were both clearly systematic in 
their approach to treatment administration. The organization demonstrated by both of these 
caregivers is best illustrated in the two images below. In the first image (Figure 8.12), 
Thenjiwe’s and Lwazi’s caregivers had separated the syringes of medication for each child. 
Medications were then administered to the child in a specific order. In the second image 
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(Figure 8.13), Khetiwe’s caregiver had measured the dose amounts and organized them for 
each child prior to administration. 
 
 
 
 
 
 
 
 
Caregiver consistency and treatment supporter. As mentioned previously, most of 
the caregivers recruited into the study were the biological mothers of the children for whom 
they were caring. Caregivers reported that in some instances another member of the 
household, usually an older child (sibling of the child on treatment) was also responsible for 
administering medication to the child (see Table 8.14).  
Table 8.14 shows the caregiver consistency coded from the video data. Among the 
children newly initiated on ART, caregivers responsible for treatment administration in the 
morning and in the evening were fairly consistent. However, caregiver inconsistency was 
observed twice. Thus, in two instances (Zoliswa and Thandiso), a different person 
administered the medication to the child at the evening visit. In both instances, the 
grandmother administered medication to the children in the morning while an aunt in one 
instance and a sibling in the other instance administered medication in the evening. During 
three morning instances (Zoliswa, Thandiso and Siyasizwe) and two evening instances 
(Zoliswa and Siyasizwe) the person administering the medication had support from another 
member of the household (a treatment supporter) to facilitate the activity. The caregiver to 
Figure 8.12. Medication organization 1  Figure 8.13. Medication organization 2 
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both Zoliswa and Thandiso was their grandmother. During morning observations both 
grandmothers had assistance from a household member during the treatment event. In the 
case of Zoliswa, the aunt assisted the grandmother by bringing LPV/r from the fridge to the 
bedroom where medication was administered. In the case of Thandiso, the sibling had 
measured the dose amounts, while the grandmother administered the doses to Thandiso. 
During the morning observation of Siyasizwe, his mother received help from his aunt during 
the treatment event. Siyasizwe refused to take his medication at first, after which his aunt 
promised him an apple if he took his medications.  
Among the children with suppressed VLs, similar observations were made. The same 
person administered the dose in the morning as well as in the evening in 10 out of 12 
instances. During two evening instances (Andile and Nandi) the person administering 
medication to the child received assistance during the treatment event. In the case of Andile, 
her mother had assistance from Andile’s grandmother. Andile’s grandmother encouraged her 
to drink her medications. In the case of Nandi, her sibling had assistance from Nandi’s 
grandmother. Nandi’s grandmother helped to administer the medication to her.  
Among the children with unsuppressed VLs, caregiver inconsistency was observed 
three times (Samu, Phila and Kwanele). During one morning instance (Busisizwe) and five 
evening instances (Samu, Nathi, Kwanele, Dingane and Busisizwe) the person administering 
the medication received assistance from another family member. In the case of Samu, his 
mother had assistance from his aunt during treatment administration. Samu’s mother did not 
live with him at home as she works in an area several kilometres away and was home 
temporarily. Samu’s aunt thus measured the doses while his mother administered the doses to 
him. In the case of Nathi, his mother had assistance from his father during the evening visit. 
Nathi’s father assisted by fetching the medications from the bedroom where they were kept. 
In the case of Kwanele, his sibling had assistance from his grandmother. Kwanele’s 
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grandmother gave the medications to the sibling (Kwanele’s brother), who then measured and 
administered the medication to him. In the case of Dingane, her aunt had assistance from 
Dingane’s mother during the evening visit. Dingane’s mother worked full-time and thus her 
aunt administered medication to her and was responsible for attending clinic visits. In the 
case of Busisizwe, both his aunts were involved in treatment-related activities. While one 
aunt measured and administered the doses (Aunt_1), the other was responsible for fetching 
the medications and medication tools.  
 
Table 8.14 
Caregiver Consistency and Treatment Supporter during Medication-giving Times 
   Morning Evening 
 
  
Treatment 
giver 
Treatment 
supporter a 
Treatment 
giver 
Treatment 
supporter 
Newly 
initiated 
Thembe Aunt None Aunt None 
 
Lungile 
Grandmoth
er 
None Grandmother None 
 
Luyando Mother None 
Visit not 
done 
Visit not done 
 
Zoliswa 
Grandmoth
er 
Aunt Aunt Aunt 
 
Tina Father None 
Visit not 
done 
Visit not done 
 Hlengiwe Mother None Mother None 
 
Amanda Mother None 
Visit not 
done 
Visit not done 
 
Thandiso 
Grandmoth
er 
Sibling Sibling None 
 Siyasizwe Mother Aunt Mother Aunt 
 Thondeka Mother None Mother None 
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Table 8.14 (continued) 
   Morning Evening 
 
  
Treatment 
giver 
Treatment 
supporter a 
Treatment 
giver 
Treatment 
supporter 
Suppressed Thabisa Mother None Mother None 
 
Sizwe 
Grandmoth
er 
None Grandmother None 
 Thenjiwe Mother None Mother None 
 Lwazi Mother None Mother None 
 Richard Mother None Mother None 
 
Mbali Mother None 
Visit not 
done 
Visit not done 
 
Ayanda Mother None 
Visit not 
done 
Visit not done 
 Andile Aunt None Mother Grandmother 
 
Tholakele 
Grandmoth
er 
None Grandmother None 
 
Sizani 
Grandmoth
er 
None Grandmother None 
 
Nandi 
Grandmoth
er 
None Sibling Grandmother 
 
Sibusiso 
Visit not 
done 
Visit not done Mother None 
Unsuppressed Samu Aunt None Mother Aunt 
 Phila Sibling None Grandmother None 
 Nathi Mother None Mother Father 
 
Muzi Aunt None 
Visit not 
done 
Visit not done 
 Kwanele Mother None Sibling Grandmother 
 Dingane Aunt None Aunt Mother 
 Busisiwe Aunt_1 Aunt_2 Aunt_1 Aunt_2 
 
Duduzile Mother None 
Visit not 
done 
Visit not done 
 
Jabulile 
Grandmoth
er 
None 
Visit not 
done 
Visit not done 
 
Khethiwe Mother None 
Visit not 
done 
Visit not done 
 
Siyabonga Mother None 
Visit not 
done 
Visit not done 
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Child-related observations  
Palatability. Most (no palatability issues in 38 out of 56 observations) of the children 
took their medications without much resistance (Table 8.15). However, I observed four 
instances (one newly initiated, one suppressed, two unsuppressed) of children spitting 
medications out; two instances of vomiting (one newly initiated, one unsuppressed); seven 
instances of coughing (two newly initiated, four suppressed, one unsuppressed) during 
medication-administration or moaning by the child; five instances of child refusal (one 
instance in which the child ran away (newly initiated); and four instances (two newly initiated 
and two suppressed) where the child pushed the caregiver’s hand away) (Table 8.15). In all 
instances of palatability difficulty, the caregiver completed dose administration. In both 
instances of vomiting in particular, the caregivers completed the dose that was measured 
within a few minutes of the occurrence.  
Table 8.15 
Child-related Observations 
  Newly initiated Suppressed VL Unsuppressed VL 
  
Morning 
visit 
(n=10) 
Evening 
visit (n=6) 
Morning 
visit 
(n=12) 
Evening 
visit (n=8) 
Morning 
visit 
(n=11) 
Evening 
visit (n=9) 
Palatability       
No 
palatability 
issues 
5 4 10 3 8 8 
Spitting 1 0 1 0 2 0 
Vomiting 1 0 0 0 0 1 
Cough/moans 2 0 0 4 1 0 
Refusal  1 2 1 1 0 0 
Taste 
distracter 
0 1 2 2 1 1 
Self admini-
stration 
4 2 1 2 5  
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Caregiver-child interaction observations 
These observations are supplemented by Tables 8.16 through 8.18.  
Communication during treatment event. Table’s 8.16 through 8.18 below show the 
frequency of verbal communication between caregiver and child during treatment 
administration in the mornings. Most (29 out of 33) of the children were present in the 
medication area and thus did not need to be called or brought into the medication giving area. 
In instances where the child was called to the medication area, he/she responded positively 
and reacted towards the caregiver’s instruction to drink his/her medications.   
Only one child (Siyasizwe, two-year-old male – newly initiated) tried to run away 
from his mother when treatment was about to be administered. In this instance Siyasizwe’s 
aunt (treatment supporter) persuaded Siyasizwe to drink his medication by offering him an 
apple afterwards (Table 8.16). As most of the children were present in the medication area, 
there was little communication between child and caregiver before or after the treatment 
administration. Younger children (below two years old) were often picked up and seated 
across their caregivers lap during treatment administration. This made treatment 
administration faster and easier as treatment was administered directly to them – i.e. from the 
syringe into their mouth (Table 8.11). Younger children therefore did not need to be called to 
the medication area as was the case with older children. Thus, treatment administration to 
younger children was predominantly a silent and fast-paced activity.  
There were two morning instances where the children had difficulty with swallowing 
the medication and the caregiver reacted towards the difficulty with little to no verbal 
communication. For example, Lungile, a newly initiated child on ART, was coughing during 
treatment administration in the morning. Even in this instance communication was poor and 
no words of encouragement were used to motivate the child to drink her medication (Table 
8.16). In the second instance with Siyasizwe, the caregiver continued to administer the 
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medication to the child by holding his head firmly in place while she administered the rest of 
the medication to him (Table 8.16).  
There were two instances (Sizwe (suppressed) and Thenjiwe (suppressed)) where 
encouragement/praise was used (Table 8.17) to motivate the child to take his/her treatment. 
Extracts from the video transcription of each of these illustrate both instances. 
Video transcript – Sizwe (two-year-old suppressed male): 
Video transcript 80: Caregiver picks up final syringe [3TC] and injects it directly into 
the child's mouth. She waits for the child to swallow and then says 'Ngiyabonga - 
thank you' and hands the syringe to the child who then drops it into the tupperware.  
Gogo then asks her to put her syringes away. Child picks up the syringes and leaves 
the video frame. [P80] 
Video transcript – Thenjiwe (three-year-old suppressed female) 
Video transcript 180: Caregiver [biological mother] slowly and carefully injects the 
liquid [3TC] directly into the child's mouth. When she is done, her grandmother claps 
her hands and praises the child, and kisses her on the head. [P180]  
Self-administration/ ownership of the medication. Across 16 (out of 56) 
observations children self-administered their medication after it had been measured by a 
caregiver (Table 8.15). These observations demonstrated that some of children showed 
interest and wanted to take part in the medication process. 
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Table 8.16 
Caregiver-child Communication during Morning Visits to Children Newly Initiated on ART 
Newly initiated (n=10) 
Observation Thembe Luyando Tina Hlengiwe Amanda Thandiso Lungile Siyasizwe Zoliswa Thondeka 
           
Medication 
area 
 
Kitchen 
area 
Lounge 
area 
Lounge 
area 
Bedroom 
area 
Lounge 
area 
Bedroom 
area 
Lounge 
area 
Lounge 
area 
Bedroom 
area 
Kitchen 
area 
Child 
present in 
medication 
area? 
(yes/no) 
Yes 
(Seated in 
medi-
cation 
area) 
Yes 
(Seated in 
medi-
cation 
area) 
Yes 
(Seated on 
mother’s 
lap) 
Yes 
(Stands 
next to 
grand-
mother) 
Yes 
(Seated in 
medi-
cation 
area) 
Yes 
(Seated on 
mother’s 
lap) 
No 
(Fetched 
and seated 
on 
mother’s 
lap) 
No 
(Fetched 
and seated 
on grand-
mother’s 
lap) 
Yes 
(Seated in 
medi-
cation 
area) 
Yes 
(Seated in 
medicatio
n area) 
Communi-
cation 
between 
caregiver 
and child? 
(yes/no) 
No Yes (calls 
child to 
drink 
medi-
cation. 
Child does 
not 
respond 
verbally) 
No Yes (calls 
child to 
drink 
medi-
cation. 
Child does 
not 
respond 
verbally) 
No   No No 
(despite 
obvious 
struggle: 
coughing - 
no 
encourage
ment no 
communic
ation) 
Yes 
(grandmot
her 
encour-
ages child 
to drink, 
but child 
has 
vomited. 
Holds 
child’s 
head in 
position to 
administer 
dose) 
Yes (calls 
child for 
doses. 
Child 
attempts 
to run 
away. 
Aunt uses 
apple as 
incentive) 
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Table 8.17 
Caregiver-child Communication during Morning Visits to Children with Suppressed VL’s on ART 
Suppressed (n=12) 
Observation Richard Ayanda Andile Mbali Nandi Sibusiso Thabisa Sizwe Thola Thenji- Lwazi Sizani 
             
Medication 
area 
Kitchen 
Lounge 
floor 
Lounge 
Lounge 
(dining 
room 
table) 
Floor 
(Single 
roomed 
house) 
Lounge 
Bedroo
m 
Lounge Kitchen Kitchen Kitchen Lounge 
             
Child 
present in 
medication 
area? 
(yes/no) 
Yes 
(Seated 
in 
medi-
cation 
area) 
Yes 
(Seated 
in medi-
cation 
area) 
No 
(Child 
called to 
medi-
cation 
area) 
Yes 
(Seated 
in medi-
cation 
area) 
Yes 
(Seated 
in 
medicati
on area) 
Yes 
(Seated 
on 
mother’s 
lap) 
Yes 
(Seated 
in 
medicati
on area) 
No 
(Child 
called to 
medi-
cation 
area) 
Yes 
(Seated 
in medi-
cation 
area) 
Yes 
(Seated 
in medi-
cation 
area) 
Yes 
(Seated 
in medi-
cation 
area) 
Yes 
(Seated 
in medi-
cation 
area) 
             
Communi-
cation 
between 
caregiver 
and child? 
(yes/no) 
No 
Yes (told 
to take 
medicati
on) 
No 
Yes (told 
to take 
medicati
on) 
No No No 
Yes 
(encour-
agement 
during 
treatmen
t event 
to 
swallow 
medicati
on) 
Yes (told 
to take 
medicati
on) 
Yes 
(encoura
gement 
during 
treatmen
t event 
to 
swallow 
medicati
on) 
Yes (told 
to take 
medicati
on) 
Yes (told 
to take 
medicati
on) 
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Table 8.18 
Caregiver-child Communication during Morning Visits to Children with Unsuppressed VL’s on ART 
Unsuppressed (n=11) 
Observation Samu Phila Nathi Muzi Kwanele Dingane Busisiwe Duduzile Jabulile Khethiwe 
           
Medication 
area  Bedroom Bedroom Lounge Bedroom Kitchen Lounge Kitchen Bedroom Lounge Bedroom 
           
Child present 
in medication 
area? (yes/no) Yes Yes Yes Yes Yes Yes  Yes Yes Yes Yes 
           
Communi-
cation 
between 
caregiver and 
child? 
(yes/no) 
Yes (told 
to take 
medi-
cation) No No No No No No No No No 
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Summary of findings 
In the second phase of this research I sought to observe and document the treatment 
administration practices of caregivers to children younger than five years on ART living in a 
predominantly rural area. Following recruitment of 33 caregiver-child dyads at two ART 
clinics in the Hlabisa sub-district, I attended one adherence counselling session with each 
dyad, as well as two home visits (a morning visit and an evening visit). I also provided each 
of the caregivers with a journal to document their daily routine to provide additional insight 
into behaviours that were observed. 
My RA and I were able to observe 25 out of 33 caregivers at a routine adherence 
counselling visit. The purpose of the observation was to document the information that 
caregivers received during these sessions. The sessions lasted on average 8.1 minutes, and 
were mostly conducted in private. Overall, very little information exchange took place during 
these sessions. The questions asked and information provided to caregivers during the 
sessions varied, but were largely concerned with reporting VLs and CD4 counts, asking 
caregivers to recall dose names and dose amounts, and indicating when the child needed to 
have their bloods taken again.  
Following the adherence counselling sessions, my RA and I attended a maximum of 
three visits to participants’ homes. The first visit was aimed at locating their homes and 
documenting the occupants and resources, while the second (a morning visit) and third (an 
evening visit) home visit was centred on video recording and observing morning and evening 
treatment administration practices.  
I analysed the video recordings, field notes, participant journal notes and observation 
schedules and obtained four clear areas/themes to describe the observations that took place, 
namely context-related observations, medication-related observations, caregiver-related 
observations and child-related observations. Context-related observations showed that 
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treatment administration times across the three criteria groups were fairly consistent, with 
treatment administration to children newly-initiated on treatment proceeding slightly faster 
compared to those children with suppressed and unsuppressed VLs. The majority of the 
households were RDP houses, usually containing two distinct living areas. For the 
participants in this study, one area was used for sleeping, while the other area was used as a 
kitchen and/or lounge. Out of 56 observations, 30 observations took place in the lounge area 
of participants’ homes. Despite the open display of treatment preparation and administration 
in the lounge area, medication was usually kept in caregivers’ bedrooms. 
Although most of the caregivers had access to a refrigerator, some still chose to keep 
LPV/r in their bedroom in either a plastic bag or on a table along with the other ARVs. 
Although caregivers reported that food was usually administered before treatment 
administration, this was not regularly observed. Caregivers used measurement tools such as 
syringes and medication cups to administer medications. However, dose-checking of the 
measured amounts was less frequently observed and, in some instances, led to noticeable 
under-dosing of the medication. 
Some caregivers demonstrated a methodological approach to treatment administration 
which may be suggestive of adequate integration of the medication into their daily routine. 
Very few palatability issues were observed among the children. However, in instances where 
children had difficulty with their medications (e.g. vomiting), caregivers rushed to complete 
the dose, rather than waiting and re-administering the full dose. Older children received 
tablets or capsules as part of their regimen. These medications were usually dissolved in 
water before administration. Although dissolving tablets made it easier to administer the dose 
to the child, I observed several instances where a noticeable amount of residue remained in 
the glass/cup. Caregiver-child interaction and communication were limited during treatment 
administration and the event often took place in complete silence.  
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CHAPTER 9 
Phase 2 - Discussion 
Introduction 
In Phase 2 I recruited children aged younger than five years with different virological 
outcomes to determine the barriers and facilitators of treatment administration practices by 
caregivers to young children on ART. Ecological models, like EST, favour behaviour-specific 
approaches to interventions, such as improving adherence to ART amongst children younger 
than five years. By focusing on specific behaviours, EST allows for the identification of the 
most relevant factors influencing a particular health behaviour at each level (Glanz et al., 
2008). Thus, by using EST in this thesis I was able to identify factors at the micro-, meso, 
exo- and macrolevel influencing adherence to ART among children younger than five years in 
a rural area of South Africa. According to Bronfenbrenner (1979), the social ecology of 
human development requires an understanding of the mutual transactions that take place 
between the individual and the environmental systems they interact with across their lifespan 
(Bronfenbrenner, 1979). This discussion is situated predominantly within the micro- and 
mesosystem of Bronfenbrenner’s model. The discussion begins at the level of the 
mesosystem. 
While Bronfenbrenner’s EST provides a useful framework to structure the levels at 
which interventions may be targeted, individual level theories provide useful insights into the 
ways in which the targeted interventions may be delivered. As argued by Glanz et al. (2008), 
“Ecological models can incorporate constructs from models that focus on psychological, 
social, and organizational levels of influence to provide a comprehensive framework for 
integrating multiple theories, along with consideration of environments and policy in the 
broader community” (p 466-467). For example, the IMB model of adherence offered by 
Fisher et al. (2006) may be used to understand and reflect on several of the factors 
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influencing adherence within the child’s micro- and mesosystems as identified in Phase 2 of 
this research. The IMB model of adherence as proposed by Fisher et al. (2006) emphasizes 
the importance of accurate information and motivation in the form of perceived self-efficacy 
to perform the behaviours necessary to achieve optimal levels of adherence. Furthermore, the 
model focuses on how information, motivation and behavioural skills factors are 
“conceptually and empirically linked to adherence and specifies situational and personal 
factors” (p.463). In this discussion the IMB model by Fisher et al. (2006) serves to provide an 
understanding and explanation of some of the findings from Phase 2 of this research.  
Mesosystem determinants of paediatric adherence to ART 
The results demonstrated that at the mesolevel, barriers to and facilitators of 
adherence to ART were best understood as a result of factors related to caregiver-child dyad 
interactions with adherence counsellors, caregiver knowledge of ART, household context, and 
adjustment to daily routine.  
Caregiver-child dyad interactions with adherence counsellors 
The previous discussion chapter identified and contextualized the influence of 
adherence counsellors on adherence to ART at the level of the exosystem. Adherence 
counsellors proved to be key in influencing adherence behaviours, but are not adequately 
trained and supported to provide adherence counselling that could influence behaviour to 
improve adherence. The unstructured training sessions and lack of follow-up and debriefing 
of counsellors were considered factors beyond the control of the counsellors, but nonetheless 
something that influences the level of psychosocial support and adherence counselling that 
they are able to offer patients during routine counselling sessions. The adherence counselling 
observations in Phase 2 provide support for these arguments.  
As mentioned previously, adherence counsellors themselves are known to receive 
short periods of unstandardized training with little to no follow-up in the form of supervision, 
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monitoring and debriefing (Petersen et al., 2014). The limited training that counsellors 
receive place them at a relative disadvantage to engage with patients in a supportive manner 
that may improve patients’ adherence to ART. For example, findings from Phase 2 show that 
although adherence counsellors were able to report children’s CD4 counts and VLs to the 
caregiver, they failed to interpret and follow up on instances where an unsuppressed VL was 
reported. The absence of probing skills suggests that adherence counsellors were unable to 
facilitate counselling sessions in a way that identified difficulties in medication 
administration and supported adherence to ART.  
These data concur with other evidence highlighting the relative inadequacy of 
adherence counsellors to recognize and follow up on issues during adherence counselling 
sessions that require further investigation (Kagee, 2013). For example, Kagee (2013) has 
trained eight female patient advocates (PAs) with counselling skills in the process of 
working with an NGO that provides psychosocial services to ART users. None of the 
women had completed high school and neither had more than two years of counselling 
experience. The women were self-selected from the NGO and received nine 2-hour-long 
training workshop that aimed to teach them basic counselling skills and allowed them to 
practice these skills. PAs’ skills were then assessed via the Counsellor Evaluation Form 
(CEF) and the Counsellor Rating Form – Short (CRF-S). Scores on the evaluation forms 
indicated that PAs had some, but not sufficient skills to perform several of the counselling 
activities they were assessed on, such as reflecting on patients’ feelings and confronting 
incongruities as they happened. Kagee (2013), however, did not conduct a baseline 
assessment of PAs’ skills level, so it is not clear to what extent the training improved PAs’ 
counselling skills and improved adherence to ART.  
On the basis of these findings, and in keeping with the EST that emphasizes the 
cross-cutting effects of multilevel influences on behaviour, one may assume that the poor 
Stellenbosch University  https://scholar.sun.ac.za
  
220 
 
skills level associated with adherence counsellors in this setting is likely to expla in the 
poor skills level associated with some of the caregivers’ treatment administration 
practices observed in Phase 2. This point is further discussed under the heading 
‘Caregiver knowledge of ART’. 
In addition to the absence of adequate counselling skills with which to facilitate 
counselling sessions, adherence counsellors’ lack of communication during consultation may 
be the result of burnout amongst counsellors. As argued by Gibson et al. (2005), burnout 
amongst counsellors may manifest in an emotional disconnect from the patients they see 
(Gibson et al., 2005). In this context, burnout may be due to the sheer volume of patients 
adherence counsellors are expected to counsel on a daily basis. Also, as shown in this study 
and others (Dewing et al., 2015), structural barriers such as inadequate space and privacy to 
perform adherence counselling may influence adherence counsellors’ engagement with their 
patients. In Phase 1, adherence counsellors stated that they had limited interaction with 
children as they were often left outside the consultation room and excluded from medication 
consultations. Yet, in Phase 2 the majority of children had been present in the consultation 
rooms. My accompaniment of caregiver-child dyads to the adherence counselling sessions 
may have resulted in caregivers choosing to bring the child into the consultation where they 
otherwise might not have. However, even with children present in the room, little attempt was 
made to include them in the counselling session. The presence of children in the consultation 
provides an opportunity to include them in the consultations about their treatment. By doing 
so, children can receive age-appropriate information regarding their treatment that may be 
beneficial to support disclosure as they get older. Early and age-appropriate disclosure has 
been shown to be beneficial for adherence to ART (Vreeman et al., 2013).  
During observation, caregivers seemed to be reserved in their engagement with 
counsellors and rarely volunteered information about difficulties they might have been 
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experiencing with the treatment or problems they had with the child on their own. The lack of 
caregivers’ reporting of difficulties associated with treatment measurement and 
administration may be as a consequence of a perceived sense of self-efficacy in the face of 
little monitoring of their knowledge and skills by adherence counsellors. A perceived sense of 
self-efficacy may also explain why some caregivers in Phase 1 reported that the pre-ART 
education sessions they received were enough for them, while doctors, nurses and counsellors 
stated that caregivers required more education and training. Apart from literature reporting on 
the feasibility of counsellors to provide behavioural interventions to ART users (Dewing et 
al., 2012; Kagee, 2013; Petersen et al., 2014), very limited evidence of routine patient-lay 
counsellor interactions exist within the context of HIV with which to compare these findings. 
However, evidence of patients’ experiences with healthcare staff at public healthcare facilities 
may provide explanations for limited engagement of caregivers during consultations. Studies 
of patients’ experiences at public healthcare facilities show that patients often have 
antagonistic relationships with healthcare staff and experience them as being rude and 
unsympathetic (Coetzee et al., 2011; Kagee et al., 2012). 
Caregiver knowledge of ART   
According to the IMB model of adherence offered by Fisher et al. (2006), 
“…information that is relevant to adherence to HAART is a prerequisite of consistent and 
correct use of therapy” (p.463). Thus, adherence to ART may be facilitated when an 
individual is provided with the correct and accurate information necessary to adhere to the 
regimen optimally. In the case of caregivers to children on ART, this information may be 
related to accurate knowledge regarding the exact amount of a medication to measure, what 
type of medication tool facilitates this type of measurement and what best the way is to 
administer this to an infant and/or a child. Alternatively, missing or inaccurate knowledge 
about treatment may inadvertently be a barrier to adherence (Fisher et al., 2006). The lack or 
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absence of knowledge or information necessary for optimal adherence may cause caregivers 
to appear careless during treatment administration, especially in instances where they use 
medication tools inappropriately or the correct responses to medication side effects had not 
been properly explained to them.   
Although the caregivers observed in this study were not receiving the adequate level 
of adherence counselling to facilitate adherence, low levels of health literacy among adults 
and caregivers of children on ART has also been associated with medication dosing errors 
among patients and caregivers in LMIC (Ciampa et al., 2012; Howard et al., 2014). Of the 
respondents engaged with in Phase 2, a large proportion (22 out of 33) of caregivers did not 
complete high school. As alluded to in Phase 1, the largest proportion of information transfer 
to caregivers regarding ART treatment occurred during the pre-ART education sessions. The 
sessions themselves are knowledge-intensive and occurred over a short period of time, often 
within a day, and were usually conducted by adherence counsellors.  
Findings from Phase 2 demonstrate that caregivers of children on ART were 
knowledgeable about some aspects of the medication, but lacked the necessary skills with 
which to perform accurate measurements of the doses. According to IMB (Fisher et al., 2006) 
information is a necessary condition for behavioural change, but it is not sufficient to bring 
about that change in itself. Motivation to adhere and behavioural skills are necessary as well. 
Behavioural skills, as Fisher et al. (2006) have argued, “… determines whether even well-
informed and motivated individuals will be capable of adhering to HAART” (p.464). 
Behavioural skills therefore include the caregivers’ abilities to perform accurate 
measurements and their perceived level of self-efficacy to adhere to the regimen.  
While caregivers used medication tools such as syringes and medication cups to 
measure doses of the medications, they lacked the necessary skills required for performing 
accurate measurements, such as dose checking (especially checking that all of the content of 
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dissolved tablets and capsules were administered) and removing bubbles in syringes. These 
findings concur with other studies assessing dosing accuracy among patients on ART 
(Howard et al., 2014; Yin et al., 2010). Howard et al. (2014) have assessed paediatric dosing 
accuracy among adult ART users (aged 18 - 49 years) from Mozambique. Participants were 
given clearly marked syringes and measuring cups together with a prescription card and 
verbal instructions. Participants were instructed to measure a hypothetical dose of AZT 
suspension [2.5 mL (25 mg)] using both measurement tools. Doses were electronically 
weighed for accuracy, and defined as no error if the dose was within 20% of the reference 
weight; some error if the dose deviated by more than 20% from the reference weight, and 
major error if the dose deviated by more than 40% from the reference weight (reference 
weight in Yin et al., 2010). Using the measuring cup, 49% (157/316) made some error, of 
which 28.4% made a major dosing error. Using syringes, 47.8% made some error, of which 
27.9% made a major dosing error. The majority of dosing errors using the medication cup 
was due to over-dosing, while the major dosing errors with the syringes were due to under-
dosing. Given the absence of dose checking when using syringes among caregivers in this 
study, and the number of bubbles observed in syringes, it is likely that several of the 
measured doses were below the required measurement. Only two of the caregivers (of 
children newly initiated on ART) were asked to demonstrate measurements of formulations 
using syringes in the adherence counselling sessions. Although tablets and capsules may be 
dissolved in water, halved and crushed (Department of Health South Africa, 2013b), failure to 
administer the entire contents of the dissolved dose may contribute to unsuppressed VL’s 
among children who received their medications in this way. Children with suppressed VLs, 
however, were observed swallowing their tablets whole. The inability to accurately 
administer a dissolved tablet and capsule medications to children with unsuppressed VLs 
supports the IMB theory in that “…adherence to therapy is directly linked with individual 
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health outcomes (e.g., viral load, CD4 count, drug resistance, physical health, and subjective 
health and quality of life…” (p.464).  
Caregiver consistency  
The presence of a caregiver, especially a stable caregiver, who is able to respond to 
the physical and emotional needs of a child has been shown to influence health and cognitive 
outcomes in children (Richter, 2004). As seen in this study and similar contexts in South 
Africa (Sikstrom, 2014), as well as other African societies (Vreeman et al., 2009; Skovdal et 
al., 2011), caregiving as a definition is best described as a dynamic concept as children often 
have various biological or non-biological individuals responsible for their care. In Phase 1 
respondents shared concerns about multiple caregivers and knowledge transfer regarding 
dose changes and other treatment-related information. In Phase 2 there were two instances of 
children who had moved away to live with other family members. Evidence shows that 
disruptions in household structure, which may come about from the unavailability of a single 
consistent caregiver and disorganized family structures, are likely to contribute to poor 
adherence (Cupsa et al., 2000).  
Social support during treatment administration 
In Phase 2, children predominantly received their medications from the individual 
who attended clinic visits. However, medication responsibilities appeared to be shared among 
household members as some caregivers had support (referred to as treatment supporters) from 
other household members during treatment administration. Unlike other studies that suggest 
that shared responsibility may act as a barrier to adherence to ART (Fetzer et al., 2011), the 
findings of this study suggest that shared responsibility was facilitative of adherence to ART 
and may represent a form of social support. The IMB model posits (Fisher et al., 2006) that 
motivation to adhere requires personal as well as social motivation. Social motivation in the 
context of these findings was demonstrated by the facilitative role that household members 
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played during the treatment event. Social support has been linked to improved adherence to 
ART (DiMatteo et al., 2002).  
Poverty and food insecurity 
The findings in Phase 1 demonstrated a reluctance on the part of caregivers to 
administer ART in the absence of food as this exacerbates side effects such as vomiting. The 
findings from Phase 1 thus suggested that caregivers were likely to forgo treatment 
administration if food was not available. However, in Phase 2, I seldom saw caregivers 
administer food to the child before medication was given. Furthermore, there was little 
evidence that food had been prepared or given to the child prior to our arrival at the 
household. 
The lack of food and the subsequent administration of medication suggest the 
caregiver’s willingness to administer treatment without food. Caregivers’ willingness to 
adhere to ART in the absence of available resources has often been associated with what Olds 
et al. (2015) have referred to as the ‘Lazarus effect’ (p.586). Based on the observable 
improvements in children’s health due to ART use, caregivers may be less inclined to miss 
treatment out of fear that the child may become progressively ill. However, given the journal 
entries made by some of the caregivers reflecting the importance of providing food to the 
child before treatment administration, it is likely that my presence in the household played a 
part in caregiver’s willingness to administer the medication. Thus, under normal 
circumstances caregivers may likely forgo treatment administration if there is no food 
available in the home. The latter statement is reflective of findings in the literature (Weiser et 
al., 2010; Young et al., 2014).  
Stigma and disclosure  
Disclosure in the context of paediatric HIV is complex and challenging in many ways. 
Disclosure not only involves disclosure of a child’s HIV status to them, but also to other 
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members of the household and the family. Furthermore, disclosure also often involves a 
discussion of the caregiver’s HIV status with the child and others (Vreeman et al., 2013). 
Although caregivers in Phase 2 reported that the other members of the household were aware 
that the child was taking treatment, I never fully ascertained whether the household members 
had been fully disclosed to. The impact of the lack of disclosure to members outside the 
house was evident when I was unable to visit certain households in the evening, or when 
caregiver-child dyads had moved into new homes. In a study by Marhefka et al. (2008), it 
was uncommon for families to disclose the child’s status to people outside of the immediate 
family (Marhefka et al., 2008). Several studies suggest that caregivers of CLWH prefer to 
keep the status of the child concealed from family members, other close relations, as well as 
from the children themselves (Wachira et al., 2012; Bikaako-Kajura et al., 2006). As 
mentioned previously, in instances where children reside with their biological fathers, 
caregivers were reluctant to disclose the HIV status of the child to the fathers and often go to 
great lengths to maintain the health of the child in order to allay suspicion from their partners. 
In Phase 2, I observed one instance of discrimination towards a child on ART. During the 
evening visit the caregiver had opted to administer the medication to the child in the child’s 
bedroom as opposed to the kitchen area where it had been done previously as the caregiver’s 
brother was home and did not want an HIV infected child around his own children. As seen in 
other studies, failure to disclose the child’s HIV status to husbands or family members 
deprives caregivers of a valuable source of social support. For example, others in the 
household could remind them to administer medicines and could also administer medicines in 
their absence (Wachira et al., 2012; Kimani-Murage et al., 2013).  
Factors influencing integration into daily routine  
Failure to maintain a structured routine has been shown to impact on treatment 
administration (Fetzer et al., 2011; Hamammi et al., 2004). Hammami et al. (2004) have 
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described three factors necessary for caregivers to successfully integrate ART into their daily 
routines based on information they gathered from adherent versus non-adherent caregivers to 
children on ART. In order to be adherent, caregivers need sufficient knowledge of the benefits 
of adherence and should be successfully convinced of the reasons why medication-taking was 
essential. Secondly, caregivers had to believe that they were capable of administering the 
medication (capacity) and lastly, they had to demonstrate a willingness to administer the 
medication (motivation). These elements were necessary in order for medication-giving to be 
a priority in their lives (Hammami et al. 2004). In their study, adherent caregivers internalized 
knowledge about the medication, making the information their own and stating their 
understanding of the treatment in their own words, as opposed to reporting what they were 
told by health personnel as less adherent caregivers would do (Hamammi et al., 2004).  
Findings by Hammami et al. (2004) have also shown that for successful integration of 
ART into their daily routines, caregivers had to be 1) proactive in recognising and 
implementing creative strategies to provide ongoing reminders to administer the medication, 
and 2) able to foresee possible situations where treatment was likely to be disrupted. The 
findings from the study by Hammami et al. (2004) support the component of the IMB model 
(Fisher et al., 2006). Accurate knowledge, motivation and behavioural skills were therefore 
necessary for caregivers to adapt medication to their daily routines.  
Caregivers in Phase 2 of this study showed a preference for storing the child’s 
medication in the bedroom. The medication was either hidden, when it was kept in a plastic 
bag within a cupboard, or not hidden when visibly displayed on a bedside table or table in the 
room. The preference for keeping the medications out of sight was also noted when 
caregivers did not refrigerate LPV/r, which requires refrigeration. Although caregivers were 
not explicitly asked why they chose to store medications in this way, one might presume that 
caregivers were hiding the medications from small children or from visitors. Keeping 
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medications hidden may prevent caregivers from accessing cue-based strategies, such as 
visibility of the medications for reminder purposes (Marhefka et al., 2008). Although many of 
the caregivers actively checked their cell phones before measurements and administration, 
only two had programmed their cell phone alarms to go off at specific times. Marhefka et al. 
(2008) have argued that in addition to memory or cue-based strategies, caregivers had to 
better integrate treatment-related activities into their daily routine. Thus, in keeping with IMB 
theory without visible or audible reminders, caregivers are likely to forget to administer 
medications should their routine be disrupted in anyway (Fisher et al., 2006).   
The literature shows that children in resource-limited settings, in South Africa in 
particular (Moodley et al., 2006), are not informed of their HIV status until adolescence 
(Vreeman et al., 2013). Despite available guidelines on disclosure, caregivers have frequently 
reported that children under 10 years are too young to be told of their status and show very 
little understanding of medication and illness (Vreeman et al., 2013). 
However, children in this study demonstrated both an understanding and observable 
comfort with their medications. Despite one instance of a child attempting to run away during 
the treatment event, none of the children in this study cried when presented with their 
medication, not even those children newly-initiated on ART and presumably still adjusting to 
taking medications every day. Furthermore, several children were able to self-administer their 
medication (after it had been measured out by a caregiver) or take part in treatment-related 
activities such as packing medications away. Thus, on a microlevel, some of the children 
(specifically those aged five years) in this study showed medication competence in that they 
were able to take ownership of their medications and successfully inject syringes filled with 
medication into their mouths.  
These observations coincide with the observations made by Rochat et al. (2008) in 
their sample of children aged five years and under. In this study 48 child-caregiver dyads 
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from South Africa were enrolled in a qualitative study aimed at better understanding 
children’s (younger than five years) experiences of HIV and their treatment. In an attempt 
to include children within this age group in the research, the authors used a series of 
visual aids to facilitate children’s’ involvement and responses. Thus, children used toy 
dolls and medication tools (e.g. syringes, spoons, cups) to demonstrate not only their 
comfort with the medication and the medication tools, but also their knowledge of 
treatment administration practices. Children showed very little discomfort with the 
treatment and took a keen interest in activities related to medication adherence (Rochat et 
al., 2008). There is evidence to suggest that children with increased shared responsibility in 
their own treatment are better able to integrate the medication routine into their daily 
routine (Hamammi et al., 2004; Marhefka et al., 2008; Fetzer et al., 2011). In their study, 
Marhefka et al. (2008) have examined the relationship between adherence to ART and family 
factors associated with medication taking, one of which was regimen responsibility. 
Caregivers of 127 children aged 2 to 15 years (mean = 7.8 years old) were interviewed about 
treatment responsibility and whether administration of medication was done solely by 
themselves, or whether the children assisted with this responsibility. Caregivers stated that 
older children often had more control of taking their own medication and shared regimen-
related tasks with them. Marhefka et al. (2008) have argued that allowing children to assume 
increasing responsibility for medication-taking as they became older presented them with the 
opportunity to prepare for self-care in adolescence and adulthood, as increased responsibility 
was likely to leave children feeling a greater sense of self-efficacy in taking their treatment 
(Marhefka, 2008). Amongst older children (children aged 9 years and above), complete 
disclosure has been shown to be appropriate, beneficial to parent-child relationships, and 
associated with better adherence to ART (Vreeman et al., 2013).  
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As children grow older they tend to become more active in their roles as members of a 
household and to participate in daily routines. Children subsequently become able to regulate 
their own behaviour and establish confidence from being able to master these routines 
(Richter et al, 2004). Children’s ability to easily, successfully and independently take 
medication at a young age is likely to facilitate the transition from partial responsibility 
for their treatment as young children, to full responsibility of their treatment as 
adolescents and adults.  
Microsystem determinants of paediatric adherence to ART 
The results demonstrated that at a microlevel, caregiver-child interactions during 
treatment administration practices were best understood as a result of factors related to the 
characteristics of the child, caregiver knowledge of ART, communication during medication 
administration, household context, and adjustment to daily routine.  
Child characteristics  
Despite palatability concerns among respondents in Phase 1, most children in 
Phase 2 took their medications without resistance. While access to flavouring agents for 
unpalatable formulations, such as LPV/r, was not always readily available, some caregivers 
were observed to adopt specific strategies such as administering the bitter tasting 
medication to the child first, followed by the sweeter medicines to facilitate dose 
administration. However, inconsistent knowledge of dose administration was evident 
amongst those caregivers who failed to re-administer doses when a child vomited the 
medication. In keeping with earlier discussions, poor knowledge of dose re-administration 
by caregivers is likely the result of the poor quality of adherence counselling provided to 
caregivers, as well as poor communication between caregivers and healthcare staff. In 
keeping with IMB, the absence of accurate information is likely to contribute to poor 
adherence to ART (Fisher et al., 2006).  
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Communication during medication administration 
In this study the treatment event (i.e. the time during which medication was being 
measured and administered to the child) was observed to be a silent process between the 
caregiver and child. Very few instances of verbal communication took place during the 
treatment event even when a child was observed to have difficulty swallowing the 
medication. Further, the treatment event took place very quickly, especially amongst the 
infants and children ≤ 3 years of age. Drawing on theories of child development, such as 
attachment theory as described by Bowlby (1969), the importance of caregiver sensitivity and 
responsiveness during periods of caregiver-child interaction is extremely important.  
Typical examples of intense interactions between caregivers and infants occur during 
daily care routines such as feeding, bathing and dressing the infant. Evidence from 
observational studies on these interactions suggest that “… even brief interactions are 
nonetheless regarded as highly emblematic of the quality of the early relationship between 
caregiver and child” (Richter, 2004, p. 14). Considering the importance of even brief intense 
interactions, one cannot underscore enough the importance of the interactions between the 
caregiver and the child during medication administration enough. For children on chronic 
medications this process may then be considered as important as feeding and cleaning, as it 
occurs multiple times a day every single day. Furthermore, medication administration has the 
potential to create a stressful situation for a child where they need to overcome challenges 
such as swallowing distasteful medications like LPV/r.  
Caregivers of CLWH are continuously confronted by the challenges associated with 
poverty, such as limited resources and food, which contributes substantially to the 
psychosocial stressors they experience, often as sole providers for themselves and other 
family members (Rochat et al., 2008). These stressors may lead to emotional disengagement 
and disrupt the caregiver’s alertness and responsiveness to important cues. An emotionally 
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distant caregiver may be unresponsive to the stress and discomfort exhibited by a child during 
a process such as this. It may consequently limit their potential to bond with the child 
(Richter, 2004). Insecure attachments have been coupled with problem behaviour in children, 
difficulty socialising with peers, and an inability to solve problems. CLWH who show 
problem behaviours may worsen as they face increased exposure to emotionally and 
psychologically compromising situations such as learning about their HIV status and being 
exposed to stigma and discrimination.  
Conclusion 
The findings of Phase 2 emphasise key elements within children’s micro- and 
mesosystems that act as either barriers to or facilitators of adherence to ART. Ecological 
theories of health are often criticized for lacking specific mechanisms through which to 
address the factors identified at each level. In this discussion I have argued that the findings 
here that pertain to the barriers and facilitators to adherence among children younger than 
five years as identified within the micro- and mesosystems may be understood and explained 
by the IMB theory (Fisher et al., 2006).  
Based on the IMB model proposed by Fisher et al. (2006), if caregivers to children on 
ART are well-informed about ART, are motivated to act and have the necessary behavioural 
skills to achieve optimal adherence, they will be more likely to maintain these adherence 
behaviours over time. However, the findings highlighted several ways in which each of these 
necessary components are disrupted. In keeping with Bronfenbrenner’s EST disruptions in 
any one of the systems is likely to have cascading effects throughout each of the other 
systems. Thus, caregiver knowledge about ART as demonstrated in this thesis is partially a 
consequence of the information provided to them from adherence counsellors. The findings 
show that adherence counsellors were ill-equipped to provide adequate adherence 
counselling, which was a consequence of the lack of structured training and support 
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programmes for adherence counsellors. Caregivers in this study, however, demonstrated 
motivation to provide ART, and had support from household members when doing so. 
However, given the fact that some medications were hidden, one can deduct that integration 
of ART into daily life is problematic. This causes a lack of access to reminder cues, which 
influences behavioural skills. As mentioned previously, merely satisfying one dimension of 
the IMB is not sufficient for behavioural change.  
Limitations and strengths 
The findings of Phase 2 have to be interpreted against the strengths and limitations 
inherent to the research. Although necessary given the methods used in Phase 2, the sample 
was limited as only caregivers whose co-household residents knew about the child’s status 
were recruited. The findings provide data on routine adherence counselling sessions that 
caregivers and children on ART receive. However, the observations were only based on a 
small number of adherence counselling sessions conducted at one peri-urban and one rural 
decentralized public healthcare facility in rural KwaZulu-Natal. My presence in the 
counselling sessions and participant homes undoubtedly biased some of the observations. 
However, I tried to limit the potential bias through multiple visits to participant homes. 
Furthermore, evidence from Phase 1 suggests that the observations during the counselling 
sessions match the perspectives on adherence counselling as held by doctors. Thus, 
caregivers may, in fact, experience more challenges to treatment administration than what I 
observed. The caregiver-child cohort represented children at varying levels of disease 
progression. Knowledge of children’s VLs allowed for an advanced qualitative understanding 
of adherence behaviour and provided age-specific information that may contribute to 
intervention development and are described in the concluding chapter.  
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CHAPTER 10 
Conclusion 
Introduction 
The findings from Phase 1 and Phase 2 have significant relevance in the context of 
paediatric HIV and emerging drug resistance among infants and young children on ART in 
South Africa. The study triangulated interview and focus group data that probed the 
perspectives of doctors, nurses, adherence counsellors, caregivers and traditional healers with 
observational data from adherence counselling sessions and treatment administration 
practices by caregivers to children on ART at their homes.  
Findings from this study emphasize the importance of qualitative studies and 
explanatory factors that might not be captured through conventional quantitative means. The 
study differs from the other qualitative research conducted on barriers and facilitators to 
paediatric adherence as it included a naturalistic observation phase which took me into the 
homes of children presumed to be doing well on treatment (suppressed VLs), children 
presumed to be doing poorly on treatment (unsuppressed VLs), and children who were newly 
adjusting to life-long therapy (newly initiated on ART). The documentation of moment-to-
moment occurrences as they unfolded within the household context provided important 
insights into the way ART was being integrated into children’s lives, the relative involvement 
(or lack of involvement) of household members, caregiver knowledge and comfort with the 
routine and the availability of resources. 
The findings provide new knowledge in the following areas: 1) the combined 
perspectives from key stakeholders in the treatment and care of children on ART on the 
barriers and facilitators to adherence to ART among children younger than five years; 2) 
empirical observations of barriers and facilitators of ‘routine’ treatment administration 
practices by caregivers to children younger than five years on ART in their homes; and 3) 
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empirical observations of ‘routine’ adherence counselling sessions with caregivers of children 
younger than five years on ART.  
Microsystem 
Through the lens of EST, the findings highlight the complexity of factors influencing 
paediatric adherence within children’s ecological environments. At the microlevel, children 
younger than five years have difficulty with the palatability of liquid LPV/r, which is a 
concern in the face of limited treatment options available to children in South Africa. More 
research is needed to develop palatable ARV formulations for infants and young children on 
ART. Taste-masking and pill-swallowing interventions have contributed suggestions for 
strategies with which caregivers may deal with these issues (Bain-Brickley et al., 2011). 
However, these interventions have not been shown to improve adherence to medication in 
children. In keeping with IMB theory (Fisher et al., 2006), knowledge is a necessary but 
insufficient condition for behavioural change. Thus, findings from this study show that 
caregivers need additional knowledge on skills associated with measuring and administering 
the medications to improve dosing accuracy. Furthermore, re-iterating knowledge of dose re-
administration after vomiting or spitting may improve adherence to ART. Counselling 
interventions thus have to be structured into sessions where adherence counsellors are 
educated on the barriers and facilitators that influence paediatric adherence to ART at the 
level of the child, caregiver, and medication.  
In addition, at the microlevel, a lack of disclosure of the child’s HIV status among 
relevant family members has negative health implications for the child. At present several 
disclosure interventions are aimed at caregivers and children. These interventions are targeted 
at facilitating disclosure of children’s HIV status to them, and of caregivers’ HIV status to 
their infected and/or uninfected children (Vreeman et al., 2013). Future research should be 
aimed at finding ways to facilitate disclosure of the child’s HIV status between those 
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responsible for both clinic attendance and treatment administration. Healthcare workers have 
to assist caregivers with identifying all those who may share responsibility in the treatment 
and care of children on ART and provide ways to facilitate communication between them. 
Given the major influence of mobile technologies on improving adherence to ART among 
adults (Nieuwlaat et al., 2014), healthcare workers could mobilize this technology to facilitate 
communication amongst those involved in the child’s treatment and care.   
Despite increased parental survival rates, elderly caregivers still provide care to 
children in this area and they are uniquely challenged by their own age to meet the caring 
needs of infants and young children. Counselling interventions may help to support elderly 
caregivers by strengthening the caregiver-child, as well as the caregiver-caregiver 
relationships though communication strengthening and social support amongst caregivers.  
Fathers are still largely absent from the lives of young children in this area. However, 
in this research, paternal presence in the context of ART seemed to negatively influence 
adherence to ART. Future research exploring fathers’ understandings of child care in the 
context of HIV is needed. Such research should be aimed at exploring paternal knowledge 
and beliefs about ART and what could be done to improve their understanding of the benefits 
associated with optimal adherence.  
Children continue to be excluded from medical consultations, which limits their 
ability to become active agents of their own treatment. Children’s comfort level and their 
ability to demonstrate ownership of their treatment indicates the potential to involve 
children as soon as possible in activities surrounding their treatment.  
These findings suggest that, unlike caregiver and healthcare provider beliefs, children 
younger than five years are able to and should be encouraged to take part in activities 
surrounding their illness. Although children under five years may be too young to process full 
disclosure, these findings as well as those of Rochat et al. (2008),) show that young children 
Stellenbosch University  https://scholar.sun.ac.za
  
237 
 
know about their medications and want to be involved in the treatment administration 
practices. Thus, partial disclosure to children at this age is possible and should be encouraged 
amongst caregivers. Although full disclosure may not be age-appropriate to children 
younger than five years, gradual involvement in treatment-related activities may facilitate 
partial disclosure and eventually full disclosure at an appropriate age.  
Healthcare workers such as nurses and counsellors that regularly interact with 
caregivers need to prioritize child involvement and encourage this involvement amongst 
caregivers as well. Regular attendance of the child can foster ongoing communication with 
healthcare staff and children can easily take ownership and some responsibility early on. 
Structural barriers, such as money for transport for a child to attend monthly clinic visits with 
the caregiver and school attendance may challenge this in future. However, if there is good 
integration with the system from an early age this may buffer adherence challenges when the 
child is older. 
Food insecurity presents an overwhelming challenge to adherence and caregivers are 
likely to forgo treatment in the absence of food. More research is needed to evaluate and 
determine the extent to which improving food security may lead to improvements in 
adherence to ART (Young et al., 2014).   
Mesosystem 
At the mesolevel, language barriers and caregiver irregularity at the clinics limit 
opportunities for rapport building. Caregiver consistency is important and may take the form 
of regular monitoring of the person attending clinic, monitoring regular communication 
between caregivers, and ensuring that treatment-related recommendations are effectively 
passed on to the person responsible. Caregivers then have to ensure that treatment knowledge 
is transferred to all those involved so that the response is family orientated. 
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Exosystem 
At the exolevel, unstandardized training of adherence counsellors and rushed pre-ART 
education sessions challenge opportunities to provide caregivers with knowledge and skills 
necessary to adhere optimally. Thus, more efforts are needed to standardize and improve the 
training counsellors receive and provide support and debriefing to them in the form of regular 
supervision. Furthermore, given the various roles of lay health personnel in the South African 
healthcare system, it is necessary to allocate specific roles to each of the health workers. Thus 
some may purely do administrative work, while others provide adherence counselling. The 
organization of roles will provide counsellors with a renewed purpose in their role. Evidence 
shows that counsellors can be trained to provide psychosocial support and adherence 
counselling to ART users (Petersen et al., 2014). However, in the absence of regular follow-
up training and supervision the intervention sessions provide little sustainable use. Providing 
adherence counsellors with regular support and debriefing is likely to improve morale, which 
has shown to facilitate HIV care provision to patients (Kagee, 2013). Furthermore, to 
facilitate counsellors’ consultations with patients the healthcare system should be an 
environment structured with suitable support to help alleviate the challenges patients may 
face.  
Macrosystem 
At the macrolevel, traditional medicines presented some barriers to adherence to ART. 
A better integration and understanding of the role of traditional healers in HIV treatment and 
care is needed. Available evidence (Appelbaum Belisle et al., 2015) has suggested that 
traditional healers in South Africa are cognisant of the role and importance of ARVs. 
However, given their limited understanding of the contra-indications of their herbal remedies 
on health outcomes, healthcare staff and researchers have to prioritize knowledge transfer in 
high prevalence areas, like KwaZulu-Natal.  
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Conclusion 
As the only effective treatment for HIV, adherence to ART remains the most important 
intervention to date to manage the sheer volume of individuals that are HIV infected globally. 
Infants and young CLWH are uniquely challenged as they face various developmental and 
age-related factors through the course of their illness that affect adherence to ART. In the 
context of prolonged lifespans due to ART, it has become increasingly important to manage 
the transition to non-communicable disease and co-morbid illness. Subsequently, ensuring 
age-appropriate and targeted interventions from a young age is crucial to mitigating this 
transition. For children younger than five years, adherence is largely dependent on a caregiver 
who faces several additional factors that influence their ability to provide treatment and care 
to children on ART. The findings from this research demonstrate the importance of 
understanding context-specific and age-specific factors that influence adherence to ART 
among infants and young children. By stratifying these factors according to the micro-, meso-
, exo- and macrolevels at which they occur, targeted interventions may be developed. 
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APPENDICES 
Appendix A – Interview flyer 
Dear__________________________________ 
I would like to invite you to take part in an interview that will be about the role of primary 
caregivers in administering ART to children under 5 years old. I would like to know what 
difficulties they experience and also what things make it easy for them to administer medication 
to such a young child. 
You have indicated that __________________________________ are usually quiet days at 
the clinic. I would like to contact you again in order to visit you on one of these days for an 
interview. 
Please contact me if you need any more information at 072 241 5028. 
Best wishes 
Bronwyne Coetzee 
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Appendix B – Informed consent (doctor/nurse) 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
Doctor/Nurse 
TITLE OF THE RESEARCH PROJECT: 
Barriers to and facilitators of paediatric adherence to antiretroviral therapy (ART) 
amongst children ≤ 5 years in rural South Africa 
REFERENCE NUMBER: S12/05/135 
PRINCIPAL INVESTIGATOR: Bronwyne Coetzee 
CONTACT NUMBER: 072 241 5028 
You are being invited to take part in a research project. Please take some time to read the 
information presented here, which will explain the details of this project. Please ask the study 
staff or doctor any questions about any part of this project that you do not fully understand. It 
is very important that you are fully satisfied that you clearly understand what this research 
entails and how you could be involved. Also, your participation is entirely voluntary and you 
are free to decline to participate. If you say no, this will not affect you negatively in any way 
whatsoever. You are also free to withdraw from the study at any point, even if you do agree to 
take part. 
This study has been approved by the Health Research Ethics Committee at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical Practice and 
the Medical Research Council (MRC) Ethical Guidelines for Research. 
What is this research study all about? 
This project aims to identify both problems faced (barriers) when administering antiretroviral 
medication to young children (by caregivers), as well as useful information (facilitators) that 
may be passed on to other families under similar circumstances. Health professionals (like you) 
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will be invited to take part in-depth interviews. The interviews will be semi-structured- which 
means that questions may be added or removed depending on how the interview flows, and 
guided by the interviewer (Bronwyne) in order to obtain as much information as possible. I 
will ask mostly open-ended questions to learn your understanding of the factors that children 
who receive antiretrovirals (ARVs) from caregivers face. 
Why have you been invited to participate? 
You have been invited to participate because you have been identified as a doctor/nurse that 
provides treatment (medical or psychological) to young children receiving ART through the 
assistance of a primary caregiver.  
What will your responsibilities be? 
You will have no direct responsibilities. However, I would like to encourage you to actively 
participate in this interview and answer all the questions that you feel comfortable with 
answering as truthfully as possible. 
Will you benefit from taking part in this research? 
There are no direct benefits; however future patients are likely to benefit from the outcomes of 
this research. 
Are there in risks involved in your taking part in this research? 
There are no physical risks involved in participating in this research.  
What will happen in the unlikely event of some form injury occurring as a direct result 
of your taking part in this research study? 
No foreseeable injury will occur from taking part in this study. 
Will you be paid to take part in this study and are there any costs involved? 
 
No, you will not be paid to take part in the study. There will be no costs involved for you, if 
you do not take part. 
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Is there anything else that you should know or do? 
You can contact the Health Research Ethics Committee at 021-938 9207 if you have any 
concerns or complaints that have not been adequately addressed by your study doctor. 
You can also contact me (the principal investigator) if you have any questions: 072 241 5028  
You will receive a copy of this information and consent form for your own records. 
Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled (insert title of study). 
I declare that: 
I have read or had read to me this information and consent form and it is written in a language 
with which I am fluent and comfortable. 
I have had a chance to ask questions and all my questions have been adequately answered. 
I understand that taking part in this study is voluntary and I have not been pressurised to take 
part. 
I may choose to leave the study at any time and will not be penalised or prejudiced in any way. 
I may be asked to leave the study before it has finished, if the study doctor or researcher feels 
it is in my best interests, or if I do not follow the study plan, as agreed to. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2013. 
Signature of participant Signature of witness 
Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
I explained the information in this document to ………………………………….. 
I encouraged him/her to ask questions and took adequate time to answer them. 
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I am satisfied that he/she adequately understands all aspects of the research, as discussed above 
I did/did not use a interpreter.  (If a interpreter is used then the interpreter must sign the 
declaration below. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2013.
    
Signature of investigator Signature of witness 
Declaration by interpreter 
I (name) ……………………………………………..……… declare that: 
I assisted the investigator (name) ………………………………………. to explain the 
information in this document to (name of participant) 
……………..…………………………….. using the language medium of Afrikaans/Xhosa. 
We encouraged him/her to ask questions and took adequate time to answer them. 
I conveyed a factually correct version of what was related to me. 
I am satisfied that the participant fully understands the content of this informed consent 
document and has had all his/her question satisfactorily answered. 
Signed at (place) ......................…........…………….. on (date) …………....……………….. 
    
Signature of interpreter Signature of witness 
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Appendix C - Doctor-nurse interview schedule  
INTERVIEW GUIDE 
Doctor/nurse Interview Guide     
         Moderator:    
Site:_____________________________________   Note-taker:    
 
Number of participants:       Transcriber: 
  
Date:    
Start time:         End time:    
Thank you for agreeing to take part in this study. In this interview I am going to ask you some 
questions about your experience in treating children with HIV and also what you think of the 
roles of caregivers in pediatric adherence to ART are. I am specifically interested in what you 
think the barriers and facilitators to adherence to ART amongst children (specifically children 
younger than 5 years) are, and the influence of the role of caregivers on this. 
Can you please state your position here: 
Please tell me about your experience/relationship with children who receive ART (What is your 
role)? 
 
 
 
Please tell me about your experience/relationship with the caregivers of children who receive 
ART (What is your role)? 
 
 
 
What do you think are the experiences of caregivers and children (under 5) when they come to 
the clinic? What in your opinion are some of the relationship dynamics between child and 
caregiver that you can observe from your time with them? 
 
 
 
What do you think is the hardest part for children (<5) in taking their medication? [Do they 
take their medication? If they don’t, what do they do with it?] 
 
 
 
What other things make it difficult for them to take their medication? Is it harder to give the 
meds in the morning or the evening? Why? 
 
 
 
What things make it easy for children to take their medication? 
 
 
 
What other things make it easy for them to take their medication? 
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What in your opinion is the role of a caregiver? 
 
 
 
Who do you find is normally the caregiver of children receiving ART? 
 
 
 
What things make it difficult for a caregiver to fulfill this role? (Do you think they understand 
the regimen- do they know how to read the prescriptions/understand what the doctors/nurses 
are saying? Do they know how to administer the drugs/who shows them how?) 
 
 
 
What things make it easy for a caregiver to fulfill this role? Are there caregivers that you have 
seen that have come up with methods that you think other caregivers should know about? 
 
 
 
Is there anything someone would like to add to the discussion, or share their thoughts about?  
 
 
 
-Some drugs need to be kept in fridges- if they don’t have fridges what do you advise? 
- Do caregivers come to you with problems about administrating drugs? How do you advise 
them? 
-In the counseling session what methods do you use to train caregivers in measuring/ making 
up doses for children? 
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Appendix D – Focus group flyer 
Dear _____________________________ 
I would like to invite you to take part in a focus group on _____________________________ 
at _______________________________ time. 
The focus group will be an hour long (at the most) and will be about the role of caregivers in 
administering antiretroviral therapy to children under 5 years old. 
I will reimburse your travel costs, and supply you with a light lunch on the day. 
Please contact me if you need any more information at 072 241 5028. 
Best wishes 
Bronwyne Coetzee 
0722415028 
Sawubona_______________________ 
Ngithanda ukukumema uba ubeyingxenye yeqoqo 
ngomhlaka_______________________indawo 
________________________________isikhathi. 
 
Lengxoxo izothatha isikhathi esingangehora, imayelana nendima edlalwa abanakekeli 
bezingane ekunikezeni ngemishanguzo kubantwana abaneminyaka engaphansa kwemihlanu 
(5). 
Ngiyonibuyisela imali yenu yokugibela, ngiphinde ngilethe nokuncane okuya ngasethunjini. 
Uma ufuna emininingwane nokunye, ngicela uxhumane nami ku 072 241 5028. 
Izilokotho ezinhle 
u-Bronwyne Coetzee  
0722415028 
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Appendix E - Informed consent - caregiver focus group 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
Focus Groups 
TITLE OF THE RESEARCH PROJECT: 
Barriers to and facilitators of paediatric adherence to antiretroviral therapy (ART) 
amongst children ≤ 5 years in rural South Africa 
REFERENCE NUMBER: S12/05/135 
PRINCIPAL INVESTIGATOR: Bronwyne Coetzee 
CONTACT NUMBER: 072 241 5028 
You are being invited to take part in a research project. Please take some time to read the 
information presented here, which will explain the details of this project. Please ask the study 
staff or doctor any questions about any part of this project that you do not fully understand. It 
is very important that you are fully satisfied that you clearly understand what this research 
entails and how you could be involved. Also, your participation is entirely voluntary and you 
are free to decline to participate. If you say no, this will not affect you negatively in any way 
whatsoever. You are also free to withdraw from the study at any point, even if you do agree to 
take part. 
This study has been approved by the Health Research Ethics Committee at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical Practice and 
the Medical Research Council (MRC) Ethical Guidelines for Research. 
What is this research study all about? 
This study will look at problems faced (barriers) when giving antiretroviral medication to 
young children, as well as useful information (facilitators) that may be passed on to other 
families who experience the same problems. People that play an important role in the lives of 
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young children receiving antiretroviral medications (like you) will be invited to take part in a 
focus group discussion. The interviews will be semi-structured and guided by the interviewer 
(Bronwyne) so that we can understand as much as possible about this. I will ask mostly 
questions that will allow you to answer with as much information as you can to learn your 
understanding of the problems faced amongst children who receive medication from a 
caregiver. 
Why have you been invited to participate? 
You have been invited to participate because you have been identified as playing an 
important role in the lives of young children receiving ART. 
What will your responsibilities be? 
You will have no direct responsibilities; however I will encourage you to actively participate 
by answering the questions that I ask, express your opinions honestly, and also respond to 
questions or discussions that are raised by other members of the group. 
Will you benefit from taking part in this research? 
There are no direct benefits; however future patients are likely to benefit from the outcomes 
of this research. 
Are there in risks involved in your taking part in this research? 
There are no physical risks involved in participating in this research. However, if you 
experience any discomfort from taking part in this research I will report this to Dr Bland who 
will then make a suitable referral to a clinician that will address your concerns. 
Who will have access to your medical records? 
We will not need access to your medical records.  
What will happen in the unlikely event of some form injury occurring as a direct result 
of your taking part in this research study? 
No foreseeable injury will occur from taking part in this study. 
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Will you be paid to take part in this study and are there any costs involved? 
No, you will not be paid to take part in the study, but relevant out-of-pocket expenses will be 
covered for each study visit. There will be no costs involved for you, if you do not take part. 
Is there anything else that you should know or do? 
You can contact the Health Research Ethics Committee at 021-938 9207 if you have any 
concerns or complaints that have not been adequately addressed by your study doctor. 
You can also contact me (the principal investigator) if you have any questions: 072 241 5028  
You will receive a copy of this information and consent form for your own records. 
Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled (insert title of study). 
I declare that: 
I have read or had read to me this information and consent form and it is written in a 
language with which I am fluent and comfortable. 
I have had a chance to ask questions and all my questions have been adequately answered. 
I understand that taking part in this study is voluntary and I have not been pressurised to take 
part. 
I may choose to leave the study at any time and will not be penalised or prejudiced in any 
way. 
I may be asked to leave the study before it has finished, if the study doctor or researcher feels 
it is in my best interests, or if I do not follow the study plan, as agreed to. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2013. 
 
Signature of participant Signature of witness 
Declaration by investigator 
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I (name) ……………………………………………..……… declare that: 
I explained the information in this document to ………………………………….. 
I encouraged him/her to ask questions and took adequate time to answer them. 
I am satisfied that he/she adequately understands all aspects of the research, as discussed 
above 
I did/did not use a interpreter.  (If a interpreter is used then the interpreter must sign the 
declaration below. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2013. 
 
Signature of investigator Signature of witness 
Declaration by interpreter 
I (name) ……………………………………………..……… declare that: 
I assisted the investigator (name) ………………………………………. to explain the 
information in this document to (name of participant) 
……………..…………………………….. using the language medium of Afrikaans/Xhosa. 
We encouraged him/her to ask questions and took adequate time to answer them. 
I conveyed a factually correct version of what was related to me. 
I am satisfied that the participant fully understands the content of this informed consent 
document and has had all his/her question satisfactorily answered. 
Signed at (place) ......................…........…………….. on (date) …………....……………….. 
 
Signature of interpreter Signature of witness 
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Appendix F - Caregiver focus group guide  
         Moderator:    
Site:_____________________________________   Note-taker:    
 
Number of participants:       Transcriber: 
  
Date:    
Start time:         End time:    
Thank you for agreeing to take part in this study. In this interview  
We are interested in the kinds of things that make it difficult for you to provide the child with 
his/her ARV medication around medication times. 
1. Please tell me about your experience with giving medicine to a child as their caregiver. 
2. How would you describe your relationship with the child? 
3. What difficulties do you think the child has? 
4. What would make it easier for them? 
5. What are the main problems that you have when you have to give the child their 
medication? 
6. Is there anything you can think of that would make it easier for you to give the child 
their medicine? 
7. If these changes were made (mention the suggestions the participant gave in above), 
can you tell me how it would be different or better for you in terms of giving the child 
their medication? 
8. Is there anything that we haven’t talked about that you want to say about any of these 
issues? 
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Appendix G - Counsellors focus group guide  
 
         Moderator:    
Site:_____________________________________   Note-taker:    
 
Number of participants:       Transcriber: 
  
Date:    
Start time:         End time:    
Thank you for agreeing to take part in this study. In this interview  
We are interested in the kinds of things that make it difficult for caregiver’s to provide the child 
with ARVs around medication times. 
Please tell me about your experience/relationship with the caregivers of children who receive 
ART (What is your role)? 
 
 
 
What do you think are the experiences of caregivers and children (under 5) when they come to 
the clinic? What in your opinion are some of the relationship dynamics between child and 
caregiver that you can observe from your time with them? 
 
 
 
What do you think is the hardest part for children (<5) in taking their medication? [Do they 
take their medication? If they don’t, what do they do with it?] 
 
 
 
What other things make it difficult for them to take their medication? Is it harder to give the 
meds in the morning or the evening? Why? 
 
 
 
What things make it easy for children to take their medication? 
 
 
 
What other things make it easy for them to take their medication? 
 
 
 
What in your opinion is the role of a caregiver? 
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Who do you find is normally the caregiver of children receiving ART? 
 
 
 
What things make it difficult for a caregiver to fulfil this role? (Do you think they understand 
the regimen- do they know how to read the prescriptions/understand what the doctors/nurses 
are saying? Do they know how to administer the drugs/who shows them how?) 
 
 
 
What things make it easy for a caregiver to fulfil this role? Are there caregivers that you have 
seen that have come up with methods that you think other caregivers should know about? 
 
 
 
Is there anything someone would like to add to the discussion, or share their thoughts about?  
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Appendix H - Traditional healer focus group guide  
         Moderator:    
Site:_____________________________________   Note-taker:    
 
Number of participants:       Transcriber: 
  
Date:    
Start time:         End time:    
Good morning/good afternoon and thank you very much for taking the time to meet with me 
today. I have learnt from other researchers that you are a valued allied health provider and that 
many members of the community seek your advice and guidance when it comes to various 
things. I think that many of them may tell you things that they may not tell a doctor or a nurse 
and that is why I would like to speak to you today. I am specifically interested whether you 
give advice to mothers and caregivers of children with HIV when it comes to taking the 
medication every day. 
So, I am interested in learning more about the influence that you have on the adherence 
behaviours of very young children (under 5 years old) receiving ART in the community. I am 
also interested in learning more about the barriers (the things that make it difficult to take the 
medication) and the facilitators (the things that help with taking medication) to adherence to 
ART. 
 
How often do you come into contact with caregivers of children who receive ART? 
 
Can you tell me about your experience in consulting with caregivers of children who receive 
ART? 
 
What role do you play in his/her life? 
 
What problems do caregivers usually come to you with? 
 
How do you generally advise these caregivers on solving these problems? 
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What do you see as the most important factors that act as barriers to caregivers when they 
provide children with their medications? (spend time here probing) 
 
What do you see as the most important factors that act as facilitators to caregivers when they 
provide children with their medications? 
 
Potential probes: 
Do you generally think that caregivers provide medications in the way that they are supposed 
to? 
 
Why do you think they might not be providing the medication in the correct ways? 
 
What do you think would help them to make medication time easier? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
  
288 
 
Appendix I - Caregiver consent form  
 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
Caregivers 
TITLE OF THE RESEARCH PROJECT: 
Barriers to and facilitators of paediatric adherence to antiretroviral therapy (ART) 
amongst children ≤ 5 years in rural South Africa 
REFERENCE NUMBER: S12/05/135 
PRINCIPAL INVESTIGATOR: Bronwyne Coetzee 
CONTACT NUMBER: 072 241 5028 
You are being invited to take part in a research project. Please take some time to read the 
information presented here, which will explain the details of this project. Please ask the study 
staff or doctor any questions about any part of this project that you do not fully understand. It 
is very important that you are fully satisfied that you clearly understand what this research 
entails and how you could be involved. Also, your participation is entirely voluntary and you 
are free to decline to participate. If you say no, this will not affect you negatively in any way 
whatsoever. You are also free to withdraw from the study at any point, even if you do agree to 
take part. 
This study has been approved by the Health Research Ethics Committee at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical Practice and 
the Medical Research Council (MRC) Ethical Guidelines for Research. 
What is this research study all about? 
This study will look at how children and the person giving their medication to them (you) 
interact. By studying this we will hopefully see what problems there are (if any) when the 
medicine is given to the child. We will also hopefully see what useful information can be 
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gathered by the way medication is given to the child. We hope to pass the useful information 
on to other families under similar circumstances. This is an observational study, which means 
that I will be present in your home for three mornings (when it best suits you) and for three 
evenings (when it best suits you) for 2hours at a time to observe you and your child during the 
times that you give medications to the child. I will also go with you (should this suit you) to 
one clinic visit and to one counselling visit for observation as well. I would like to invite 60 
children and caregivers to participate in this study. This study will be conducted in Mtubatuba, 
in the homes of participants who consent. Should you agree, I would like to video record these 
observations in addition to the field notes that I will be taking. Identifying characteristics (e.g 
face) will be removed from the footage. 
Why have you been invited to participate? 
You have been invited to participate because you have been identified as a caregiver to a child 
that receives antiretroviral therapy.  
What will your responsibilities be? 
You will have no direct responsibilities. However, it will be important that you continue with 
your daily routines (as close to reality as possible) in my presence.  
Will you benefit from taking part in this research? 
There are no direct benefits; however future patients are likely to benefit from the outcomes of 
this research. 
Are there in risks involved in your taking part in this research? 
There are no physical risks involved in participating in this research. If however you realise 
that you do not feel comfortable with the amount of time that I am spending in your home you 
can report this to me, and I will adjust to your needs.  
 
Who will have access to your medical records? 
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We will not need access to your medical records. However, Dr Ruth Bland (primary clinician 
at your clinic) may need to refer to your file. No other person involved in this research will 
have access to any personal/ identifying information in your medical records. 
What will happen in the unlikely event of some form injury occurring as a direct result 
of your taking part in this research study? 
No foreseeable injury will occur from taking part in this study. However, if you experience any 
discomfort from taking part in this research I will report this to Dr Bland who will then make 
a suitable referral to a clinician that will address your concerns. 
Will you be paid to take part in this study and are there any costs involved? 
No, you will not be paid to take part in the study, but out-of-pocket expenses will be covered 
for each study visit. There will be no costs involved for you, if you do not take part. 
Is there anything else that you should know or do? 
You can contact the Health Research Ethics Committee at 021-938 9207 if you have any 
concerns or complaints that have not been adequately addressed by your study doctor. 
You can also contact me (the principal investigator) if you have any questions: 072 241 5028  
You will receive a copy of this information and consent form for your own records. 
Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled (insert title of study). 
I declare that: 
I have read or had read to me this information and consent form and it is written in a language 
with which I am fluent and comfortable. 
I have had a chance to ask questions and all my questions have been adequately answered. 
I understand that taking part in this study is voluntary and I have not been pressurised to take 
part. 
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I may choose to leave the study at any time and will not be penalised or prejudiced in any way. 
I may be asked to leave the study before it has finished, if the study doctor or researcher feels 
it is in my best interests, or if I do not follow the study plan, as agreed to. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2013. 
Signature of participant Signature of witness 
Declaration by investigator 
I (name) ……………………………………………..……… declare that: 
I explained the information in this document to ………………………………….. 
I encouraged him/her to ask questions and took adequate time to answer them. 
I am satisfied that he/she adequately understands all aspects of the research, as discussed above 
I did/did not use a interpreter.  (If a interpreter is used then the interpreter must sign the 
declaration below. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2013. 
Signature of investigator Signature of witness 
Declaration by interpreter 
I (name) ……………………………………………..……… declare that: 
I assisted the investigator (name) ………………………………………. to explain the 
information in this document to (name of participant) 
……………..…………………………….. using the language medium of Afrikaans/Zulu. 
We encouraged him/her to ask questions and took adequate time to answer them. 
I conveyed a factually correct version of what was related to me. 
I am satisfied that the participant fully understands the content of this informed consent 
document and has had all his/her question satisfactorily answered. 
Signed at (place) ......................…........…………….. on (date) …………....……………….. 
Signature of interpreter Signature of witness 
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Appendix J - Home visit 1 observation schedule 
Home Visit #1 
Baseline observation of house and occupants 
 
What does the structure of the house look like? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
_____________________ 
How many people live in this house? 
___________________________________________________________________________
___________________________________________________________________________ 
How many bedrooms are there? 
___________________________________________________________________________
___________________________________________________________________________ 
Is there running water/ a bath/toilet etc…? 
___________________________________________________________________________ 
Where is the child’s medication kept? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
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___________________________________________________________________________
_____________________ 
 
Where is the child’s medications usually administered? 
___________________________________________________________________________
___________________________________________________________________________ 
 
At what time has the medication been administered? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
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Appendix K - Home visit 2 and 3 observation schedule and video recorder  
 
Home Visit # 2 and 3 
Details:__________________________________________________ 
________________________________________________________ 
How is the child called to the medication area? 
___________________________________________________________________________
___________________________________________________________________________ 
How is it administered (liquid-form/pill form)? 
___________________________________________________________________________
___________________________________________________________________________ 
How does the caregiver go about measuring volumes of medication if liquid formulations are 
made? 
___________________________________________________________________________
___________________________________________________________________________ 
How does the caregiver interact with the child during administration of the medication? 
___________________________________________________________________________
___________________________________________________________________________ 
How does the child interact with caregiver during administration of the medication? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
What are the main concerns expressed by the child during administration of the medication? 
 
___________________________________________________________________________
___________________________________________________________________________ 
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How does the caregiver respond to this? 
___________________________________________________________________________
___________________________________________________________________________ 
 
How long does it take to administer the medication? 
___________________________________________________________________________
___________________________________________________________________________ 
Does the child have something to eat before or after taking medication? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
Is there only one person involved in the activities surrounding the administration of the 
medication to the child? 
___________________________________________________________________________
___________________________________________________________________________ 
Summarise step-by-step the steps involved in administering the treatment to the child based on 
footage and observation: 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
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___________________________________________________________________________
___________________________________________________________________________ 
Medication specific observations: 
What measurement tool is being used? 
Syringe 
Spoon 
Cup 
None 
How many mills of liquid formulation are being given? 
___________________________________________________________________________
___________________________________________________________________________ 
How many of each tablet is being given? 
___________________________________________________________________________
___________________________________________________________________________ 
How clearly is the measuring tool marked? 
___________________________________________________________________________
___________________________________________________________________________ 
After 3rd visit assess caregiver knowledge 
Ask caregiver to recall medication names  
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
Ask caregiver to recall dose 
amount_____________________________________________________________________
___________________________________________________________________________ 
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Ask caregiver whether she thinks she administered the treatment correctly or not? 
___________________________________________________________________________
___________________________________________________________________________ 
Ask caregiver what difficulties she had in giving treatment in the past? 
___________________________________________________________________________
___________________________________________________________________________ 
Ask caregiver how Dr/counsellor prescribed medication? 
___________________________________________________________________________
___________________________________________________________________________ 
Ask caregiver whether she had adjusted this in any way to make it easier for herself? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
Demographic data: 
Age:_____ 
Date of Birth:_____ 
Gender: M/F 
Marital status; 
Single 
Separated 
Widowed 
Divorced 
Married or living with a significant other in a marriage-like relationship 
Current living situation: 
Live alone 
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Live with other adult(s), no children 
Live with other adults and children 
Live with children only 
Live in an institution or retirement home 
 
Level of education: 
No formal education 
Completed primary school 
Attended high school but did not complete matric 
Completed matric 
Attended university, or college or technicon but did not graduate 
Graduated from uni, college or tech 
Current work situation: 
Employed full time 
Unemployed 
Homemaker 
Disabled 
Employed part-time 
Student 
Retired 
Annual income: 
Less than R12000 a month 
R10, 001-R40, 000 
R40, 001- R80, 000 
R80, 001-R110, 000 
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R110, 001-R170, 000 
R170, 001-R240, 000 
R240, 001 and above 
Don’t know 
Grant (R_____)First language? ______________ 
Additional questions: 
Did you receive the three pre-initiation counselling sessions from the ARV counsellor? 
YES/NO 
Are you the only one who brings the child to the clinic? YES/NO 
Who else?__________________________ 
Are you the only person who gives the child his/her medication? YES/NO 
Who else gives the medication?____________________ 
When do you administer the ARVS? MORNING/EVENING/MORNING & EVENING 
Does the child receive other treatment as well? YES/NO 
How many children do you look after? 
Additional Notes: 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
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Appendix L - Counsellor consent form 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
COUNSELLORS 
TITLE OF THE RESEARCH PROJECT: 
Barriers to and facilitators of paediatric adherence to antiretroviral therapy (ART) 
amongst children ≤ 5 years in rural South Africa 
REFERENCE NUMBER: S12/05/135 
PRINCIPAL INVESTIGATOR: Bronwyne Coetzee 
CONTACT NUMBER: 072 241 5028 
You are being invited to take part in a research project. Please take some time to read the 
information presented here, which will explain the details of this project. Please ask the study 
staff or doctor any questions about any part of this project that you do not fully understand. It 
is very important that you are fully satisfied that you clearly understand what this research 
entails and how you could be involved. Also, your participation is entirely voluntary and you 
are free to decline to participate. If you say no, this will not affect you negatively in any way 
whatsoever. You are also free to withdraw from the study at any point, even if you do agree to 
take part. 
This study has been approved by the Health Research Ethics Committee at Stellenbosch 
University and will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical Practice and 
the Medical Research Council (MRC) Ethical Guidelines for Research. 
What is this research study all about? 
This study will look at how children and the person giving their medication to them interact. 
By studying this we will hopefully see what problems there are (if any) when the medicine is 
given to the child. We will also hopefully see what useful information can be gathered by the 
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way medication is given to the child. We hope to pass the useful information on to other 
families under similar circumstances. This is an observational study, which means that I will 
be present in the home of children and their caregivers for three mornings and for three 
evenings to observe how the child receives his/her treatment. I have also received written 
permission from each of the caregivers of the children enrolled in the study whether I can attend 
one routine adherence counselling session with them. During these counselling sessions I will 
observe and document what information caregivers receive from adherence counsellors during 
a typical counselling session and how long the counselling session takes.  
Why have you been invited to participate? 
You have been invited to participate because you have been identified as an adherence 
counsellor that provides routine adherence counselling to children and caregivers attending this 
clinic.  
What will your responsibilities be? 
You will have no direct responsibilities. However, it will be important that you continue with 
your counselling session as you would do normally.  
Will you benefit from taking part in this research? 
There are no direct benefits; however future patients are likely to benefit from the outcomes of 
this research. 
Are there in risks involved in your taking part in this research? 
There are no physical risks involved in participating in this research.  
 
 
What will happen in the unlikely event of some form injury occurring as a direct result of your 
taking part in this research study? 
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No foreseeable injury will occur from taking part in this study. However, if you experience any 
discomfort from taking part in this research I will report this to the Hospital Manager who will 
then make a suitable referral to a clinician that will address your concerns. 
Will you be paid to take part in this study and are there any costs involved? 
No, you will not be paid to take part in the study. There will be no costs involved for you, if 
you do not take part. 
Is there anything else that you should know or do? 
You can contact the Health Research Ethics Committee at 021-938 9207 if you have any 
concerns or complaints that have not been adequately addressed by your study doctor. 
You can also contact me (the principal investigator) if you have any questions: 072 241 5028  
You will receive a copy of this information and consent form for your own records. 
Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled (insert title of study). 
I declare that: 
I have read or had read to me this information and consent form and it is written in a language 
with which I am fluent and comfortable. 
I have had a chance to ask questions and all my questions have been adequately answered. 
I understand that taking part in this study is voluntary and I have not been pressurised to take 
part. 
I may choose to leave the study at any time and will not be penalised or prejudiced in any way. 
I may be asked to leave the study before it has finished, if the study doctor or researcher feels 
it is in my best interests, or if I do not follow the study plan, as agreed to. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2013. 
Signature of participant Signature of witness 
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Declaration by investigator 
I (name) ……………………………………………..……… declare that: 
I explained the information in this document to ………………………………….. 
I encouraged him/her to ask questions and took adequate time to answer them. 
I am satisfied that he/she adequately understands all aspects of the research, as discussed above 
I did/did not use a interpreter.  (If a interpreter is used then the interpreter must sign the 
declaration below. 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2013. 
Signature of investigator Signature of witness 
Declaration by interpreter 
I (name) ……………………………………………..……… declare that: 
I assisted the investigator (name) ………………………………………. to explain the 
information in this document to (name of participant) 
……………..…………………………….. using the language medium of Afrikaans/Xhosa. 
We encouraged him/her to ask questions and took adequate time to answer them. 
I conveyed a factually correct version of what was related to me. 
I am satisfied that the participant fully understands the content of this informed consent 
document and has had all his/her question satisfactorily answered. 
Signed at (place) ......................…........…………….. on (date) …………....……………….. 
Signature of interpreter Signature of witness 
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Appendix M - Counselling observation schedule  
NAME OF CV-CHILD 
COMBO:___________________________________________________________ 
MONTH:___________________________________________________________________
________ 
TIME START:_________ 
TIME END:__________ 
DRAW SET UP COUNSELLING ROOM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. IS CHILD PRESENT? YES/NO 
2. WHAT IS YOUR IMPRESSION OF THE COUNSELLORS MOOD? 
 
 
 
 
 
3. WHAT IS YOUR IMPRESSION OF THE CAREGIVERS MOOD? 
 
 
 
 
 
 
4. WHAT IS ASSESSED IN THIS COUNSELLING SESSION? 
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Appendix N - Ethics 
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Appendix O - CAB approval letter 
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Appendix P – External auditing 
Publication: 
Coetzee, B., Kagee, A., & Bland, R. (2015). Barriers and facilitators to paediatric adherence 
to antiretroviral therapy in rural South Africa: a multi-stakeholder perspective. AIDS 
Care, 27(3), 315–21. doi:10.1080/09540121.2014.967658  
Conferences: 
2015: Oral presentation: Short coming of adherence counselling provided to caregivers of 
children receiving antiretroviral therapy (ART), 7TH SA AIDS CONFERENCE, 09 - 12 
JUNE 2015, ICC DURBAN, SOUTH AFRICA 
2014: Oral presentation: Using video and observation to understand ART administration 
practices amongst children ≤ 5 years in rural KwaZulu-Natal , RuDASA Conference 
Worcester, 21-24 September 
2013: Poster presentation: The Role of The Caregiver (Poster); 8th International Conference 
on HIV Treatment and Prevention Adherence; June 2nd – June 4th 2013; Miami, Florida, 
United States of America;  
2013: Poster presentation: Paediatric Resistance to Antiretroviral Therapy: The Role of The 
Caregiver (Poster); 6th SA AIDS Conference; June 18th – June 21st 2013; Durban; South 
Africa 
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